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Abstract 
DNA replication is continually impeded by endogenous lesions that cause the 
stalling of replication forks.  If left unchecked, this threatens the integrity of the genome 
and may be a driver of cancer development.  Utilizing the Mcm4
chaos3
 mouse model, we 
found that dormant replication origins, which act as backup initiation sites, play a critical 
role in the recovery of stalled replication forks.  A reduced number of dormant origins in 
these mice led to persistently stalled forks, incomplete replication and the mis-
segregation of sister chromatids in mitosis, causing elevated genome instability. 
Mcm4
chaos3/chaos3
 cells also displayed intrinsic activation of the Fanconi anemia 
(FA) pathway, suggesting that it too plays a functional role in fork progression.  Indeed, 
disruption of FA pathway activation in the Mcm4
chaos3/chaos3
 background led to an even 
higher number of persistently stalled forks.  Furthermore, we discovered that a lack of 
dormant origins also leads to delayed replication, as seen by extremely late DNA 
synthesis.  Accordingly, concomitant loss of both mechanisms led to heightened genomic 
instability, causing mice to either die shortly after birth or exhibit accelerated 
tumorigenesis. 
Finally, we investigated if HELQ is perhaps another FA gene by characterizing 
the first Helq mutant mouse model (Helq
gt
).  Helq
gt/gt
 cells/mice displayed modest FA-
like phenotypes such as interstrand crosslink hypersensitivity and hypogonadism, but not 
defects in homologous recombination repair.  Rather, HELQ was found to work in 
parallel to the FA protein FANCC to suppress replication-associated genome instability. 
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CHAPTER I: Introduction 
  
 2 
 
Introduction 
 All of the information required for the formation and maintenance of a human 
organism is stored in its DNA.  The diploid human genome, consisting of 6 billion base 
pairs spread out over 23 pairs of chromosomes, resides in all the nuclei of the trillions of 
cells that make up the human body.  Despite this complexity, research throughout the past 
few decades has provided fascinating insights into how the cell is able to accurately 
duplicate (DNA replication) and maintain (DNA repair) the integrity of all this genetic 
information throughout our lifetimes.  Such information is vital to our understanding of 
human health, as even a single mutation in the genetic code can lead to birth defects, 
genetic disorders or the development of cancer. 
 Replication is made more difficult due to the fact that the DNA can be damaged 
by a number of both exogenous environmental agents as well as endogenous chemical 
alterations during DNA metabolism
1
.  Damaged sites cannot be processed by the high-
fidelity replicative polymerases and if found on the leading strand template, on which 
synthesis is continuous, the replication fork can stall.  If left in this state, large regions of 
the genome could go unreplicated and be lost in subsequent daughter cells.  This would 
lead to the loss of significant amounts of genetic information that could wreck havoc on 
the integrity of the genome. 
To guarantee that replication is complete, cells possess many strategies for the 
recovery of stalled forks
2
.  One solution that seems most simple is to newly initiate DNA 
synthesis at a nearby adjacent region of the DNA.  This is achieved through the firing of 
 3 
 
dormant replication origins that exist in excess throughout the genome.  However, if 
dormant origins are unavailable or prove inappropriate for certain lesions, specialized 
proteins can be recruited to help the fork progress past the lesion.  For example, error-
prone translesion synthesis (TLS) polymerases can be temporarily recruited to directly 
bypass the lesion by inserting any base across from the damaged site.  In addition, a 
homology-directed mechanism can replicate past the lesion in an error-free manner by 
temporarily switching the template to the newly-synthesized sister chromatid strand.  
This requires the homologous recombination (HR) machinery.  Members of the Fanconi 
anemia (FA) pathway may play a key role in regulating these latter two mechanisms, 
though exactly how this occurs remains elusive. 
This chapter will provide pertinent background information regarding how these 
mechanisms promote the complete replication of the genome.  First, we will discuss how 
cells separate the events of “origin licensing” from “origin firing” to achieve precisely 
one new copy of the DNA after replication.  Importantly, excess (“dormant”) origins 
produced through the licensing process are needed to fully complete replication and 
prevent tumors in mice.  We will also discuss how certain regions of the genome called 
common fragile sites (CFSs) are intrinsically difficult to replicate due to a lack of origins 
and thus depend on the FA pathway for their stability.  Multiple lines of evidence suggest 
that the FA pathway plays a critical role in the recovery of spontaneously stalled forks, 
and loss of this pathway leads to the human cancer susceptibility disease Fanconi anemia.  
Finally, the potential role of a candidate FA gene, HELQ, will also be explored.  
Together, this body of information shows how cells utilize a multi-layered system, 
 4 
 
including dormant origins and the FA pathway, to ensure complete replication and 
prevent chromosome instability that may otherwise lead to cancer. 
 
DNA replication: origin licensing and origin firing 
 In order for replication to commence, the DNA double helix must initially be 
opened at special starting loci called replication origins.  In bacteria, such as E. coli, this 
occurs at a single, sequence-specific element.  A single pair of replication forks initiated 
at this site is sufficient to replicate the entire circular genome.  However, the human 
genome is about 700 times larger than the E. coli genome and replication forks proceed 
about 20-fold more slowly.  It would therefore take at least 20 days to achieve one round 
of replication if there were only one origin per chromosome
3
. 
 In order to efficiently replicate larger and more complex genomes, mammalian 
cells activate approximately 30,000-50,000 origins at each S phase
4
.  Accordingly, 
shorter distances between activated origins means less time to complete replication.  
However, this brings the added complexity of making sure that the DNA is fully 
replicated without activating the same origins more than once, which would lead to re-
replication
5
.  Eukaryotic cells solve this problem by temporally separating DNA 
replication into two sequential steps of “origin licensing” and “origin firing”.  While 
origin licensing determines all origin sites exclusively during the late M and early G1 
phases, origins can only be activated to fire upon entry into S phase, during which 
licensing is inhibited. 
 5 
 
 Origin licensing entails the formation of pre-replicative complexes (pre-RCs) at 
prospective origin sites.  This begins when a six-membered origin recognition complex 
(ORC) binds to origin loci.  In the budding yeast Saccharomyces cerevisiae, this occurs 
exclusively at regions containing a specific sequence element called an autonomously 
replicating sequence (ARS)
6
.  In other eukaryotes, however, there are no clear origin 
consensus sequences and the ORC proteins, though evolutionarily conserved, don’t 
maintain their sequence specificity.  Rather, origins appear to be determined by a 
complex combination of general sequence elements (AT-rich regions), chromatin context 
and transcriptional activity
3
. 
 Once ORC is bound to origin sites, two proteins called cell division cycle 6 
(CDC6) and chromatin licensing and DNA replication factor 1 (CDT1) work together to 
load the heterohexameric MCM2-7 complexes onto the chromatin
7-13
.  Comprised of the 
essential, conserved and structurally related minichromosome maintenance proteins 2 
through 7, MCM2-7 is a core component of the replicative helicase
14-19
.  These proteins 
derive their name from the original  screen performed in budding yeast for mutants that 
were unable to fully replicate and thereby maintain mini-chromosomes containing a 
single origin
20
.  As they will later travel with bidirectional replication forks, MCM2-7 
complexes are loaded onto the chromatin as double hexamers
21-23
.  At this point, any 
locus containing a pair MCM2-7 hexamers is considered licensed (complete pre-RC) and 
is competent to initiate firing if activated
24-26
.  It is now understood that a single ORC can 
load several MCM2-7 double hexamers onto origin sites, and it is estimated that there is 
anywhere from a 10- to 40-fold excess of origins that are normally licensed compared to 
 6 
 
the number of ORC-bound sites or the number of functional origins
24,27,28
.  Because this 
vastly exceeds the number of origins which are sufficient to complete replication
29,30
, 
researchers originally referred to this phenomenon as the “MCM paradox”31.  The 
significance of such excess or “dormant” origins will be discussed in detail below. 
Three overall mechanisms are at work in eukaryotic cells to make sure that origin 
licensing is restricted to the late M and early G1 phases.  First, S and M phase specific 
cyclin-dependent kinases (CDKs) function to degrade or re-localize several pre-RC 
components during S phase and mitosis
32-35
.  The other two mechanisms involve the 
regulation of CDT1, which can either be bound and inhibited by the protein Geminin
36-40
 
or targeted for proteolytic degradation by the CUL4/DDB1 ubiquitin ligase
41-43
.  Because 
the anaphase-promoting complex/cyclosome (APC/C), which causes ubiquitin-mediated 
degradation of Geminin and mitotic cyclins, is active during G1 phase
36,44
 and because 
CUL4-DDB1-dependent degradation of CDT1 requires chromatin-bound PCNA
45,46
, 
these three inhibitory mechanisms are inactive in G1 phase so that licensing can occur. 
 Once cells enter into S phase, licensed origins (or pre-RCs) are then converted to 
pre-initiation complexes (pre-ICs) through the recruitment of several “firing factors”.  
Cell division cycle 45 (CDC45) and the GINS complex (GINS stands for “Go, Ichi, Nii 
and San” or “5, 1, 2 and 3” in Japanese) combine with MCM2-7 to form the CMG 
helicase, the complete replicative helicase essential for replication initiation as well as 
elongation
47-54
.  This requires a host of other factors, including the kinases CDC7-DBF4 
(DDK) and CDK.  While DDK phosphorylates multiple MCM subunits
55-58
, CDK 
 7 
 
phosphorylates RECQL4 and Treslin, which work together with TOPBP1 to promote the 
interaction of CDC45 and GINS with MCM2-7
59-63
.  Other factors such as MCM10
64,65
, 
GEMC1
66
, DUE-B
67
 and Idas
68
 also appear to be required for initiation in higher 
eukaryotes, with MCM10 playing an additional role in elongation
64,69
. 
 After pre-ICs have formed, initiation complexes can be completed through the 
recruitment of the replicative polymerases and other replisome components.  Origins can 
then be fired to generate bidirectional replication forks.  Because MCM2-7 hexamers 
travel with each fork as the replicative helicases
70,71
 this returns fired origins to the 
unlicensed state.  Inactive MCM2-7 complexes and other pre-RC components are then 
passively displaced from the chromatin as active replisomes pass through them
30,72,73
.  All 
origins do not fire at once, but are activated throughout S phase (early to late) in a distinct 
program determined by both chromatin context
74-76
 and the availability of limiting firing 
factors
77-81
. 
 
Dormant replication origins 
 As mentioned previously, eukaryotic cells license an excessive number of 
potential origins compared to the number that are needed to complete replication under 
normal conditions.  Still, early studies indicated that reduced MCM levels compromised 
both origin licensing and genome stability in yeast
82,83
, suggesting that excess origins 
might have an important function after all. 
 8 
 
In light of the fact that new origins cannot be licensed once S phase begins, it was 
proposed that this excessive licensing protects cells from the possibility of incomplete 
replication under conditions of replicative stress.  In 2006, Woodward et al. analyzed 
DNA replication kinetics in Xenopus laevis egg extracts in which the chromatin was 
manipulated to be either “minimally licensed” or “maximally licensed”30.  While 
minimally licensed chromatin replicated poorly in the presence of low levels of 
replication inhibitors, maximally licensed chromatin was able to maintain complete 
replication by activating additional origins that would have otherwise remained dormant 
(hence the name “dormant origins”).  Furthermore, the authors showed that treatment of 
Caenorhabditis elegans with a small interfering RNA (siRNA) targeting MCM7 caused a 
drastic hypersensitivity to the replication inhibitor hydroxyurea (HU)
84
, indicating a 
physiologically important role of dormant origins in normal replication.  This led the 
authors to propose a model in which dormant origins can be seen as a method of stalled 
fork rescue, ensuring that no region of the genome gets left unreplicated. 
Shortly after this, two studies using human cancer cell lines provided clear 
evidence that dormant origins play a similar role in mammalian cells
25,26
.  Up to 50% 
depletion of MCM2-7 complexes in these cells had little effect on replication kinetics in 
unperturbed conditions, but co-treatment with replication inhibitors induced chromosome 
instability and cell death.  This suggested a role of dormant origins in preserving genomic 
stability only in the context of replicative stress. 
 9 
 
How exactly dormant origins are activated under stressful conditions was 
confusing for many years due to the actions of the ATR (ataxia telangiectasia mutated 
and Rad3-related) kinase.  In response to stalled forks, such as those induced by 
replication stress, ATR and its downstream effector CHK1 were reported to actually 
inhibit the firing of additional origins
85-88
.  This apparent contradiction was eventually 
resolved in 2010, when it was demonstrated that ATR/CHK1 prevent the global firing of 
new replication clusters while simultaneously stimulating the local firing of dormant 
origins in clusters where replication has already begun
89
.  This allows cells to efficiently 
redirect their limited replication resources to active clusters until full replication is 
achieved
90
.  How cells are able to distinguish between local and global origins remains a 
mystery, though several models have been proposed
91
. 
 
Mcm mutant mouse models 
 The critical role of dormant origins in preserving genomic stability in normal, 
physiological conditions did not become clear until the characterization of several Mcm 
mutant mouse models.  Using a N-ethyl-N-nitrosourea (ENU) mutagenesis screen for 
chromosome instability mutants
92
, Shima et al. identified chaos3 (chromosome 
aberrations occurring spontaneously 3), a mutant allele of the Mcm4 gene
93
.  This allele 
was found to harbor a point mutation encoding a single amino acid substitution (F345I) in 
the MCM4 protein.  This change was found to significantly reduce overall MCM levels 
in mouse embryonic fibroblasts (MEFs) homozygous for chaos3 (Mcm4
chaos3/chaos3
), 
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leading to a lower number of dormant origins.  Mcm4
chaos3/chaos3
 MEFs also showed an 
increased number of chromosome breaks after treatment with aphidicolin (APH), an 
inhibitor of the replicative polymerases α, δ and ε94-96.  Most striking, however, was the 
observation that nearly all Mcm4
chaos3/chaos3
 females succumbed to mammary tumors with 
a mean latency of 12 months, suggesting for the first time that dormant origins play a 
critical role in tumor suppression.  Importantly, these findings proved consistent with 
regards to other MCM subunits, as a hypomorphic Mcm2 allele in mice also leads to 
decreased dormant origin usage and tumorigenesis
97,98
. 
Additional intriguing insights emerged when our lab later discovered that all 
MEFs derived in a C57BL/6J background display intrinsically lower origin densities 
when compared to other backgrounds
99
, suggesting that such replication kinetics are 
genetically controlled.  Mcm4
chaos3
 homozygosity in this context was sufficient to make 
the active origin density even lower and caused semi-lethality in mice.  These findings 
match well with another group that found that incremental increases or decreases in the 
amount of chromatin-bound MCMs can modify the phenotypes of Mcm4
chaos3/chaos3
 
mice
100
.  Namely, decreased MCM levels led to accelerated tumor onset or lethality while 
increased MCM levels significantly delayed tumorigenesis.  Together, these findings 
indicate that it is likely the amount of MCM2-7 complexes loaded on the chromatin that 
directly impacts genome stability, cell viability and tumor suppression. 
 
 11 
 
A lack of active origins induces fragility at CFSs 
 In every human genome, there exist certain loci called common fragile sites 
(CFSs) that are highly prone to chromosome breakage simply due to the fact that they are 
intrinsically difficult to replicate.  These loci were originally identified as sites where 
gaps, breaks or constrictions formed on metaphase chromosomes under conditions of 
mild replicative stress, such as APH treatment
101
.  Breakage at these sites was termed 
CFS “expression” and hundreds of such loci have since been identified in the human 
genome
102
. 
 What makes CFSs particularly difficult to replicate?  There seems to be multiple 
correct answers to this question, none of which are mutually exclusive and may depend 
on the individual locus or cell type being studied
103,104
.  Early studies reported that AT-
rich sequences, due to their ability to form secondary structures, can impede the 
replication machinery and thereby induce fragility in a subset of CFSs
105-108
.  The 
presence of large genes
104,109
 and intrinsically late replication timing
110-112
 also appear to 
correlate with fragility.  Then in 2011, two very elegant studies provided striking new 
evidence that fragility at the FRA3B and FRA16C loci were due to either a paucity of 
replication initiation events
103
 or an inability to activate additional origins after fork 
stalling
108
, respectively.  These contexts sound very much like a reduction in the number 
of dormant origins, and indeed, the latter study found an increase in the expression of 
several CFSs upon knockdown of MCM3
108
. 
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The role of the FA pathway in CFS stability 
Perhaps unsurprisingly, factors required for the stability of stalled replication 
forks, such as ATR and CHK1, have been shown to induce CFS expression when 
absent
113-115
.  This also includes the Fanconi anemia (FA) proteins
116
, which play a 
necessary role in fork stabilization/protection
117-119
.  In 2005, cells deficient for FA 
pathway components were shown to display higher frequencies of CFS expression under 
conditions of replication stress
116
.  Treatment with low doses of replication inhibitors 
induced robust mono-ubiquitination and nuclear localization of FANCD2, key measures 
of FA pathway activation
120
.  Together with the fact that FA pathway activation occurs 
during normal S phase
117,121
, these data strongly implicated the FA pathway in 
responding to spontaneously stalled forks. 
In 2009, it was observed that low levels of APH treatment robustly induced the 
focus formation of the FA proteins FANCD2 and FANCI at CFSs throughout the G2/M 
phases
122
.  This led the authors to propose that FANCD2/FANCI mark sites of unresolved 
replication intermediates that go unrecognized by normal checkpoint processes.  As these 
cells progressed into anaphase, it was found that such FANCD2/FANCI foci actually 
flank structures called DNA ultra-fine bridges (UFBs)
122,123
.  UFBs are thin threads of 
DNA caught between segregating chromosomes that can only be visualized by staining 
for the BLM or PICH proteins
124,125
.  While such structures may be resolved through the 
actions of PICH/BLM and the FA proteins, they might also represent a pathogenic 
consequence of under-replicated loci.  CFS sequences were also reported to be present in 
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micronuclei (MN)
122
, implicating unresolved replication intermediates in chromosome 
mis-segregation as well.  Finally, another group found that under-replicated loci at CFSs 
could manifest as a newly identified form of chromosome instability called 53BP1 
nuclear bodies (53BP1-NBs)
126
.  Though not yet well understood, it was observed that 
CFSs can “rupture” during their passage through mitosis and are then “shielded” by the 
53BP1 protein in the subsequent G1 phase daughter nuclei.  Together, these studies 
reveal that UFBs, MN and 53BP1-NBs are all useful markers of unresolved replication 
intermediates and may be sources of replication-associated genomic instability.  Notably, 
FA mutant cells have been shown to exhibit increased frequencies of MN
123
, 53BP1-
NBs
127
 and UFBs
128
. 
 
Fanconi anemia 
The FA pathway derives its name from the human disease Fanconi anemia, a rare 
genetic disorder that occurs in approximately 1 in every 100,000 births
129
.  The disease is 
characterized at the clinical level by congenital abnormalities, hypogonadism, bone 
marrow failure (BMF) and a heightened predisposition to cancer, particularly acute 
myeloid leukemias and squamous cell carcinomas of the head, neck or ano-genital 
regions
130,131
.  It is genetically heterogeneous with 16 different complementation groups 
having been identified to date, including FANCA, FANCB, FANCC, FANCD1/BRCA2, 
FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ/BRIP1/BACH1, FANCL, FANCM, 
FANCN/PALB2, FANCO/RAD51C, FANCP/SLX4 and, most recently, 
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FANCQ/ERCC4
130,132,133
.  For a subset of patients, no complementation group has yet 
been assigned, indicating that other FA genes are yet to be identified. 
At the cellular level, FA patient cells display a slight accumulation in G2 phase of 
the cell cycle with increased numbers of spontaneous chromosome aberrations
134,135
.  But 
the hallmark of these cells is an exquisite hypersensitivity to agents that produce DNA 
interstrand crosslinks (ICLs), such as mitomycin C (MMC), cisplatin and 
diepoxybutane
136
.  ICLs create a covalent bond between the two DNA strands so that 
they cannot be opened for either replication or transcription.  This makes them extremely 
toxic to replicating cells and  potent chemotherapeutic agents
137
.  ICL-inducing agents 
also cause a drastic increase in chromosome breaks and radial structures in FA cells, and 
are thus used as the standard method of FA diagnosis
138,139
. 
Because of this, the molecular details of FA pathway activation have largely been 
determined by studying its role in ICL repair.  The canonical FA pathway is described as 
having three main tiers.  The first includes the 8 members of the FA core complex 
(FANCA, -B, -C, -E, -F, -G, -L and -M) and their associated co-factors (MHF1, MHF2, 
FAAP20, FAAP24 and FAAP100)
131,140
.  Upon fork stalling, these proteins function 
together as an E3 ubiquitin ligase, of which FANCL is the catalytic subunit
141
, to mono-
ubiquitinate the second tier proteins FANCD2 and FANCI.  This action allows for the 
recruitment of FANCD2/FANCI to the chromatin and is considered the key step for 
pathway activation
120,142,143
.  Proteins comprising the third tier are not needed for 
FANCD2/FANCI mono-ubiquitination and are therefore called the downstream 
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members.  These include FANCD1, -N, -J, -O, -P and -Q.  Several of these factors are 
known to have integral roles in HR and heterozygous mutations in FANCD1, FANCN, 
FANCJ, and FANCO cause susceptibility to breast and ovarian cancers
144-149
.  Mono-
ubiquitinated FANCD2/FANCI coordinates these factors to process the damaged fork.  In 
the case of ICL repair, this involves the excision of the ICL by nucleases
150-154
, bypassing 
the lesion via TLS polymerases
150,151
, and finally repair of the newly created DNA double 
strand break (DSB) by HR using the sister chromatid
155
. 
Given that APH treatment also robustly induces FA pathway activation
116,122,123
, 
the FA pathway may coordinate similar DNA repair mechanisms for the processing of 
non-ICL stalled forks.  This would explain its association with unresolved replication 
intermediates and its requirement for CFS stability.  Such a role would also seem to be 
more pertinent to physiological conditions, as ICLs are apparently very rare in the 
endogenous cellular environment
156
.  Therefore, understanding how the FA pathway 
works at spontaneously stalled forks appears essential for solving the enigmatic 
connection between FA pathway function and the clinical phenotypes of the disease.  It is 
currently thought that cancer predisposition in FA patients stems from increased 
chromosome instability, but how exactly this occurs or what the tumor-driving events are 
remains enigmatic.  Additionally, the FA pathway plays a specialized role in the 
survival/maintenance of hematopoietic stem cell populations
157
, but if this is due to a 
specific repair function of the FA pathway in these cells is unknown.  A pair of recent 
studies may have provided part of the answer by revealing important roles of the FA 
pathway in aldehyde metabolism
158,159
.  Fancd2 homozygous null mutant mice that were 
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deprived of aldehyde dehydrogenase 2 (ALDH2) activity either experienced embryonic 
lethality or succumbed to acute lymphoblastic leukemias at very early ages.  These 
findings suggest that aldehydes, which are present in the endogenous cellular 
environment and can form both crosslink and non-crosslink DNA damage
160-162
, may be 
linked to the phenotypes observed in FA patients. 
The generation of several FA mutant mouse models has also led to a greater 
understanding of the genetics underlying FA.  All models to date have faithfully 
recapitulated the cellular ICL hypersensitivity and hypogonadism seen in FA patients, the 
latter stemming from a reduced number of primordial germ cells
163,164
.  Surprisingly, 
however, these models show subtle, if any phenotypes regarding other developmental 
abnormalities, overt BMF or cancer predisposition
165,166
.  In fact, the most common 
developmental abnormality observed apart from hypogonadism is an increased incidence 
of microphthalmia in a C57BL/6J genetic background
167-170
.  These findings suggest that 
certain differences in the murine genetic model may mask the role of the FA pathway in 
physiological conditions. 
Another strategy that may help us to better understand FA pathway function is to 
identify the yet unassigned complementation groups of FA.  One compelling candidate 
FA gene is HELQ (previously known as HEL308), which encodes the DNA repair 
helicase HELQ.  The Drosophila melanogaster ortholog of HELQ was first identified in a 
screen for ICL hypersensitive mutants
171
.  It was later found to be required for meiotic 
DSB repair
172
, suggesting a role in HR.  Similar functions were shown for the C. elegans 
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ortholog
173,174
, with ICL resistance being epistatic to the FANCD2 ortholog in this 
organism
173
.  Knockdown of HELQ in human cells was shown to confer MMC 
hypersensitivity as well as decreased HR efficiency, the latter being epistatic to 
knockdown of FANCD2
175
.  Finally, GFP-tagged HELQ was found to co-localize with 
RAD51 and FANCD2 foci at stalled replication forks in human cells
176
.  However, up to 
this point there had been no mutant model system in which to study HELQ’s role in 
genome stability or its connection to the FA pathway in mammalian cells. 
 
Replication stress is linked to genomic instability and cancer 
 While genomic instability has long been known to be a hallmark of cancer 
cells
177
, how it is formed and whether it is a significant driver of tumor progression were 
not well understood for decades.  The mutator hypothesis originally proposed that 
precancerous cells acquire mutations in important “caretaker genes” that are necessary 
for genomic stability
178,179
.  The loss of such genes, it was thought, might lead to an 
increased mutation frequency that could drive cancer progression.  This seems to be the 
case for many hereditary cancers
180
, such as mutations in FA genes.  However, large-
scale sequencing studies later revealed that caretaker gene mutations are extremely rare in 
sporadic cancers
181-184
.  Rather, the most commonly mutated genes included TP53 and 
major oncogenes/tumor suppressor genes that regulate cell proliferation. 
 In 2005, a pair of studies made a surprising discovery when they found that 
precancerous lesions actually exhibit a highly activated DNA damage response (DDR), 
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including phosphorylation of ATM, CHK2, histone H2AX and p53
185,186
.  This correlated 
with an increased number of DSBs as well as an increased loss of heterozygosity of CFS 
loci.  A short time later, it was shown that oncogene-induced senescence occurs via this 
same mechanism
187,188
.  This led to the oncogene-induced replication stress model
189
, 
which suggests that activated oncogenes, while driving excessive proliferation, also cause 
perturbed replication kinetics (replication stress).  This leads to a higher number of forks 
stalling and eventually collapsing to form DSBs, particularly at CFSs with reduced origin 
densities.  This in turn hyper-activates the DDR, which serves as a major anti-tumor 
barrier by inducing p53-mediated cell cycle arrest, senescence or apoptosis.  In this 
context, late-stage mutations inactivating the ATM-CHK2-p53 checkpoint axis can lead 
to the uncontrolled proliferation of cells with severely perturbed replication and rampant 
genomic instability.  The fact that CFSs are a major source of the chromosomal 
rearrangements seen in tumors supports this model
104,190,191
. 
 
Summary 
 In summary, cells license an excess of potential origins for DNA replication prior 
to entering S phase.  While only a small subset of these origins is needed to complete 
replication under normal conditions, dormant origins can be activated as backups when 
needed.  Certain genomic loci called CFSs lack a sufficient number of active origins and 
therefore depend on the FA pathway for their stability during replication.  In this way, 
both dormant origins and the FA pathway work in parallel to maintain fork 
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stability/progression and suppress chromosome instability that might otherwise lead to 
cancer. 
 How exactly a loss of dormant origins might confer chromosome instability and 
tumorigenesis in the Mcm4
chaos3
 mutant mouse model had been a mystery.  In 
CHAPTER II, our studies reveal that MEFs homozygous for Mcm4
chaos3
 exhibit a ~60% 
decrease in the number of chromatin-bound MCMs, leading to a substantial loss of 
dormant origins.  We found that this led to an elevated number of persistently stalled 
forks, indicating that dormant origins play a pivotal role in stalled fork recovery even in 
unchallenged S phase.  Unresolved replication intermediates in these cells persisted even 
into M phase, as indicated by an increased number of FANCD2 foci in early M phase, 
suggesting that a number of lesions are not fully replicated upon mitotic entry.  This 
correlated with a higher frequency of chromosome non-disjunction in Mcm4
chaos3/chaos3
 
cells, leading to elevated levels of MN, aneuploidy and chromosome breaks.  These 
findings suggest that stalled fork recovery mediated by dormant origins is required to 
suppress multiple forms of chromosome instability that could promote tumorigenesis. 
 An intrinsically high number of FANCD2 foci in Mcm4
chaos3/chaos3
 cells suggested 
an important function of the FA pathway in stalled fork recovery when dormant origins 
are lacking.  In CHAPTER III, we investigated this functional interaction by disrupting 
the FA pathway in Mcm4
chaos3/chaos3
 cells via a null allele of Fancc (Fancc
-
).  As we 
predicted, Mcm4
chaos3/chaos3
;Fancc
-/-
 MEFs displayed a much greater number of 
persistently stalled forks than either single mutant.  However, we were also surprised to 
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uncover a unique role of dormant origins in replication completion.  A closer examination 
of FANCD2 foci in Mcm4
chaos3/chaos3
 cells revealed that DNA synthesis was still going on 
at these sites in early M phase, indicating delayed replication.  We thus concluded that 
dormant origins are required to preclude the presence of long, origin-poor loci that cannot 
finish replicating until extremely late.  Together, these collective roles of dormant origins 
and the FA pathway in fork progression proved essential for maintaining chromosome 
stability, and almost all Mcm4
chaos3/chaos3
;Fancc
-/-
 mice displayed perinatal lethality in an 
inbred C57BL/6J genetic background.  Surviving mice succumbed to tumors more 
quickly than Mcm4
chaos3/chaos3
 littermates, implicating both mechanisms in tumor 
suppression. 
Finally, the role of mammalian HELQ in relation to the FA pathway was 
unknown.  In CHAPTER IV, we describe the characterization of the first Helq mutant 
mouse model (Helq
gt
).  We found that mice homozygous for this allele exhibited mild 
forms of FA-like phenotypes such as hypogonadism and MMC sensitivity when 
compared to Fancc
-/-
 mutants, despite displaying no defects in FANCD2 mono-
ubiquitination.  Helq
gt/gt
 MEFs also showed no significant reduction in the levels of HR 
when measured in vivo.  Rather, Helq was shown to play an important role in the 
suppression of replication-associated genome instability, as Helq
gt/gt
;Fancc
-/-
 double 
mutant cells exhibited very high levels of spontaneous MN and 53BP1-NBs.  These data 
suggest that Helq acts in parallel to the FA pathway in the recovery of stalled forks.  
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CHAPTER II: Stalled Fork Rescue via Dormant 
Replication Origins in Unchallenged S Phase Promotes 
Proper Chromosome Segregation and Tumor 
Suppression 
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Summary 
Eukaryotic cells license far more origins than are actually used for DNA replication, 
thereby generating a large number of dormant origins. Accumulating evidence suggests 
that such origins play a role in chromosome stability and tumor suppression, though the 
underlying mechanism is largely unknown. Here, we show that a loss of dormant origins 
results in an increased number of stalled replication forks, even in unchallenged S phase 
in primary mouse fibroblasts derived from embryos homozygous for the Mcm4
Chaos3
 
allele. We found that this allele reduces the stability of the MCM2-7 complex, but confers 
normal helicase activity in vitro. Despite the activation of multiple fork recovery 
pathways, replication intermediates in these cells persist into M phase, increasing the 
number of abnormal anaphase cells with lagging chromosomes and/or acentric fragments. 
These findings suggest that dormant origins constitute a major pathway for stalled fork 
recovery, contributing to faithful chromosome segregation and tumor suppression. 
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Introduction 
 Replication origin licensing is a prerequisite for genome duplication, as DNA 
synthesis in S phase initiates exclusively from licensed origins (reviewed in
1
). This 
process is restricted to the late M and early G1 phases, during which heterohexamers of 
the six minichromosome maintenance proteins (MCM2-7) are loaded onto origin 
recognition complex (ORC)-bound chromatin sites (reviewed in
2,3
). In the ensuing S 
phase, origins fire only once, when chromatin-bound MCM2-7 forms a replicative 
helicase complex (CMG complex) with cofactors CDC45 and GINS unwinding the 
DNA
4,5
. Active MCM2-7 complexes are then likely to travel along with ongoing 
replication forks, returning fired origins to the unlicensed state
6,7
. Following S phase 
entry, multiple factors prohibit origin relicensing, thereby preventing rereplication of 
DNA
8
. It should be noted that the majority of replication origins in mammalian cells are 
not defined by specific DNA sequences
9
. 
It is known that an excessive amount of MCM2-7 complex is loaded onto 
respective ORC-bound chromatin sites
10,11
 and that these complexes are presumably 
competent to initiate origin firing if permitted
11-13
. So, while a huge excess of potential 
origins exists throughout the genome in eukaryotic cells, only a fraction of them is 
apparently sufficient for DNA replication
14,15
. Therefore, the role of such excess 
chromatin-bound MCM2-7 complexes has not been well understood. 
Recent studies have investigated the role of these excess origins in human cancer 
cell lines
12,13
. Consistent with an overabundance of MCM2-7 complexes on chromatin, 
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up to 90% depletion of the MCM2-7 proteins had little effect on the densities of active 
origins in unperturbed S phase. However, MCM2-7-depleted cells did exhibit poor 
survival in the presence of low levels of the replication inhibitors aphidicolin (APH) or 
hydroxyurea. These findings suggest that dormant origins licensed by excess MCM2-7 
complexes are most likely used as backups for “emergency” situations by increasing the 
number of replication forks, promoting the completion of DNA replication. However, it 
should be noted that the use of cancer cell lines in these studies might have hindered the 
ability to reveal the true role of dormant origins in vivo, as they exhibit greatly 
upregulated expression of the MCM2-7 proteins
16,17
. Although it was previously thought 
that dormant origins are essentially dispensable in unperturbed S phase
12,13
, we and others 
have reported that a reduced level of MCM2-7 proteins causes spontaneous tumors in 
mice with complete penetrance
18-21
, suggesting that dormant origins play an important 
role in such conditions. These mouse models exhibited a high level of spontaneous 
micronuclei in erythrocytes, a surrogate phenotype for chromosome instability
20,21
. 
However, it remained to be determined whether chromosome instability occurs in other 
types of cells in these mice and how it is generated upon a loss of dormant origins, 
leading to spontaneous tumorigenesis in these mice. 
Here, we used the Mcm4
Chaos3
 allele to investigate the complex role of dormant 
origins in chromosome stability, as the Phe345Ile change encoded by this allele 
compromises the stability of the MCM2-7 complex and leads to a reduced number of 
dormant origins. We found that this loss of dormant origins results in an accumulation of 
stalled replication forks in unchallenged S phase. Furthermore, despite the activation of 
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multiple DNA repair pathways, a significant fraction of stalled forks persist into M phase 
and interfere with chromosome segregation. 
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Results 
Chromatin-Bound MCM2-7 Protein Levels Are Significantly Reduced in 
Mcm4
chaos3/chaos3
 MEFs, Resulting in a Loss of Dormant Origins 
Previously, we reported that Mcm4
Chaos3
 homozygosity causes lower levels of the 
MCM2-7 proteins
21
. As these proteins exist in vast excess of the number of replication 
origins that fire in S phase, we investigated whether Mcm4
Chaos3
 homozygosity also 
causes lower levels of chromatin-bound MCM2-7 proteins in primary fibroblasts (MEFs) 
isolated from Mcm4
Chaos3/Chaos3
 embryos. Western blots (Figure 1A) revealed an 
approximately 60% reduction of all components of the MCM2-7 complex on chromatin 
compared to wild-type cells. Chromatin immunoprecipitation followed by quantitative 
polymerase chain reaction also gave a similarly reduced rate of MCM2 at all specific loci 
examined (Figure S1A). To verify this reduced number of dormant origins 
in Mcm4
Chaos3/Chaos3
 cells, we performed a DNA fiber assay using consecutive dual 
labeling of two kinds of modified dUTPs
22
 (Figure 1B). Previous studies
12,13,19
 have 
demonstrated that a moderate loss of the MCM2-7 complexes from chromatin has little 
effect on active origin density in untreated conditions. Indeed, there was no difference in 
the average origin-to-origin distances between wild-type and Mcm4
Chaos3/Chaos3
 MEFs in 
untreated conditions (49.1 ± 2.6 kb and 49.6 ± 3.8 kb, respectively) (Figures 1C 
and S1B). However, in the presence of APH, which triggers dormant origin firing
12
, the 
average origin-to-origin distance in wild-type cells was reduced to 37.4 ± 1.9 kb, 
significantly smaller than the 41.5 ± 0.97 kb observed in Mcm4
Chaos3/Chaos3
 cells (Figures 
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1C and S1B). These findings collectively support the idea that Mcm4
Chaos3/Chaos3
 cells 
have a significantly reduced number of dormant origins. 
 
Mcm4
Chaos3/Chaos3
 Cells Have an Increased Number of Spontaneously Stalled Forks 
Even in unchallenged conditions, we found that Mcm4
Chaos3/Chaos3
 cells had nearly twice 
as many asymmetric bidirectional forks (one fork being stalled) as wild-type cells 
(Figure 1D). These observations suggest that fork stalling occurs at a higher frequency 
in Mcm4
Chaos3/Chaos3
 cells and may explain why they show reduced levels of replication 
proteins on chromatin, such as proliferating cell nuclear antigen (PCNA) and CDC45 
(Figure 1A). Indeed, we found that an increased number of Mcm4
Chaos3/Chaos3
 cells were 
positive for discrete, bright RPA32 foci (Figure 2A), which form at stalled replication 
forks
23,24
. Moreover, the frequency of Mcm4
Chaos3/Chaos3
 cells positive for RAD17 
phosphorylated at Ser645 (pRAD17)
25
 was increased about 2-fold in untreated conditions 
(Figure 2A). RAD17 is a substrate of ATR and is involved in fork recovery
25
. It functions 
upstream of CHK1, a major effector kinase in the ATR pathway
26
. Previous studies 
reported that MCM depletion compromises checkpoint signaling in human cancer cell 
lines
14,27
. However, Mcm4
Chaos3/Chaos3
 cells exhibited levels of CHK1 phosphorylation at 
Ser345 (pCHK1) similar to wild-type when challenged (Figure S2), suggesting that there 
is no major defect in the ATR-CHK1 pathway. This observation is consistent with data 
from a recent study using Mcm2 hypomorphic mouse cells
19
. Despite relatively consistent 
detection of pRAD17 foci (Figure 2A), pCHK1 was barely detectable in 
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unchallenged Mcm4
Chaos3/Chaos3
 cells (Figure S2). This may indicate that the number of 
stalled forks in Mcm4
Chaos3/Chaos3
 cells is still not sufficient to induce full activation of the 
ATR-CHK1 pathway, allowing cell-cycle progression in the majority of Mcm4
Chaos3/Chaos3
 
cells. Stalled forks can potentially collapse, leading to the formation of double-strand 
breaks (DSBs). Mcm4
Chaos3/Chaos3
 cells exhibited only a modest increase in the formation 
of γH2AX foci, a marker of DSBs28, in S phase (Figure 2B, left). It should be noted that 
only a small percentage of S phase cells were positive for γH2AX foci regardless of 
genotype (Figure 2B). Thus, stalled forks appear to be stably maintained during S phase. 
 
The Phe345Ile Change Impairs the Stability of the MCM2-7 Complex, but Not Helicase 
Activity 
To understand what causes fork stalling in Mcm4
Chaos3/Chaos3
 cells, we measured fork 
velocity using the DNA fiber technique (Figure 1B). Surprisingly, fork velocity was 
actually faster in Mcm4
Chaos3/Chaos3
 cells compared to wild-type (Figure S1C). This 
apparently faster fork velocity could be partially explained by a lower level of fork 
terminations in Mcm4
Chaos3/Chaos3
 cells due to a loss of dormant origins (see Figures S1D 
and S1E). The helicase functions of the MCM2-7 complex are carried out in the CMG 
complex (
4
; A. Costa, I.I., N. Tamberg, T. Petojevic, E. Nogales, M.R.B., and J.M. 
Berger, unpublished data). As the phenylalanine residue mutated in Mcm4
Chaos3/Chaos3
 
cells lies in a highly conserved domain (Figure S3A), we reconstituted 
the Drosophila CMG complex with the same mutant MCM4 to investigate its actual 
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helicase activity. The mutant complex was purified with a stoichiometry identical to 
wild-type (Figure 3A). Interestingly, the mutant CMG was slightly more efficient 
helicase than the wild-type CMG (Figure 3B), which may explain the faster fork speed 
in Mcm4
Chaos3/Chaos3
 cells (Figures S1C and S1D). However, the consistently lower yields 
of the mutant CMG complex prompted us to examine the stability of the mutant MCM2-7 
complex. Wild-type and mutant MCM2-7 complexes were purified and subjected to 
analytical fractionation. While the wild-type complexes were stable, it was clear that the 
mutant complexes dissociated into subfractions (Figure 3C), reflecting a suspected 
weaker association between MCM6 and MCM4 (Figure S3B). Similarly reduced 
interactions between MCM6 and MCM4 were also found in Mcm4
Chaos3/Chaos3
 cells 
(Figure S3C). Therefore, these weaker associations are the most likely cause of the 
instability of the mutant complex, thereby contributing to a decreased amount of MCM2-
7 proteins. Taken together, these data suggest that a loss of dormant origins, rather than a 
defect in helicase activity, is the major cause of stalled fork accumulation 
in Mcm4
Chaos3/Chaos3
 cells. 
 
Mcm4
Chaos3/Chaos3
 Cells Exhibit Significantly Elevated Levels of RAD51 and BLM Foci 
Stalled forks can be rescued by homology-directed repair involving RAD51
29
. We found 
that Mcm4
Chaos3/Chaos3
 cells exhibit a mild increase (~2-fold) in spontaneous RAD51 foci 
formation (Figure 4A) and a drastic increase in foci formation for BLM helicase 
(Figure 4B), another protein involved in stalled fork recovery that counteracts 
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RAD51
30,31
. As yeast mcm mutants exhibit a hyperrecombination phenotype
32,33
, we 
measured the frequency of homologous recombination (HR) events using the FYDR 
(fluorescent yellow direct repeat) transgenic locus system (Figures S4A and 
S4B)
34
. Mcm4
Chaos3/Chaos3
 MEFs exhibited slightly higher frequencies of spontaneous HR 
events at this locus (Figures 4C and S4C), but were not significantly different from wild-
type. Next, we challenged these MEFs with APH, which induces fork stalling and 
RAD51 foci formation (Figure 4A). Unlike treatment with a higher dose of APH (3 µM) 
or camptothecin (CPT), an inducer of DSBs at replication forks
35
 (see Figure S2), a low 
dose of APH did not increase HR events (Figure 4D). Therefore, the rescue of stalled 
forks in Mcm4
Chaos3/Chaos3
 cells may occur via the RAD51/BLM-mediated pathways 
without a significant increase in canonical HR events. 
 
The Occurrence of Replication Intermediates Marked by FANCD2 Sister Foci in 
Prophase Is Markedly Enhanced in Mcm4
Chaos3/Chaos3
 Cells, Leading to an Increased Level 
of Micronucleus Formation 
Recent studies reported that unreplicated regions flanked by two stalled forks can persist 
into M phase and are marked with sister foci of FANCD2, a Fanconi anemia protein that 
presumably directs the resolution of such structures
36,37
. To investigate whether stalled 
forks are resolved before M phase entry in Mcm4
Chaos3/Chaos3
 cells, we examined the 
formation of FANCD2 sister foci in prophase. While FANCD2 sister foci were very 
rarely found in wild-type cells, nearly 50% of Mcm4
Chaos3/Chaos3
 cells were positive for 
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such foci at prophase (Figure 5A). Higher numbers of FANCD2 foci were also observed 
in Mcm4
Chaos3/Chaos3
 cells throughout M phase (Figure S5A). We also found that foci 
formation for FANCI, a critical FANCD2-interacting protein
38,39
, was drastically 
increased in Mcm4
Chaos3/Chaos3
 cells as well (Figure S5B). This drastic increase in 
FANCD2 sister foci was associated with an elevated incidence of aberrant anaphase cells 
containing lagging and/or acentric chromosomes (Figure 5B). In accord with such 
structures in anaphase leading to micronucleus formation
37
, Mcm4
Chaos3/Chaos3
 cells also 
exhibited a 2-fold increase in spontaneous micronuclei MN compared to wild-type cells 
(Figure 5B). This is a relatively small increase compared to the 20-fold increase observed 
in erythrocytes, the original phenotype that led to the identification of Mcm4
Chaos3
 
21
. 
However, this can be attributed to the specific nature of erythrocytes as enucleated cells, 
as MN may occur more frequently in the absence of functional DNA repair and 
checkpoint responses in erythroblasts. 
 
Mcm4
Chaos3/Chaos3
 Cells Exhibit Chromosome Number and Structural Instability in Late M 
Phase 
To understand the extent to which lagging chromosomes contribute to MN formation 
in Mcm4
Chaos3/Chaos3
 cells, we quantitated the number of MN positive for the centromeric 
protein CENP-A
40
. We found that the incidence of CENP-A positive MN is significantly 
elevated in Mcm4
Chaos3/Chaos3
 cells compared to wild-type (Figure 5C), indicating an 
increased level of aneuploidy. Since aneuploid cells are rare and may have a reduced rate 
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of proliferation
41
, we performed interphase fluorescence in situ hybridization (FISH) 
using probes specific to near-centromeric regions of chromosome 16. This revealed not 
only a significant increase in aneuploidy in Mcm4
Chaos3/Chaos3
 cells but also a significant 
increase in tetraploidy (Figure S5C). The exact mechanism responsible for 
tetraploidization has not been determined, but could result from cytokinesis failure 
(Movies S1–S3). Acentric chromosomes resulting from chromosome breaks, on the other 
hand, create CENP-A-negative MN, which were found in ~40% of all MN in 
untreated Mcm4
Chaos3/Chaos3
 cells (compare the MN frequencies in Figures 5B and 5C). As 
reported previously
21
, G-banding analysis of metaphase chromosomes revealed no 
significant increase in spontaneous breaks in Mcm4
Chaos3/Chaos3
 cells. However, it did 
reveal an increase in numerical and structural aberrations in Mcm4
Chaos3/Chaos3
 cells, such 
as translocations and dicentric chromosomes (Figures 5D and S5D). Therefore, it is likely 
that acentric fragments arise after metaphase through the conversion of unresolved 
replication intermediates to DSBs. Indeed, we found a >2-fold increase in the number of 
MN positive for γH2AX foci in Mcm4Chaos3/Chaos3 cells that had just completed mitosis 
(Figure 5E). Interestingly, we also found a significant increase in the number of γH2AX 
foci in the main nuclei of Mcm4
Chaos3/Chaos3
 cells in early G1 phase (Figure S5E). These 
data indicate that unresolved replication intermediates are more susceptible to collapse 
after metaphase, giving rise to DSBs. 
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The Chromosome Instability Seen in Mcm4
Chaos3/Chaos3
 Cells Promotes the Formation of a 
Variety of Spontaneous Tumors 
Previously, we reported that Mcm4
Chaos3/Chaos3
 females in the C3HeB/FeJ (C3H) 
background develop mammary tumors only
21
. Since tumor spectrum is strongly 
influenced by genetic background, as seen in Mcm2 hypomorph mice
19
, we 
bred Mcm4
Chaos3
 into the C57BL/6J (B6) strain to investigate the effect of genetic 
background on Mcm4
Chaos3
 tumorigenesis. All B6 Mcm4
Chaos3/Chaos3
 females succumbed to 
neoplasms by the age of 16 months with a mean latency of 12.4 months (Figure 6A 
and Table S1). However, unlike C3H Mcm4
Chaos3/Chaos3
 females, B6 Mcm4
Chaos3/Chaos3
 
females were highly prone to histiocytic sarcomas. Histiocytic sarcoma is a rare 
malignant proliferation of macrophage-like cells in humans and mice (Figure 6B)
42,43
. We 
also generated 21 F1 Mcm4
Chaos3/Chaos3
 females by crossing B6 congenic (N8) and C3H 
congenic (N8) mice. All F1 Mcm4
Chaos3/Chaos3
 females developed tumors with a mean 
latency of 14.2 months (Figure 6A and Table S2). Histiocytic sarcomas and lymphomas 
were the predominant neoplasms (Figures 6B and 6C), while three mammary 
adenocarcinomas were also observed. These data suggest that the chromosome instability 
seen in Mcm4
Chaos3/Chaos3
 cells (Figure 6D) is not restricted to mammary tumor formation 
but is relevant to the formation of a variety of tumors.  
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Discussion 
In the present study, we used primary Mcm4
Chaos3/Chaos3
 MEFs as a model to 
investigate the mechanism by which a loss of dormant origins confers chromosome 
instability. As summarized in Figure 6D, our findings suggest that a loss of dormant 
origins leads to the accumulation of stalled forks, ultimately resulting in incomplete DNA 
replication. The resulting unresolved replication intermediates are then carried over into 
M phase, thereby interfering with proper chromosome segregation. As a 
consequence, Mcm4
Chaos3/Chaos3
 cells exhibit increased incidences of aneuploidy, 
chromosome breaks, translocations, and tetraploidy, all of which are commonly observed 
in cancer cells. Given the high tumor predisposition of Mcm4
Chaos3/Chaos3
 mice, the 
chromosome instability seen in Mcm4
Chaos3/Chaos3
 cells is likely to promote tumorigenesis. 
Collectively, these findings suggest that dormant origins exist in abundance because of 
their critical role in fork recovery in unchallenged S phase, thereby promoting 
chromosome stability and tumor suppression. 
Even in unchallenged S phase, replication forks stall due to the presence of 
endogenous DNA lesions. It is currently thought that stalled forks can be recovered by 
(1) homology-directed repair, (2) translesion synthesis (TLS) with error-prone DNA 
polymerases, or (3) passive replication from an adjacent origin
44
. The use of dormant 
origins for stalled fork rescue can be viewed as an example of the last option, although 
this option originally implied rescue by adjacent major origins without any de novo 
firing. Our data show that the average density of active origins remains unchanged 
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between wild-type and Mcm4
Chaos3/Chaos3
 cells in unchallenged S phase (Figure 1C). This 
observation supports the previously held notion
12
 that only dormant origins in the vicinity 
of stalled forks are allowed to fire and are therefore not likely to be detected as clearly as 
major origins by DNA fiber analysis (see model in Figure S6). Further studies are needed 
to elucidate the molecular mechanisms responsible for the use of dormant origins for 
stalled fork rescue. 
Among the multiple pathways for stalled fork recovery, how an appropriate 
pathway is chosen for spontaneously stalled forks is largely unknown. An increased 
frequency of spontaneously stalled forks in Mcm4
Chaos3/Chaos3
 cells led us to hypothesize 
that dormant origins play a more significant role in the recovery of spontaneously stalled 
forks than previously anticipated
12,13
. In agreement with this hypothesis, a loss of 
dormant origins appears to activate homology-directed repair for the recovery of stalled 
forks (Figure 4A). Moreover, a recent study showed that MCM depletion in human 
primary lymphocytes leads to an increase in RAD51 foci formation
45
. Unlike some yeast 
mcm mutants
32,33,46
, Mcm4
Chaos3/Chaos3
 cells exhibited no significant increase in canonical 
HR events when measured at the FYDR locus. This finding is consistent with recent 
data
29
 and can also be explained by the antirecombinogenic role of BLM
30
, which also 
forms an elevated number of foci in Mcm4
Chaos3/Chaos3
 cells (Figure 4B). It should be 
noted that this reporter assay detects only unequal recombination events with tract lengths 
of more than a few hundred bases. Therefore, our data cannot exclude the possibility of 
an increase in gene conversion events with much shorter tract lengths. 
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Despite the activation of homology-directed repair, stalled forks do not seem to be 
fully rescued, as >50% of Mcm4
Chaos3/Chaos3
 cells exhibit FANCD2/I foci in prophase 
(Figures 5A and S5B), a marker of unresolved replication intermediates
36,37
. These 
observations suggest that dormant origins could be a preferred option for fork recovery 
over other pathways. This idea is quite feasible, considering the possible harmful 
consequences of homology-directed repair and TLS, such as genome rearrangements
47
 
and point mutations
48
, respectively. A recent study reported that MCM depletion in 
human primary lymphocytes causes hyperactivation of the nonhomologous end-joining 
(NHEJ) pathway, resulting in an increase in the misrepair of DSBs
45
. Interestingly, we 
found that Mcm4
Chaos3/Chaos3
 cells exhibited an increased incidence of translocations and 
dicentric chromosomes (Figures 5D and S5D). Based on our model (Figure 6D), 
chromosome breakage is likely to occur in late M phase. It is then possible that these 
broken chromosome ends are repaired by NHEJ in G1 phase, generating translocations. 
Taken together, these data suggest the hypothesis that the preferential use of dormant 
origins for stalled fork rescue occurs to prevent a possible increase in misrepair events 
resulting from hyperactivated DNA repair pathways. 
In contrast to the commonly held idea that stalled forks eventually collapse, we 
found that spontaneously stalled forks are actually well preserved in S phase in primary 
mouse cells (Figure 2B). In fact, a fraction of stalled forks persisted into M phase, as 
evidenced by an increased number of FANCD2/I foci in prophase (Figures 5A and S5B). 
While the majority of these stalled forks are likely to be resolved by the downstream 
Fanconi pathway, a certain fraction of them remain unresolved, presumably physically 
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interconnecting sister chromatids
36,37
. Our study showed that a loss of dormant origins 
alone is capable of inducing such chromosome missegregation events without any 
exogenous replication inhibitor. The persistence of stalled forks in Mcm4
Chaos3/Chaos3
 cells 
also partially activates the ATR pathway, as evidenced by a significant increase in 
pRAD17 foci formation (Figure 2A). This may explain why there exists a subtle but 
significant level of Mcm4
Chaos3/Chaos3
 cells accumulated at the G2/M phases as described 
previously
21
. It should also be noted that a low level of unresolved replication 
intermediates apparently escape from any known cell-cycle checkpoint, as previously 
demonstrated
49,50
. 
Consistent with the role of dormant origins in tumor suppression, a recent study 
reported that tumor formation in Mcm4
Chaos3/Chaos3
 mice is significantly delayed by 
increasing the levels of chromatin-bound MCM2-7 proteins
18
. We find 
that Mcm4
Chaos3/Chaos3
 mice exhibit phenotypes very similar to what has been seen 
in Mcm2 hypomorph mice
19,20
, such as a modest increase in the levels of γH2AX and 
phosphorylated p53 (Figure S2). While it remains to be determined, 
Mcm4
Chaos3
 and Mcm2 hypomorph mice may share essentially the same mechanism for 
tumorigenesis. One striking difference between these two mouse models is tumor 
latency; Mcm2 hypomorph mice develop tumors much faster than Mcm4
Chaos3/Chaos3
 mice. 
As discussed elsewhere
20
, this difference could be attributed to the distinct roles of each 
component of the MCM2-7 complex. Moreover, the presence of the transgene 
in Mcm2 hypomorph mice may additionally contribute to tumorigenesis by altering the 
expression of nearby genes. 
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Chromosome instability is a hallmark of cancer cells. However, how it is 
generated is still not well understood. We found that an increased frequency of stalled 
forks is sufficient to induce multiple types of chromosome instability. This idea is also 
consistent with an emerging hypothesis that replication stress is the major cause of the 
chromosome instability observed in cancer
51,52
. Since the majority of cancer-initiating 
events deregulate the proper G1/S transition
53
, a loss of dormant origins may occur at an 
early stage of carcinogenesis. In this context, the findings presented in this study are 
highly relevant to our understanding of cancer development.  
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Experimental Procedures 
Animals and MEFs 
Mcm4
Chaos3
 was introduced into the B6 and C3H backgrounds by backcrossing seven 
times (N8). F1 mice were generated by crossing congenic B6 and C3H lines. All 
experiments involving mice were approved by the Institutional Animal Care and Use 
Committee (IACUC). MEFs were generated from 12.5–14.5 dpc embryos and cultured 
using a standard procedure. F1 MEFs were used for all experiments unless otherwise 
noted. 
 
Western Blotting and Immunofluorescence Microscopy 
Western blotting and immunofluorescence staining were carried out using standard 
procedures. Cell fractionation was performed using the Qproteome Nuclear Protein Kit 
(QIAGEN, Germantown, MD). Detailed procedures are provided in Supplemental 
Experimental Procedures. 
 
DNA Fiber 
We used the DNA fiber protocol previously developed by Sugimura et al
22
. Briefly, 
ongoing forks were labeled with digoxigenin-dUTPs for 20 min and then with biotin-
dUTPs for 30 min. Labeled cells were dropped onto slides, fixed, and dipped into lysis 
buffer. The resulting DNA fibers were released and extended by tilting the slides. 
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Incorporated dUTPs were then visualized by immunofluorescent detection using Anti-
digoxigenin-rhodamine (Roche, Branford, CT) and streptavidin, Alexa Fluor 488 
(Invitrogen, Carlsbad, CA). 
 
HR Events at the FYDR Locus 
HR-positive recombinant cells were detected by methods described previously
34
. Detailed 
procedures are provided in Supplemental Experimental Procedures. 
 
 Aberrant Anaphase and Cytokinesis-Block Micronucleus Assays 
For both analyses, cells were cultured on coverslips, fixed, and stained with DAPI for 
fluorescence microscopy. At least 100 anaphases were scored per experiment. To score 
micronuclei, cytochalasin B (0.72 µg/ml) was added to block cytokinesis 16 hr before 
harvest. The resulting binucleated cells were scored for the presence of micronuclei. At 
least 200 binucleated cells were scored per experiment. For the CENP-A and γH2AX 
analyses, cells were subjected to antibody treatment following fixation. 
 
Purification and Characterization of the MCM2-7 and CMG Complexes 
The baculovirus vector expressing the Drosophila melanogaster MCM4
Chaos3
 protein was 
constructed by standard PCR-based site-directed mutagenesis and the Invitrogen Bac-to-
Bac protocol. The conserved residue Phe349 was replaced by isoleucine in the resulting 
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mutant protein. The purification of the Drosophila CMG and MCM2-7 complexes was 
performed as described previously
4
. The MCM3 and Sld5 proteins carry N-terminal 
FLAG and HA affinity tags, respectively. For the MCM2-7 stability experiments, 
fractions from the Mono Q HR 5/5 column chromatography step that contained the MCM 
2-7 hexameric complex were pooled and injected onto the Mono Q PC 1.6/5 column 
connected to the Pharmacia SMART micropurification system. The column was 
developed with ten column volumes of linear 300–1100 mM potassium acetate gradient, 
and 20 fractions were collected and analyzed by SDS-PAGE and Coomassie brilliant blue 
staining. The DNA helicase assays were carried out with an M13-based circular substrate 
as described previously
4
, except that the ATP concentration was kept at 10 mM. 
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Figure legends 
Figure 1 
Mcm4
Chaos3/Chaos3
 Cells Have Reduced Amounts of the MCM2-7 Proteins on Chromatin, 
Resulting in a Reduced Number of Dormant Origins. (A) All components of the MCM2-
7 complex are significantly reduced in Mcm4
Chaos3/Chaos3
 cells. Reduction levels of 
chromatin-bound MCM2/4/7 as well as other replication proteins in Mcm4
Chaos3/Chaos3
 
(C3) cells were estimated by referencing wild-type (WT) proteins loaded in different 
amounts (left). In Mcm4
Chaos3/Chaos3
 cells, the MCM3/5/6 proteins were also reduced in 
both the chromatin fraction and whole-cell extract (WCE) (right). Protein samples were 
obtained from cells cultured asynchronously. Actin and stained membranes were used as 
loading controls. (B) Schematic presentation of consecutive dual labeling in the DNA 
fiber assay. Replication forks were labeled with digoxigenin-dUTPs (dig-dUTPs, red) for 
20 min followed by biotin-dUTPs (green) for 30 min. (C) There is no significant 
difference in the average density of active origins between wild-type and 
Mcm4
Chaos3/Chaos3
 cells in untreated conditions (UNT). However, APH treatment induced 
a significantly lower origin density in Mcm4
Chaos3/Chaos3
 cells (p < 0.05, t test). These 
values were determined by measuring the distances between adjacent origins as shown 
(left). Bars show standard error of the mean (SEM). (D) Mcm4
Chaos3/Chaos3
 cells show a 
significant increase in the frequency of asymmetric forks (see image on the left). The 
average frequencies are shown with SEMs and are compared by χ2 test (p < 0.005, see 
asterisk). 
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Figure 2 
Elevated Levels of RPA, pRAD17, and γH2AX Foci Formation Are Observed 
in Mcm4
Chaos3/Chaos3
 Cells. (A) An increased number of Mcm4
Chaos3/Chaos3
 cells are positive 
for RPA32 and pRAD17 (Ser645) foci. Shown are the average percentages of cells 
positive for each marker in the untreated (UNT) and APH-treated (300 nM for 24 hr) 
conditions. Bars are SEMs for ten different fields obtained from two independently 
performed experiments. Representative images are shown on the right with a magnified 
view of the selected nuclei. Nuclei are stained with DAPI (blue). Scale bars are 40 µm. 
(B) Mcm4
Chaos3/Chaos3
 cells show a slight increase in the formation of γH2AX foci in S 
phase. Shown are the average percentages of cells positive for γH2AX foci and the 
distribution of the number of γH2AX foci per cell in the untreated condition (left). S 
phase cells were detected by incorporation of dUTPs. Bars are SEMs for three 
independent experiments. Representative images are shown on the right. Scale bars are 
10 µm. 
 
Figure 3 
The Mutant MCM2-7 Complex Is Unstable but Retains Proper Helicase Activity in the 
CMG Complex. (A) Silver-stained 10% SDS-polyacrylamide gels (PAGE) show purified 
wild-type and mutant CMG complexes. (B) An autoradiograph of a helicase assay 
showing the radiolabeled products separated by PAGE (top). M13 circular DNA annealed 
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with a radiolabeled oligonucleotide was used as a substrate. The migration of double-
stranded substrate and displaced oligo is shown with arrows. The amount of protein in 
femtomoles in each reaction is indicated. The first two lanes show the completely 
denatured substrate and the substrate with no protein. The reactions were performed in 
duplicate and quantified as a percentage of substrate processed, as shown in the bottom 
graph. Error bars show standard deviations. (C) The salt elution profiles of wild-type and 
mutant MCM2-7 from Mono Q anion-exchange chromatography show the relative 
instability of the mutant complex (top). Blue and red lines show the relative absorbance 
at 280 nm for the wild-type and mutant gradient runs, respectively (left y axis); the gray 
axis indicates salt concentration (right y axis). The peak protein fractions from the mutant 
gradient were separated by SDS-PAGE and stained with Coomassie brilliant blue 
(bottom); the fraction numbers are shown above each lane. The starting stoichiometric 
mutant MCM2-7 complex that was loaded onto this column is shown in the first lane, and 
the pooled peak fractions (15 and 16) from the WT gradient are shown in the last lane. 
 
Figure 4 
An Increase in RAD51 and BLM Foci Formation in Mcm4
Chaos3/Chaos3
 Cells Does Not 
Lead to a Significant Increase in Homologous Recombination Events. (A) An increased 
number of Mcm4
Chaos3/Chaos3
 cells are positive for RAD51 foci. (B) BLM foci formation is 
drastically elevated in Mcm4
Chaos3/Chaos3
 cells. Shown in (A) and (B) are the average 
percentages of cells positive for ≥2 foci in the untreated and APH-treated conditions 
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(left). The average number of foci per cell is also shown. Bars are SEMs for ten different 
fields obtained from two independently performed experiments. Representative images 
are shown on the right. Scale bars are 20 µm. (C) No significant increase in HR events 
was detected at the FYDR locus in Mcm4
Chaos3/Chaos3
 cells compared to wild-type. Bars are 
SEMs for recombinant frequencies determined by analyzing at least 16 embryos per 
genotype. (D) No significant increase in HR events was detected at the FYDR locus in 
either wild-type or Mcm4
Chaos3/Chaos3
 cells after a low dose of APH treatment. CPT and a 
higher dose of APH were used as positive controls. Bars are SEMs for recombinant 
frequencies determined by analyzing at least three independent MEF lines. 
 
Figure 5 
Mcm4
Chaos3/Chaos3
 Cells Have a Drastically Increased Number of FANCD2 Sister Foci at 
Prophase, Preceding Abnormal Anaphase and Micronucleation. (A) An increased 
frequency of FANCD2 sister foci is found in Mcm4
Chaos3/Chaos3
 cells. The average 
percentages of cells positive for FANCD2 sister foci (top) and the average numbers of 
FANCD2 sister foci per cell (bottom) are shown with SEMs. Note that the number of 
FANCD2 sister foci per cell increases approximately 2-fold in Mcm4
Chaos3/Chaos3
 cells 
compared to wild-type cells, while nearly all cells become positive for such foci in the 
presence of APH. Representative images are shown on the right with a magnified view 
(indicated by squares). (B) An increased number of Mcm4
Chaos3/Chaos3
 cells undergo 
abnormal anaphase, forming micronuclei (MN). The average frequencies of abnormal 
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anaphases containing lagging chromosomes and/or fragments are shown for wild-type 
and Mcm4
Chaos3/Chaos3
 cells with SEMs (left, top). B6 MEFs were used for anaphase 
analysis. The average MN frequencies are also shown for wild-type and Mcm4
Chaos3/Chaos3
 
cells with SEMs (left, bottom). MN were detected using the cytokinesis-block 
micronucleus assay
54
. Representative images are shown on the right for a normal 
anaphase, an abnormal anaphase containing lagging chromosomes, a normal binucleated 
cell, and one with a micronucleus. Scale bars are 5 µm. (C) Mcm4
Chaos3/Chaos3
 cells have 
an increased number of centromeric (CENP-A
+
) MN compared to wild-type cells. The 
average frequencies of CENP-A
+
 MN were determined from three independently 
performed experiments and are shown with SEMs. Representative images are shown on 
the right. (D) G-banding analysis of metaphase chromosomes shows no evidence for 
increased chromosome breaks but does reveal an increased occurrence of translocations 
in Mcm4
Chaos3/Chaos3
 cells. Representative karyotypes containing translocations are also 
shown (bottom). (E) Mcm4
Chaos3/Chaos3
 cells have an increased number of γH2AX-foci-
positive (γH2AX+) MN compared to wild-type cells. The average frequencies of 
γH2AX+ MN were determined from three independently performed experiments and are 
shown with SEMs. Representative images are shown on the right for MN positive and 
negative for γH2AX (red) in binucleated cells. APH was used as a positive control (150 
nM for 24 hr). Nuclei are stained with DAPI (blue). Scale bars (A, C, and E) are 10 µm. 
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Figure 6 
Many Different Types of Spontaneous Tumors Are Observed in Mcm4
Chaos3/Chaos3
 Mice. 
(A) Tumor-free survival curves for B6 and F1 Mcm4
Chaos3/Chaos3
 (C3) and wild-type (WT) 
females. (B) Representative images of histiocytic sarcomas. A hematoxylin and eosin 
(H&E) stain (top) shows a diffusely hypercellular liver area with round cells (black 
arrowheads) smaller than hepatocytes (unfilled arrowheads). Immunohistochemistry 
(IHC) with Mac-2, a macrophage marker, identified these small round cells (stained 
brown) as histiocytes (bottom). (C) Representative images of F1 Mcm4
Chaos3
 
gastrointestinal lymphomas, including an H&E image (top) and an IHC image with B220, 
a B cell marker (bottom). (D) A model for chromosome instability driven by a loss of 
dormant origins. A lack of dormant origins increases the frequency of unresolved 
replication intermediates marked with FANCD2 sister foci (red diamonds) in M phase. 
Although such lesions can be rescued in a Fanconi-pathway-dependent manner, a 
significant fraction persists into anaphase, interconnecting sister chromatids. As a result, 
the disjunction of sisters is disrupted and lagging chromosomes occur. This has three 
possible consequences: (1) Tetraploidy may occur due to cytokinesis failure, when the 
frequency of nondisjunction is high
55
, (2) Aneuploidy could occur due to the 
nondisjunction of a few sisters, forming MN positive for CENP-A, or (3) Breaks may 
arise when unresolved replication intermediates are converted into DSBs, generating 
acentric fragments. In this case, MN positive for γH2AX foci would be formed. These 
aberrations lead to multiple types of chromosome instability, thereby contributing to 
tumorigenesis.
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Supplemental experimental procedures 
ChIP 
Sigma’s Imprint Chromatin Immunoprecipitation Kit was used. Briefly, cells in an 
asynchronous culture were harvested. The DNA and proteins were cross-linked using 1% 
formaldehyde and then quenched in 0.125M glycine. After cell lysis, the nuclei were 
precipitated and the DNA was fragmented by sonication. A portion of the fragmented 
DNA was saved as an input control. For the rest of the sample, immunoprecipitation (IP) 
was performed with the anti-MCM2 antibody (Abcam, ab3159) that gave the best 
performance judged by semi-quantitative PCR results using the primer pairs specific to 
the rDNA locus origins
56
 among all antibodies tested in our laboratory. After reversal of 
the cross-links and proteinase K digest, DNA was used for quantitative PCR using 
standard conditions. 
 
Coimmunoprecipitation 
Coimmunoprecipitation was performed using a kit (Dynabeads Co-Immunoprecipitation 
Kit, Invitrogen). Briefly, 3x106 cells were harvested in PBS and proteins were extracted 
using an extraction buffer (Buffering salts pH7.4, 110 mM KOAc, 0.5% Triton X-100, 
protease inhibitor; complete EDTA-free). After centrifugation (2600 x g for 5min), the 
supernatant was incubated with anti-MCM2 or anti-rabbit IgG antibody-bound beads, 
  Kawabata et al., 2011 
70 
 
followed by several washes. Bound proteins were released by buffer EB (Buffering salts, 
pH2.8) and used for western blotting. 
 
Interphase FISH  
DNA isolated from BAC clones RP23-290E4 and RP23-356A24 was used to make 
probes specific to regions flanking the centromere of chromosome 16
57
 using the Vysis 
Nick Translocation kit (Abbott Molecular) as well as Green-496-dUTPs and Orange-552-
dUTPs from Enzo Life Sciences. Hybridization was performed under standard 
conditions. Images were captured using the Axio Imager A1 (Zeiss). At least 200 nuclei 
were scored for the number of FISH signals per experiment. A total of >600 nuclei was 
observed per genotype in three sets of independently performed experiments. 
 
Generation of MEFs 
MEFs were obtained from 12.5-14.5 dpc embryos using a standard procedure. A 
homogenized embryo was plated onto a 10 cm dish (p0), replated onto a 15 cm dish (p1), 
and frozen in three vials. For experiments, one vial was thawed and the cells were 
cultured on a 10 cm dish for a few days (p2). The resulting 6-9 x 106 cells (p3) were then 
replated for experimental use. 
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Antibodies 
For western blotting and immunocytofluorescence, we used Abcam anti-MCM antibodies 
(ab3159, ab4460, ab4459, ab17967, ab4458 and ab2360 for MCM2, MCM3, MCM4, 
MCM5, MCM6 and MCM7, respectively), anti-pan actin (Thermo Scientific; MS-1295-
P1ABX), anti-RAD51 (Calbiochem; PC130) anti-CDC45, anti-FANCD2, anti-BLM, 
anti-FANCI (Abcam; ab56476, ab2187, ab476, and ab74332, respectively), anti-
phospho-RAD17, anti-phospho-CHK1, anti-H2AX, anti-PCNA, anti-CENP-A, anti-
RPA32, anti-phospho-p53, and anti-histone H3 (Cell Signaling; #3421, #2341, #2577, 
#2586, #2048, #2208, #9284, and #9847, respectively). 
 
Western Blotting 
Cell extracts were harvested using Laemili’s sample buffer, run on 8 or 12% SDS-
polyacrylamide gels, and transferred to polyvinylidene membranes. Membranes were 
then incubated with primary antibodies, followed by incubation with the appropriate 
secondary antibodies. Proteins were visualized using the Immobilon Western 
Chemiluminescent HRP substrate (Millipore, WBKLS0500). Cell fractionation was 
performed using the Qproteome Nuclear Protein Kit (Qiagen). Briefly, cells were first 
treated with hypotonic solution to remove cytosolic proteins, followed by incubation with 
a buffer containing a high concentration of salt. Histone-containing pellets were separated 
from soluble nuclear fractions by centrifugation and incubated with Benzonase to 
completely digest DNA and release proteins tightly associated with chromatin. 
  Kawabata et al., 2011 
72 
 
 
Immunofluorescence Microscopy 
To observe discrete foci of RPA32, phospho-RAD17, BLM, and RAD51 on chromatin, 
cells were pretreated with 0.5% Triton X-100 in PBS for 1 minute before fixation with 
paraformaldehyde (PFA) for 15 minutes. After permeabilization in 0.1% Triton X-100 in 
PBS for 15 min, cells were subjected to treatment with the Image-iT signal enhancer 
(Invitrogen) before being incubated with primary antibodies. Staining with the 
appropriate secondary antibodies and fluorescence microscopy (Zeiss) were used to 
visualize foci. FANCD2, FANCI, CENP-A, and H2AX foci were visualized by the same 
method without the pre-extraction step. All procedures were performed at room 
temperature. 
 
DNA Fiber 
We used the DNA fiber protocol developed by Sugimura et al
22
. Ongoing forks were 
labeled with digoxigenin-dUTPs for 20 min and then with biotin-dUTPs for 30 min. To 
allow efficient incorporation of the dUTPs, a hypotonic buffer (10mM HEPES, 30mM 
KCl, pH7.4) treatment precedes each dUTP labeling step. To visualize the labeled fibers, 
cells were mixed with a 10-fold excess of unlabeled cells, fixed, and dropped onto slides. 
After cell lysis, the DNA fibers were released and extended by tilting the slides. 
Incorporated dUTPs were then visualized by immunofluorescent detection using anti 
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digoxigenin-Rhodamine (Roche) and streptavidin-Alexa-Fluor-488 (Invitrogen). Images 
were captured using the Axio Imager A1 (Zeiss). 
 
HR Events at the FYDR Locus 
MEFs were generated as described above. Cells at passage 2 were harvested and analyzed 
by the FACSCalibur (BD Biosciences) using the FL1 and FL2 channels. To determine 
the spontaneous recombinant frequency, at least 16 independent MEF cultures were used 
per genotype and at least 106 cells were analyzed per MEF line. To determine the 
recombinant frequency induced by replication inhibitors, MEFs were treated with APH or 
CPT for 24 hrs. After a 48-hr recovery period, cells were analyzed by flow cytometry. 
 
Live Cell Imaging 
0.5x106 wildtype or Mcm4Chaos3/Chaos3 MEFs were plated onto a 60 mm dish for 24 
hrs and observed using the DeltaVision microscope (Applied Precision). Each dish 
contained standard medium supplemented with 0.25μM DRAQ5 (Sigma), a DNA dye. 
Each image was assembled into a movie file using the DeltaVision SoftWoRx software. 
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Supplemental table, figure and movie legends 
Table S1 
Summary of B6 Mcm4Chaos3 Tumor Histopathology 
 
Table S2 
Summary of F1 Mcm4Chaos3 Tumor Histopathology 
 
Figure S1, Related to Figure 1 
(A) Chromatin-immunoprecipitation (ChIP) data from selected loci show reduced levels 
of chromatin-bound MCM2 in Mcm4
Chaos3/Chaos3
 cells. The rDNA locus contains a well-
defined origin
56
, and was thus used as a control. The additional four loci from 
chromosomes 1 and 8 were selected due to their defined replication timing with I/II, and 
V indicating early and late replication timing, respectively
58
. Whether or not origins are 
present in these loci is unknown. Reduction levels relative to wildtype were determined 
by quantitative PCR on ChIP’ed DNA. The averages of three experiments are shown. (B) 
Similar distributions of origin-to-origin distance are found between wildtype and 
Mcm4
Chaos3/Chaos3
 cells (upper panel). While there was no significant difference in the 
distributions in the untreated conditions (p=0.777, Kolmogorov-Smirnov test), 
Mcm4
Chaos3/Chaos3
 cells did have an increased number of origin-to-origin distances larger 
than 80kb (p<0.05, 2-test). Although aphidicolin (APH) treatment resulted in a 
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significant decrease in origin-to-origin distances in both genotypes, the average distance 
in Mcm4
Chaos3/Chaos3
 cells was significantly larger than that of wildtype cells (lower panel, 
p=0.0102, t-test). (C) Fork velocity in Mcm4
Chaos3/Chaos3
 cells is faster than that of 
wildtype (left, p<0.005, t-test). The distribution of fork velocity (right) in 
Mcm4
Chaos3/Chaos3
 cells is also significantly different from that of wildtype cells (p<0.001, 
Kolmogorov-Smirnov test). This apparently faster fork velocity in Mcm4
Chaos3/Chaos3
 cells 
can be explained by different levels of fork termination. Faster forks are more likely to 
merge together, resulting in fork termination. An increased level of stalled forks in 
Mcm4
Chaos3/Chaos3
 cells might have led to a reduction in fork terminations, causing more of 
the faster forks to be visible for measurement. Faster forks in wildtype cells, on the other 
hand, might have been excluded from the measurement due to a higher level of fork 
terminations. To address this concern, fork velocity was re-measured using a short-pulse 
labeling method (10 min for dig-dUTP and 15 min for Biotin-dUTP) to reduce the 
frequency of fork terminations as shown in (D). (D) While fork velocity in wildtype cells 
is ~15% faster (left) than the data shown in (C), forks are still faster in Mcm4
Chaos3/Chaos3
 
cells (p<0.005, t-test). Note the increase in faster forks (>1.2 kb/min) in wildtype cells 
(right). (E) The average origin-to-origin distance remains the same after the short-pulse 
labeling experiments in both wildtype and Mcm4
Chaos3/Chaos3
 cells. Therefore, a reduced 
number of dormant origins might have led to a lower level of fork terminations in 
Mcm4
Chaos3/Chaos3
 cells. 
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Figure S2, Related to Figure 2 
Mcm4
Chaos3/Chaos3
 cells exhibit a normal checkpoint response following treatment with 
replication inhibitors. Increased phosphorylation of CHK1, p53 and H2AX was observed 
6 hours after treatment. Note that Mcm4
Chaos3/Chaos3
 cells (indicated as “C”) have 
intrinsically higher levels of phospho-p53 and γ-H2AX in untreated conditions (UNT) 
compared to wildtype cells (indicated as “W”). However, these basal levels of 
phosphorylation are substantially lower than those after treatment with replication 
inhibitors. 
 
Figure S3, Related to Figure 3 
(A) The phenylalanine residue mutated in Mcm4
Chaos3/Chaos3
 cells is conserved in all 
eukaryotes and resides at a position that affects complex stability. An alignment of the 
amino acid sequences from several organisms is shown with conservation levels. (B) The 
Phe345Ile change in Mcm4
Chaos3/Chaos3
 cells resides at the interface between MCM4 and 
MCM6. The presence of a gap between MCM2 and MCM5 has been predicted for the 
inactive form of the MCM2-7 complex
59
, and has been recently confirmed (Costa et al., 
in press). These two factors seem to play a role in the formation of the sub-complexes 
MCM2/6 (see fractions #18 & 19) and MCM4/7/3/5 (fractions #11 & 12), as seen in Fig. 
3C. (C) Co-immunoprecipitation results show a robust in vivo interaction between 
MCM2 and MCM6 in both wildtype and Mcm4
Chaos3/Chaos3
 cells but a somewhat weaker 
interaction between MCM2 and MCM4 in Mcm4
Chaos3/Chaos3
 cells. An interaction between 
  Kawabata et al., 2011 
77 
 
MCM2 and MCM5 was very weak regardless of genotype. These data are consistent with 
the in vitro sub-complexes detected in Fig. 3C. 
 
Figure S4, Related to Figure 4 
(A) eYFP expression arises from homologous recombination at the FYDR locus, which 
contains two tandem repeats of incomplete eYFP expression cassettes. The resolution of 
homologous recombination between these repeats has two different outcomes at the 
molecular level. While gene conversion can occur as a non-crossover event (top), unequal 
sister chromatid exchange (SCE) can result from a crossover event (bottom). The use of 
both wildtype and Mcm4
Chaos3/Chaos3
 MEFs that carry the FYDR locus in the hemizygous 
state allows for the detection of HR events only during and/or after this locus is 
replicated. (B) Recombinant cells that express eYFP are detected by flow cytometry. 
eYFP signals were detected using the FL1 and FL2 channels. The gate was set using cells 
without the FYDR locus to distinguish eYFP signals from autofluorescence. (C) 
Distributions of spontaneous recombinant frequencies are shown for wildtype and 
Mcm4
Chaos3/Chaos3
 cells. The average frequencies are shown in Figure 4C. 
 
Figure S5, Related to Figure 5 
(A) The number of FANCD2 sister/twin-foci throughout M phase is significantly higher 
in Mcm4
Chaos3/Chaos3
 cells. The average number of foci determined by three independent 
  Kawabata et al., 2011 
78 
 
experiments is shown (left). Spontaneous FANCD2 sister/twin foci, rarely observed in 
wildtype cells, were significantly increased in Mcm4
Chaos3/Chaos3
 cells. Aphidicolin (APH) 
treatment (150 nM for 24 hrs) increased the number of foci even in wildtype cells, while 
Mcm4
Chaos3/Chaos3
 cells still contained a relatively higher amount. Pro: prophase, PM: 
prometaphase, M: metaphase, A: anaphase. Bars indicate SEMs. Representative images 
of FANCD2 sister/twin foci are shown on the right. Scale bar is 10 μm. (B) 
Mcm4
Chaos3/Chaos3
 cells also have a drastically increased number of FANCI foci in 
prophase. Much like FANCD2 foci (Figure 5A), FANCI foci were observed in more than 
50% of Mcm4
Chaos3/Chaos3
 cells in the untreated condition (UNT, left). Although APH 
treatment nearly saturated the formation of FANCI foci in both wildtype and 
Mcm4
Chaos3/Chaos3
 cells, the number of FANCI foci per cell was still significantly higher in 
Mcm4
Chaos3/Chaos3
 cells. Representative images of FANCI foci are shown on the right. 
Scale bar is 10 μm. (C) An increased frequency of aneuploidy in Mcm4Chaos3/Chaos3 cells is 
revealed by interphase FISH using probes specific to near-centromeric regions of 
Chromosome 16 (top, left). The percentage of aneuploid cells was determined by 
dividing the number of cells with chromosome loss (-1) and chromosome gain (+1) 
signals by the total number of cells observed (see representative images of interphase 
FISH below). The percentage of tetraploid cells was also significantly increased in 
Mcm4
Chaos3/Chaos3
 cells (top, right). Scale bar is 10 μm. (D) G-banding analysis of 
metaphase chromosomes shows an increased frequency of translocations in 
Mcm4
Chaos3/Chaos3
 cells. The top portion includes the results for wild-type cells, while the 
bottom portion includes results for Mcm4
Chaos3/Chaos3
 cells. A total of 40 chromosomes 
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were fully analyzed per genotype. Numbers in brackets indicate the number of cells with 
karyotypes shown on the left. (E) Mcm4
Chaos3/Chaos3
 cells exhibit a significantly elevated 
level of twin H2AX foci formation in early G1 phase. G1 phase cells were detected as 
binucleated cells following a 4hr-treatment with cytochalasin B. Only binucleated cells 
that contained H2AX foci in both nuclei were considered positive for twin foci. Scale bar 
is 10 μm. 
 
Figure S6, Related to Figure 6 
The use of dormant origins may provide a simple and prompt pathway for stalled fork 
recovery. A speculative model of stalled fork rescue by dormant origin firing is shown. In 
both wildtype and Mcm4
Chaos3/Chaos3
 cells, active origins (indicated as filled orange 
hexagons) fire to generate bidirectional forks. When fork stalling occurs in wildtype cells, 
a nearby dormant origin (open orange hexagons) immediately fires and fork progression 
continues. However, the lack of dormant origins in Mcm4
Chaos3/Chaos3
 cells results in 
persistent fork stalling. In this model, only those in the vicinity of stalled forks are 
allowed to fire, causing the apparent inter-origin distances to remain unchanged between 
wildtype and Mcm4
Chaos3/Chaos3
 cells, as seen in Fig 1C. 
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Movie S1 
Normal Cytokinesis of Wild-Type MEF. Movie S1, related to Figure 5, shows a living 
wild-type cell in cytokinesis. Cells were cultured in the presence of DNA dye DRAQ5 
(0.25 µM) and subjected to fluorescence microscopy to monitor cytokinesis. The duration 
of the movie is 30 min, and the time interval between captures is 2 min. 
 
Movie S2 
Normal Cytokinesis of Mcm4
Chaos3/Chaos3
 MEF. Movie S2, related to Figure 5, shows a 
living Mcm4
Chaos3/Chaos3
 cell in cytokinesis. Cells were cultured in the presence of DNA 
dye DRAQ5 (0.25 µM) and subjected to fluorescence microscopy to monitor cytokinesis. 
The duration of the movie is 22 min, and the time interval between captures is 2 min. 
 
Movie S3 
Cytokinesis Failure Resulting in Binucleated Mcm4
Chaos3/Chaos3
 MEF. Movie S3, related to 
Figure 5, is of a Mcm4
Chaos3/Chaos3
 cell in aberrant cytokinesis. Cells were cultured in the 
presence of DNA dye DRAQ5 (0.25 µM) and subjected to fluorescence microscopy to 
monitor cytokinesis. The duration of the movie is 30 min, and the time interval between 
captures is 2 min. 
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Table S1 
Case 
Age 
(mo.) 
Location Diagnosis Immunohistochemistry 
160 15 Small intestine Lymphoma N.D. 
161 12 Small intestine Lymphoma N.D. 
  
Peripancreatic adipose 
tissue 
Histiocytic sarcoma Mac-2: +, CD3: -, B220: - 
193 11 Adipose tissue Histiocytic sarcoma Mac-2: +, CD3: -, B220: - 
194 16 
Liver and abdominal 
mass 
Histiocytic sarcoma Mac-2: + 
202 10 Liver Histiocytic sarcoma Mac-2: + 
203 15 Liver Histiocytic sarcoma N.D. 
204 14 
Peripancreatic adipose 
tissue 
Histiocytic sarcoma N.D. 
211 4 
Mammary gland and 
subcutis 
Spindle cell sarcoma N.D. 
250 15 Liver Histiocytic sarcoma N.D. 
265 10 Liver Histiocytic sarcoma N.D. 
311 10 Liver Histiocytic sarcoma N.D. 
312 11 Vertebrae Osteosarcoma N.D. 
314 11 Vertebrae Osteosarcoma N.D. 
216 15 LN of shoulder region Lymphoma CD3: ±, B220: + 
391 10 Thymus Lymphoma N.D. 
388 13 Thymus Histiocytic sarcoma Mac-2: + 
316 12 Peripancreatic mass Histiocytic sarcoma N.D. 
LN: lymph node 
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Table S2 
Case 
Age 
(mo.) 
Location Diagnosis Immunohistochemistry 
328 12 Mesenteric LN Histiocytic sarcoma Mac-2: + 
329 15 Uterus 
Endometrial 
hemangioma 
N.D. 
330 15 Intestine Lymphoma N.D. 
  Liver Histiocytic sarcoma Mac-2: + 
331 14 Mammary gland Adenocarcinoma N.D. 
332 10 Spleen Round cell sarcoma Mac2: ±, B220: ± 
224 12 Intestine Lymphoma N.D. 
  Liver, Mesenteric LN Histiocytic sarcoma N.D. 
231 14 Intestine Lymphoma, B cell 
CD3: ±, B220: ++, Pax-
5: ++ 
232 11 Mesenteric LN Histiocytic sarcoma N.D. 
221 15 Spleen Round cell sarcoma Mac-2: ± 
377 10 Uterus Spindle cell tumor N.D. 
378 12 Uterus Histiocytic sarcoma N.D. 
335 13 Tibia Osteosarcoma a N.D. 
395 16 Liver, Ovary-uterus Histiocytic sarcoma N.D. 
396 17 Vertebrae Osteosarcoma a N.D. 
469 12 
Spleen, Liver, 
Intramammary LN 
Lymphoma B220: + 
470 17 
Spleen, Liver, 
Mesenteric LN 
Lymphoma Mac-2: +, B220: ++ 
471 16 
Intestine, Spleen, 
Thoracic nodule 
Lymphoma N.D. 
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436 17 Mammary gland Adenocarcinoma N.D. 
437 7 Mammary gland Adenocarcinoma N.D. 
438 16 Spleen, Liver, LN Histiocytic sarcoma N.D. 
439 16 Intestine Lymphoma Mac-2: -, B220: + 
  Thymus Histiocytic sarcoma Mac-2: + 
LN: lymph node  
aDiagnoses were given by X-ray. 
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Movie S1 
Movie S1 can be found online at: 
http://www.sciencedirect.com/science/article/pii/S109727651100089X 
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Movie S2 
Movie S2 can be found online at: 
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Movie S3 
Movie S3 can be found online at: 
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Summary 
Accumulating evidence suggests that dormant DNA replication origins play an important 
role in the recovery of stalled forks.  However, their functional interactions with other 
fork recovery mechanisms have not been tested.  We previously reported intrinsic 
activation of the FA pathway in a tumor-prone mouse model (Mcm4
chaos3
) with a 60% 
loss of dormant origins.  To understand this further, we introduced a null allele of Fancc 
(Fancc
-
), encoding a member of the FA core complex, into the Mcm4
chaos3
 background.  
Primary embryonic fibroblasts double homozygous for Mcm4
chaos3
 and Fancc
-
 
(Mcm4
chaos3/chaos3
;Fancc
-/-
) showed significantly increased levels of markers of 
stalled/collapsed forks compared to either single homozygote.  Interestingly, a loss of 
dormant origins also increased the number of sites in which replication was delayed until 
prophase, regardless of FA pathway activation.  These replication defects coincided with 
substantially elevated levels of genome instability in Mcm4
chaos3/chaos3
;Fancc
-/- 
cells, 
resulting in a high rate of perinatal lethality of Mcm4
chaos3/chaos3
;Fancc
-/-
 mice and the 
accelerated tumorigenesis of surviving mice.  Together, these findings uncover a 
specialized role of dormant origins in replication completion while also identifying 
important functional overlaps between dormant origins and the FA pathway in 
maintaining fork progression, genome stability, normal development and tumor 
suppression. 
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Introduction 
Origin licensing builds a fundamental basis for genome stability during eukaryotic 
DNA replication as it provides replication origins with the competency to fire and 
restricts their firing to once per S phase
1-3
.  This process occurs during the late M to early 
G1 phases of the cell cycle, when heterohexameric complexes of the minichromosome 
maintenance proteins (MCM2-7), essential components of the replicative helicase, are 
loaded onto chromatin
4-6
.  While any genomic loci bound by MCM2-7 complexes can 
potentially act as origins, only a small fraction of them (~10%) assemble active helicases 
with their co-factors to unwind the DNA and initiate genome duplication in S phase
7,8
.  In 
fact, chromatin-bound MCM2-7 complexes exist in a large excess (10- to 20-fold) over 
the number of replication origins that actually fire in S phase
9-12
, thereby licensing 
additional origins termed dormant origins.  Although dormant origins represent the vast 
majority (>90%) of all licensed origins
13,14
, their role in DNA replication has only 
recently been revealed.  These dormant origins can be activated as “backups” under 
conditions of replication stress to compensate for slow fork progression and rescue stalled 
replication forks, thereby contributing to completion of DNA replication
13-15
. 
Using a mouse model called Mcm4
chaos3
, we demonstrated that dormant origins 
also play an important role in the rescue of stalled forks even in unchallenged S phase
16
.  
Mcm4
chaos3
 is a hypomorphic allele encoding a Phe345Ile change in the MCM4 protein, a 
subunit of the MCM2-7 complex
17
.  Cells homozygous for this allele (Mcm4
chaos3/chaos3
) 
exhibit a decreased rate of assembly of the MCM2-7 complex, leading to a ~60% loss of 
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chromatin-bound MCM2-7 complexes
16
.  This results in a significant reduction of 
dormant origins, causing the accumulation of stalled forks and increased levels of 
spontaneous micronuclei in Mcm4
chaos3/chaos3
 cells.  Reflecting intrinsic genome 
instability, Mcm4
chaos3/chaos3
 mice are highly prone to spontaneous tumors
16,17
.  These 
properties of Mcm4
chaos3/chaos3
 mice substantiate the formerly underappreciated role of 
dormant origins in stalled fork recovery
18
.  In our previous work
16
, Mcm4
chaos3/chaos3
 cells 
were also found to exhibit intrinsic activation of the Fanconi anemia (FA) pathway of 
DNA repair, though the functional relevance of this had yet to be determined. 
FA is a rare genetic disorder characterized by congenital abnormalities, bone 
marrow failure and a heightened predisposition to cancer
19,20
.  It is a genetically 
heterogeneous disease, with 16 complementation groups identified to date
19,21,22
.  Our 
current understanding is that the products of these genes coordinately function to promote 
genome stability with a specialized role in the repair of DNA inter-strand crosslinks 
(ICLs) 
20,23,24
 and certain endogenous lesions
25
.  Activation of the FA pathway is typically 
observed by mono-ubiquitination of the FANCD2 and FANCI proteins by the FA core 
complex (composed of at least 8 FA proteins), promoting their recruitment to chromatin 
and focus formation
26-29
.  Even in the absence of exogenous sources of ICLs, this 
activation occurs in normal S phase
29,30
.  Moreover, treatment of cells with a low dose of 
aphidicolin (APH), a polymerase inhibitor
31
, robustly activates the FA pathway, 
indicating a role of the FA proteins during DNA replication
32
.  Previous studies reported 
that APH-induced FANCD2/FANCI foci often form as a pair (sister foci) during the 
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G2/M phases, presumably flanking late replication intermediates at common fragile 
sites
33,34
.  These chromosomal loci are prone to breakage after partial inhibition of DNA 
replication
35
, likely due to a paucity of DNA replication origins at these sites
36,37
.  As FA 
proteins are required for the stability of common fragile sites
32
, they are likely to be 
involved in guiding successful replication of loci with fewer replication origins. 
 As Mcm4
chaos3
 homozygosity significantly decreases the total number of licensed 
origins on a genome-wide scale, it is likely to increase the number of loci lacking 
dormant origins or perhaps any origins.  We therefore hypothesized that intrinsic 
activation of the FA pathway in Mcm4
chaos3/chaos3
 cells occurs in an attempt to support 
replication fork progression at these sites.  To test this hypothesis, we introduced a null 
allele of Fancc (Fancc
-
), encoding a member of the FA core complex
38
, into the 
Mcm4
chaos3
 background.  Here, we report that loss of an intact FA pathway in 
Mcm4
chaos3/chaos3
 cells severely impairs replication fork stability even in unchallenged 
conditions.  Furthermore, a reduced number of dormant origins also increased the number 
of sites in which replication was delayed until prophase, regardless of FA pathway 
activation.  This increase in late replication intermediates as well as replication delay led 
to highly elevated levels of genome instability in Mcm4
chaos3/chaos3
;Fancc
-/- 
cells and 
almost all Mcm4
chaos3/chaos3
;Fancc
-/- 
pups died shortly after birth in an inbred C57BL/6J 
background.  While viable in a mixed genetic background, Mcm4
chaos3/chaos3
;Fancc
-/- 
mice 
still succumbed to spontaneous tumors at much younger ages than their Mcm4
chaos3/chaos3
 
littermates.  These findings confirm the role of dormant origins in stalled fork recovery 
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while also unveiling their unique function in the complete replication of the genome, as 
other pathways are not able to fully compensate in their absence.  Moreover, our results 
provide new insights into how the FA pathway functions in unchallenged conditions to 
promote genome stability. 
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Materials and methods 
Mouse strains and MEFs 
All experiments were performed using mice/cells derived from an inbred C57BL/6J 
genetic background or a C57BL/6J x C3HeB/FeJ mixed genetic background and were 
approved by the Institutional Animal Care and Use Committee (IACUC).  MEFs were 
generated from 12.5-14.5 dpc embryos and cultured using standard procedures.  All mice 
were genotyped by PCR.  The primers used are available upon request. 
 
Immunocytochemistry 
Cells were grown on coverslips for two days and then fixed using 10% formalin.  When 
RPA immunocytostaining was performed, cells were additionally pre-extracted with a 
0.5% Triton X-100 in PBS solution for about 1 minute prior to fixation.  For analyses 
involving APH treatment, cells were given doses of either 150nM or 300nM APH for 24 
hours before harvest.  Coverslips were then treated with the appropriate primary 
antibodies (4°C, overnight) and secondary antibodies (RT, 1 hour) and stained with DAPI 
(1 µg/ml, 10 minutes) before being mounted onto slides using Vectashield (Vector 
Laboratories, #H-1000) or ProLong Gold antifade reagent (Life Technologies, #P36930).  
The Axio Imager A1 (Zeiss) was used for fluorescence microscopy analysis and to 
collect all images. 
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Antibodies 
For immunocytochemistry, immunohistochemistry and western blotting procedures, we 
used anti-phospho-histone H3-AlexaFluor488 conjugate, anti-phospho-histone H3, anti-
RPA32, anti-γH2AX, anti-CENP-A (Cell Signaling; #9708, #9706, #2208, #2577, #2048, 
respectively), anti-FANCD2, anti-FANCI, anti-53BP1 (Abcam; #ab2187, #ab74332, 
#ab36823, respectively), anti-pan actin, anti-MPO (Thermo Scientific; #MS-1295-
P1ABX, #RB-373-A1, respectively), anti-F4/80, anti-Mac-2 (Cedarlane; #CL8940AP 
and #CL8942AP, respectively), anti-CD-3 (Serotec; #MCA1477), anti-B220 (BD 
Biosciences; #550286), anti-digoxigenin (Roche; #11333062910), anti-FANCD2 
(Epitomics; #2986-1), anti-PICH (Abnova; #H00054821-D01P) and Streptavidin-
AlexaFluor488 conjugate antibody (Invitrogen, #S-32354).  For the DNA Fiber assay, the 
digoxigenin-Rhodamine conjugate antibody from Roche (#11207750910) and 
Streptavidin-AlexaFluor488 conjugate antibody from Invitrogen (#S-32354) were used. 
 
DNA fiber assay and cell cycle analysis 
All techniques and methods of analysis used were performed as described previously
16,39
. 
 
EdU spots analysis 
EdU (Life Technologies, #A10044) was added to cells at a final concentration of 20µM 
for 10 minutes prior to harvest.  After fixation, cells were subjected to the Click-iT™ 
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reaction using Biotin-Azide (Life Technologies, #B10184) for 1 hour at RT, according to 
the manufacturer’s instructions.  Cells were then stained with the appropriate antibodies 
using normal immunocytochemistry techniques. 
 
Cytokinesis-block micronucleus assay and 53BP1 nuclear bodies analysis 
The cytokinesis-block micronucleus assays and 53BP1-NBs analyses were performed as 
described previously
40
.  Though the identification G1 nuclei for the analysis of 53BP1 
nuclear bodies is typically determined by those that are cyclin A-negative
41,42
, the lack of 
a cyclin A antibody that works well for mouse cells precluded use of this technique.  As 
an alternative, G1 nuclei were identified as those contained within binucleated cells 
following cytochalasin B treatment. 
 
DNA ultra-fine bridge analysis 
To measure the levels of DNA ultra-fine bridges (UFBs), another consequence of late 
replication intermediates
33,34,43
, anaphase cells were stained for the Pkl1-interacting 
checkpoint helicase (PICH) and analyzed for the presence of PICH-coated UFBs. 
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Results 
Mcm4
chaos3
 homozygosity results in a reduced number of dormant origins and a lower 
active origin density in a C57BL/6J background 
The phenotypes of Mcm4
chaos3/chaos3
 and Fancc
-/-
 mice in a C57BL/6J background have 
been relatively well characterized and share several similarities, including semi-lethality 
and a heightened predisposition to microphthalmia
39,40,44
.  We therefore generated wild-
type, Mcm4
chaos3/chaos3
, Fancc
-/-
 and Mcm4
chaos3/chaos3
;Fancc
-/-
 primary mouse embryonic 
fibroblasts (MEFs) in this inbred background to perform various types of cellular assays.  
First, we verified that Mcm4
chaos3/chaos3
 and Mcm4
chaos3/chaos3
;Fancc
-/-
 cells have reduced 
levels of chromatin-bound MCM4 compared to wild-type and Fancc
-/-
 cells, indicating a 
reduced number of licensed origins (Supplementary Figure S1A)
16
.  Consistent with our 
previous work
16
, Mcm4
chaos3/chaos3
 cells exhibited higher levels of FANCD2 foci at 
prophase compared to wild-type cells (Supplementary Figure S1B).  Expectedly, the lack 
of FANCC abolished FANCD2 chromatin loading to sub-detectable levels in both Fancc
-
/-
 and Mcm4
chaos3/chaos3
;Fancc
-/-
 cells  (Supplementary Figure S1C).  To understand DNA 
replication kinetics in these MEFs, we began our analysis with a DNA fiber assay.  
Previously, we reported that Mcm4
chaos3
 homozygosity in this inbred background not only 
results in a reduced number of dormant origins but also lowers the density of active 
origins, thereby contributing to the semi-lethality of newborn mice
39
.  To verify that this 
was also the case for Mcm4
chaos3/chaos3
;Fancc
-/-
 cells, we measured origin-to-origin 
distances (Figure 1A and B).  Compared to wild-type cells (63.3kb3.57), significantly 
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longer average origin-to-origin distances were observed in Mcm4
chaos3/chaos3
 (80.0kb4.32, 
p<0.01) and Mcm4
chaos3/chaos3
;Fancc
-/-
 cells (75.0kb3.60, p<0.05), indicating lower 
densities of active origins.  While Fancc
-/-
 cells exhibited a slightly longer average origin-
to-origin distance (68.3kb4.12), this was not statistically different from wild-type cells 
(p=0.361).  To determine if overall replication fork movement was substantially altered in 
mutant cells, fork velocities were also measured.  Average fork velocities were largely 
similar among the four genotypes, with only Fancc
-/-
 and Mcm4
chaos3/chaos3
;Fancc
-/-
 cells 
exhibiting very slightly faster and slower forks, respectively (Figure 1B). 
 
Loss of FANCC leads to a drastic increase in stalled/collapsed forks in Mcm4
chaos3/chaos3
 
cells 
The FA proteins function to support replication fork stability as well as fork restart
30,45-47
. 
Thus, Mcm4
chaos3/chaos3
;Fancc
-/-
 cells lack two important fork recovery mechanisms: 
dormant origins and another mechanism mediated by FANCC.  To investigate fork 
progression under these circumstances, we examined the focus formation of RPA32 
(Figure 2A), a marker of stalled replication forks
48,49
.  Compared to wild-type cells, 
slightly increased numbers of Mcm4
chaos3/chaos3
 and Fancc
-/-
 cells were positive for ≥5 
RPA32 foci (1.2- and 1.6-fold, respectively) though only Fancc
-/-
 cells exhibited a 
significant increase (p<0.001), similar to our previous observations
40
.  The marginal 
increase in RPA32 foci in Mcm4
chaos3/chaos3
 cells may be due to intrinsic upregulation of 
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the FA pathway, which could compensate for a loss of dormant origins in the recovery of 
stalled/collapsed forks, preventing the formation of such foci.  Indeed, loss of FANCC in 
Mcm4
chaos3/chaos3
 cells resulted in drastically increased levels of RPA32 foci (>3-fold, 
p<0.001, relative to wild-type cells).  Furthermore, the number of RPA32 foci co-
localizing with H2AX foci, a marker of DNA double strand breaks50, exhibited a similar 
trend with the highest increase (>3.8-fold, p<0.001, relative to wild-type cells) seen in 
Mcm4
chaos3/chaos3
;Fancc
-/-
 cells.  These findings suggest that FANCC plays a crucial role 
in preventing stalled/collapsed forks, particularly in the absence of dormant origins.  We 
then investigated the ability of Mcm4
chaos3/chaos3
;Fancc
-/-
 cells to progress through the cell 
cycle.  Cell cycle analysis reproduced a typical profile of Mcm4
chaos3/chaos3
 cells
17,39,51
 
including a reduced S phase fraction (24.6% vs. 28.1% in wild-type, p<0.01) and G2/M 
accumulation (24.1% vs. 21.1% in wild-type, p<0.01)(Figure 2B; Supplementary Figure 
S2).  While cell cycle profiles for Fancc
-/-
 cells were indistinguishable from 
Mcm4
chaos3/chaos3
 cells, these trends were further exacerbated in Mcm4
chaos3/chaos3
;Fancc
-/-
 
cells, in which the S phase and G2/M fractions were 19.3% and 28.0%, respectively 
(p<0.001).  Mcm4
chaos3/chaos3
;Fancc
-/-
 cells therefore suffer from a greatly increased level 
of late replication intermediates, accumulating during the G2/M phases. 
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Despite FA pathway activation, Mcm4
chaos3/chaos3
 cells exhibit an increase in sites of 
isolated DNA synthesis in early M phase 
Although Mcm4
chaos3/chaos3
 cells exhibited only a marginal increase in RPA32/H2AX 
foci, they still exhibited significant G2/M phase accumulation (Figure 2B).  This may 
therefore stem from an additional defect, such as delayed completion of DNA replication.  
Recent studies reported that delayed DNA replication can be identified as sites of 
localized DNA synthesis persisting until early M phase by pulse-labeling with EdU, a 
thymidine analogue (referred to as “EdU spots”)52,53.  We therefore quantified EdU spots 
in prophase cells after a short pulse labeling (10 min) of EdU.  We also examined the co-
localization of EdU spots with FANCD2 foci in wild-type and Mcm4
chaos3/chaos3
 cells 
(Figure 3A), as EdU spots co-localize with FANCD2 foci
52,53
 as well as FANCI foci 
(Supplementary Figure S3A) in early M phase.  Compared to wild-type cells, a greatly 
elevated percentage (>3-fold, p<0.001) of Mcm4
chaos3/chaos3
 cells contained prophase EdU 
spots even in the untreated condition (Figure 3B).  Consistent with previous studies
52,53
, 
the majority of EdU spots indeed co-localized with FANCD2 foci in either genotype, 
resulting in a corresponding increase in the number of Mcm4
chaos3/chaos3
 cells positive for 
EdU-FANCD2 co-localizations.  This was further supported by the analysis of individual 
EdU spots, which showed that only a minor fraction failed to co-localize with FANCD2 
in either genotype (Figure 3C), possibly representing loci that are naturally late 
replicating.  Interestingly, analysis of individual FANCD2 foci revealed an almost 
exclusive increase in those co-localizing with EdU spots in Mcm4
chaos3/chaos3
 cells (Figure 
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3C).  Consistent with previous findings
52
, we also observed that treatment with a low 
dose of APH greatly elevated the numbers of both EdU spots and FANCD2 foci in both 
genotypes (Supplementary Figure 3B), yielding trends very similar to the untreated 
condition.  Taken together, these observations indicate that the elevated number of 
FANCD2 foci seen in Mcm4
chaos3/chaos3
 cells is primarily due to an increased number of 
sites exhibiting isolated DNA synthesis, though this activation is apparently insufficient 
to prevent this synthesis from being delayed until prophase.  We interpret these findings 
as follows: a loss of dormant origins not only lowers the efficiency of stalled fork 
recovery but also generates long, origin-poor regions.  The FA pathway can effectively 
compensate for the former, thus preventing the formation of RPA32/H2AX foci as seen 
in Mcm4
chaos3/chaos3
 cells (Figure 2A).  In the latter case, however, it is almost inevitable 
that fork stalling occurs and persists more frequently in origin-poor regions, thereby 
delaying the completion of DNA replication in these regions until early M phase despite 
FA pathway activation. 
 
The FA pathway exerts its role in preventing delayed DNA replication under conditions 
of replication stress 
Based on our interpretations, activation of the FA pathway should act against the 
formation of EdU spots at prophase, though its effect may be limited.  On the other hand, 
given the high level of EdU-FANCD2 co-localizations, an alternative possibility is that 
FANCD2 mono-ubiquitination is actually required for this isolated form of DNA 
Luebben et al., 2014 
 
111 
 
synthesis.  To distinguish between these two possibilities, we repeated our pulse-labeling 
experiments to score prophase EdU spots in all four genotypes in the untreated conditions 
(Figure 4A and B).  A reproducibly elevated percentage (>2-fold, p<0.001) of 
Mcm4
chaos3/chaos3
 cells were positive for EdU spots relative to wild-type cells, whereas 
Fancc
-/-
 cells displayed no significant difference from wild-type (p=0.251), consistent 
with the idea that mono-ubiquitinated FANCD2 is dispensable for this isolated DNA 
synthesis.  Interestingly, however, a slightly increased percentage of 
Mcm4
chaos3/chaos3
;Fancc
-/-
 cells contained EdU spots compared to Mcm4
chaos3/chaos3
 cells 
(p<0.01), suggesting that FANCC is actually required to prevent the formation of EdU 
spots in the absence of dormant origins.  To further test the role of the FA pathway in 
preventing this delayed replication, we treated cells with a low dose of APH, which 
substantially increased the number of EdU spots in all genotypes (Figure 4C and D).  A 
significantly increased number (1.5-fold compared to wild-type cells, p<0.001) of Fancc
-
/-
 cells were now positive for ≥10 APH-induced EdU spots.  As APH is known to slow 
fork velocities
36,53
, increase the frequency of fork stalling
16,54
 and hyper-activate dormant 
origins
14,16
, it seems likely that such conditions make the role of the FA pathway more 
crucial to sustain fork progression and prevent delayed replication.  Indeed, we observed 
a sharp increase in the number of Mcm4
chaos3/chaos3
;Fancc
-/-
 cells exhibiting ≥10 APH-
induced EdU spots (1.9-fold increase compared to wild-type cells, p<0.001), with a 2-
fold higher number of APH-induced EdU spots per cell compared to all other genotypes.  
These data support the idea that FANCC, and potentially other components of the FA 
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pathway, function to prevent delayed DNA replication, particularly under conditions of 
replication stress. 
 
The frequencies of spontaneous MN and 53BP1 nuclear bodies are significantly 
increased in Mcm4
chaos3/chaos3
;Fancc
-/-
 cells 
Based on the above findings, we conclude that Mcm4
chaos3/chaos3
;Fancc
-/-
 cells suffer from 
two distinct defects: 1) a greatly increased level of stalled/collapsed forks due to the lack 
of two major fork recovery mechanisms (dormant origins and the FA pathway), and 2) an 
increased number of sites in which replication is delayed until early M phase.  To 
investigate the consequences of these accumulated late replication intermediates, we first 
looked at the formation of MN, which occurs at an elevated frequency in Mcm4
chaos3/chaos3
 
and Fancc
-/-
 cells
16,40
.  Using the cytokinesis-block MN assay
55
, we observed that 
Mcm4
chaos3/chaos3
 cells reproducibly exhibited a 2.9-fold increase in spontaneous MN 
compared to wild-type cells (p<0.001, Figure 5A).  Fancc
-/-
 cells showed an even higher 
increase (3.5-fold, p<0.001), with the most severe phenotype seen for 
Mcm4
chaos3/chaos3
;Fancc
-/-
 cells (5.3-fold, p<0.001).  If unresolved, late replication 
intermediates can also manifest as 53BP1 nuclear bodies (53BP1-NBs) in the subsequent 
G1 phase nuclei
41,42
.  These structures co-localize with γH2AX and are often exquisitely 
symmetrical in terms of their appearance within the daughter nuclei, suggesting that they 
are derived from a common breakage event occurring during passage through M phase
41
.  
We thus measured the levels of 53BP1-NBs in G1 phase daughter nuclei contained 
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within binucleated cells using essentially the same protocol as the cytokinesis-block MN 
assay.  While Mcm4
chaos3/chaos3
 and Fancc
-/-
 cells displayed slightly increased numbers 
(1.16- and 1.5-fold, respectively) of G1 nuclei positive for 53BP1-NBs (p<0.01 and 
p<0.001, respectively) compared to wild-type, Mcm4
chaos3/chaos3
;Fancc
-/-
 cells had a 
substantial increase in 53BP1-NBs compared to either single mutant (1.9-fold, 
p<0.001)(Figure 5B).  Taken together, these findings suggest that FANCC and dormant 
origins coordinately function to prevent genome instability derived from late replication 
intermediates. 
 
Almost all B6 Mcm4
chaos3/chaos3
;Fancc
-/-
 pups die right after birth 
Given the additive effect of Fancc
-
 and Mcm4
chaos3
 in causing genome instability, we 
hypothesized that B6 Mcm4
chaos3/chaos3
;Fancc
-/-
 mice may exhibit more severe phenotypes 
than either single homozygote.  We therefore set up Fancc
+/-
 heterozygous intercrosses in 
the Mcm4
chaos3
 homozygous background to obtain B6 double homozygous mutants.  
Among 74 newborns, the numbers of pups for the three expected genotypes were not 
statistically different from the expected Mendelian ratio (p=0.640, see Table 1).  
However, 13 out of 15 double homozygous (Mcm4
chaos3/chaos3
;Fancc
-/-
) pups died shortly 
after birth, revealing a strikingly high rate of perinatal lethality.  We previously reported 
that Mcm4
chaos3
 and Fancc
-
 homozygosity each cause semi-lethality in this 
background
39,40
.  However, this cannot fully explain the high lethality of 
Mcm4
chaos3/chaos3
;Fancc
-/-
 pups, as their survival rate (13%) was substantially lower than 
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that of their Mcm4
chaos3/chaos3
;Fancc
+/+
 littermates (85%, p=7.64x10
-15
) or of Fancc
-/-
 mice 
(65%)
40
.  We also noticed that Mcm4
chaos3/chaos3
;Fancc
+/-
 pups exhibited a decreased rate 
of survival (69%) at 3 weeks of age compared to Mcm4
chaos3/chaos3
;Fancc
+/+
 pups 
(p=0.00582).  This Fancc dosage-dependent survival of Mcm4
chaos3/chaos3
 pups supports a 
synthetic lethal/sickness interaction between Mcm4
chaos3
 and Fancc
-
.  Histopathological 
analyses of Mcm4
chaos3/chaos3
;Fancc
-/-
 pups did not reveal an apparent cause of death.  Of 
the two Mcm4
chaos3/chaos3
;Fancc
-/-
 pups that survived past 3 weeks, one was euthanized for 
a non-tumor abscess at the age of 128 days while the other developed disseminated T-cell 
lymphoma in only 163 days (Supplementary Figure S4), much more quickly than the 
average tumor latency of about 12.4 months for Mcm4
chaos3/chaos3
 mice in the B6 
background
16
.  However, due to the very high rate of perinatal lethality, it has been 
extremely difficult to generate additional Mcm4
chaos3/chaos3
;Fancc
-/-
 pups even after the 
expansion of mating crosses.  Together, these data indicate that a concomitant loss of 
dormant origins and Fancc is incompatible with postnatal development in this inbred 
background. 
 
Mcm4
chaos3/chaos3
;Fancc
-/-
 mice are viable in a mixed genetic background but succumb to 
spontaneous tumors at much younger ages 
It is well known that phenotypic expression in mice is greatly influenced by genetic 
background.  We therefore reasoned that performing the same intercrosses in a different 
genetic background would allow us to obtain viable Mcm4
chaos3/chaos3
;Fancc
-/-
 mice to test 
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their tumor predisposition.  Indeed, we found Mcm4
chaos3/chaos3
;Fancc
-/-
 mice were viable 
when generated in a mixed background between C57BL/6J and C3HeB/FeJ.  Fancc
-/-
 and 
Mcm4
chaos3/chaos3
;Fancc
-/-
 mice were again born at reduced frequencies compared to the 
expected numbers (Supplementary Tables S1-2), but these differences were not 
statistically significant.  While Mcm4
chaos3/chaos3
;Fancc
-/-
 mice did not show any apparent 
developmental abnormalities, they did exhibit a slightly decreased average body weight 
(p<0.05)(Figure 6A).  A loss of dormant origins also worsened the hypogonadism 
phenotype of Fancc
-/-
 mice, as Mcm4
chaos3/chaos3
;Fancc
-/-
 mice exhibited a smaller average 
testes size (p<0.05 when compared to Fancc
-/-
 mice) with an increased number of empty 
seminiferous tubules (Supplementary Figure 5A and B).  After verifying an enhanced 
level of replication-associated genome instability in Mcm4
chaos3/chaos3
;Fancc
-/-
 MEFs in 
this background (Supplementary Figure S6), we aged cohorts of wild-type, 
Mcm4
chaos3/chaos3
, Fancc
-/-
 and Mcm4
chaos3/chaos3
;Fancc
-/-
 mice to observe the formation of 
spontaneous tumors until 14 months of age.  In agreement with previous findings
44,56
, 
>95% of wild-type and Fancc
-/-
 mice survived to the end of the study, with only one 
Fancc
-/-
 mouse exhibiting tumors at necropsy (Figure 6B).  As expected, the majority 
(~71%) of Mcm4
chaos3/chaos3
 mice succumbed to tumors before 14 months, as did ~84% of 
Mcm4
chaos3/chaos3
;Fancc
-/-
 mice.  The tumor spectrum displayed by 
Mcm4
chaos3/chaos3
;Fancc
-/-
 mice was largely similar to that of Mcm4
chaos3/chaos3
 mice, 
though the entire cohort that developed tumors before 235 days succumbed exclusively to 
lymphosarcomas (Figure 6C and Supplementary Tables S3-4).  Most of these tumors 
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were of T-cell origin (CD-3 positive), though B-cell tumors (B220 positive) were also 
observed (Supplementary Figure S7).  Notably, a myeloid leukemia was seen as well.  
Overall, Mcm4
chaos3/chaos3
;Fancc
-/-
 mice exhibited an average tumor latency of 279.7 days, 
much shorter than the 361.9 days seen for Mcm4
chaos3/chaos3
 mice.  This difference did not 
reach statistical significance (Log-Rank test, p=0.264), most likely due to great variation 
in the latencies in individual mice and gender-specific effects in this background 
(Supplementary Tables S3-4) 
57
.  However, it should be noted that a much greater 
proportion of Mcm4
chaos3/chaos3
;Fancc
-/-
 mice (~53%) developed spontaneous tumors 
before 300 days of age compared to Mcm4
chaos3/chaos3
 mice (~7%, p=1.21x10
-19
) 
suggesting that a concomitant loss of dormant origins and Fancc can accelerate 
tumorigenesis. 
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Discussion 
Exploiting the Mcm4
chaos3
 mouse model, we investigated the nature of FA 
pathway activation in the absence of dormant origins.  We hypothesized that this 
activation occurs to compensate for the rescue of stalled forks.  In agreement with our 
hypothesis, Mcm4
chaos3/chaos3
;Fancc
-/-
 cells exhibited impaired fork stability, an increased 
number of sites displaying delayed replication and greatly enhanced levels of genome 
instability.  Furthermore, we found that an intact FA pathway is required in 
Mcm4
chaos3/chaos3
 mice not only for promoting tumor suppression but also for supporting 
postnatal development under conditions in which the density of active origins is relatively 
low
39
. 
While the exact role of the FA pathway in unchallenged S phase is still largely 
unknown, a loss of Fancc in Mcm4
chaos3/chaos3
 cells clearly revealed its function in 
replication fork progression as well as stability.  In the absence of dormant origins, the 
FA core complex may facilitate translesion synthesis (TLS) to recover stalled forks
58-60
.  
Another recent study demonstrated a role of FANCD2 in BLM-mediated fork restart
47
.  
This mechanism may come into play in the absence of dormant origins.  Alternatively, if 
no appropriate choice is available for stalled fork recovery during S phase, the FA 
pathway may function to stabilize stalled forks, thereby manifesting as FANCD2/FANCI 
foci during the G2/M phases, as proposed earlier
33
.  Indeed, lack of a functional FA 
pathway leads to the degradation of nascent strands at stalled forks, supporting its role in 
fork protection
46,47,61
.  Furthermore, given the increased levels of spontaneous genome 
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instability in Fancc
-/-
 cells, it seems that there must be certain types of endogenous 
lesions that are primarily taken care of by the FA pathway rather than dormant origins.  
Fork recovery at such lesions may also be shared with HELQ, as double homozygosity 
for Fancc
-
 and Helq
gt
 greatly elevates genome instability
40
. 
In this study, we observed that an elevated level of FANCD2 focus formation in 
Mcm4
chaos3/chaos3
 cells during prophase (Supplementary Figures S1B) is primarily 
associated with the formation of EdU spots (Figure 3).  A recent study reported that 
polymerase eta deficiency induces common fragile site instability and the formation of 
EdU spots co-localizing with FANCD2 foci in early M phase, suggesting that EdU spots 
most likely represent delayed DNA replication within loci where replication 
intermediates long persist
52
.  Consistent with this idea, APH treatment predominantly 
induced EdU spots co-localizing with FANCD2 foci both in wild-type and 
Mcm4
chaos3/chaos3
 cells (Figure 3).  Despite the high rate of EdU-FANCD2 co-
localizations, an intact FA pathway is apparently dispensable for this type of DNA 
synthesis.  On the contrary, lack of a functional FA pathway actually increases the 
number of prophase EdU spots under conditions of replication stress, as seen in 
Mcm4
chaos3/chaos3
;Fancc
-/-
 cells in the untreated condition and both Fancc
-/-
 and 
Mcm4
chaos3/chaos3
;Fancc
-/-
 cells in the APH-treated condition (Figure 4).  These findings 
suggest the presence of an FA-independent mechanism(s) to support DNA synthesis at 
such loci until early M phase.  Such mechanisms may include HELQ, which functions 
parallel to FANCC, as we reported very recently
40
.  Moreover, it was recently shown that 
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the structure-specific endonucleases MUS81 and ERCC1 are also found at EdU spots 
along with FANCD2 but their presence on mitotic chromosomes does not depend on 
FANCC
53
.  While the exact mechanism(s) remains to be unveiled, it was demonstrated 
that depletion of these endonucleases increased the formation of MN, DNA ultra-fine 
bridges at anaphase and 53BP1-NBs
53,62
.  It will therefore be important to understand the 
roles of these endonucleases in the formation of EdU spots as well as the role of this late 
DNA synthesis in the resolution of late replication intermediates. 
Mcm4
chaos3/chaos3
 and Fancc
-/-
 cells/mice are phenotypically similar, particularly in 
the B6 background, with respect to genome instability (Figure 5) and susceptibility to 
newborn lethality and microphthalmia
39,44
.  However, Mcm4
chaos3/chaos3
 mice are highly 
prone to spontaneous tumorigenesis while Fancc
-/-
 mice are not.  One major phenotype 
that was found in Mcm4
chaos3/chaos3
 but not Fancc
-/-
 cells was an increased number of EdU 
spots in prophase in the untreated condition (Figure 4B).  We thus speculate that a 
reduction in the number of licensed origins by Mcm4
chaos3
 homozygosity not only causes 
a loss of dormant origins but also generates relatively long stretches of the genome that 
are devoid of any replication origins.  So, fork stalling within small regions lacking 
dormant origins may be fully replicated by the fork rescuing actions of the FA pathway 
described above.  However, this activity may not be sufficient in large, origin-poor loci 
so that completion of DNA synthesis in these regions is delayed until early M phase 
despite FA pathway activation, thus manifesting as a large increase in the number of 
EdU-FANCD2 co-localizations.  It is possible that a fraction of these sites may not even 
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fully complete DNA replication prior to anaphase.  Therefore, a combination of intrinsic 
chromosome instability along with an increased number of un-replicated loci could be a 
driving factor in spontaneous tumorigenesis in Mcm4
chaos3/chaos3
 mice. 
 While several mouse models have been generated to study the FA pathway, the 
majority fails to recapitulate the phenotypes of human FA patients, including tumor 
predisposition
63,64
.  We were unable to further test to what extent Mcm4
chaos3/chaos3
;Fancc
-
/-
 mice recapitulate other phenotypes of human FA patients, such as bone marrow failure.  
However, we think that Mcm4
chaos3
 homozygosity provides a unique condition in which 
to understand the role of the FA proteins as well as others in genome stability in 
unchallenged conditions, as recently shown for ATM
57
.  In particular, an FA core 
complex-independent role of FANCD2 in replication fork stability
61
 can also be 
investigated in Mcm4
chaos3/chaos3
 mice, which may clarify the role of FANCD2 in the 
formation of EdU spots.  Very recently, the first human genetic disorder caused by a 
mutant MCM4 gene was discovered
65,66
.  Cells from these patients exhibit chromosome 
fragility much like Mcm4
chaos3/chaos3
 cells.  Due to a very limited number of patients with 
this disorder, however, it is not yet unknown whether they are cancer prone.  
Nevertheless, it is quite possible that there remain undiscovered genetic disorders caused 
by mutations in MCM2-7 genes in which the physiological role of the FA pathway may 
become more apparent. 
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Table and figure legends 
Table 1 
Mcm4
chaos3/chaos3
;Fancc
-/-
 mice exhibit severe perinatal lethality in an inbred C57BL/6J 
background. 
 
Figure 1 
(A) A schematic of the consecutive dual labeling steps of the DNA fiber assay is shown 
at left.  Active replication forks were labeled with digoxigenin-conjugated dUTPs 
(250µM, red) for 20 minutes followed by labeling with biotin-conjugated dUTPs 
(250µM, green) for 30 minutes.  Fork velocity and origin-to-origin distances were 
determined as shown.  A representative image of adjacent origins is shown on the right 
with staining for digoxigenin-dUTPs (red) and biotin-dUTPs (green).  White arrowheads 
indicate the location of origins.  The scale bar is 10 µm.  (B) Box plots show the ranges 
observed for the origin-to-origin (ori-to-ori) distance (left) and fork velocity (right) 
values for each genotype.  Lines within the shaded boxes indicate the medians while the 
“+” signs show the location of the mean.  Black dots represent outliers.  The tables on the 
right show the summaries for ori-to-ori distances (top) and fork velocities (bottom).  
Significance was determined by t-test.  Asterisks denote: *p<0.05, **p<0.01 and 
***p<0.001.  NS means not significant.  WT, C3, FAC and C3;FAC refer to wild-type, 
Mcm4
chaos3/chaos3
, Fancc
-/-
 and Mcm4
chaos3/chaos3
;Fancc
-/-
, respectively. 
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Figure 2 
(A) Mcm4
chaos3/chaos3
;Fancc
-/-
 cells display a drastic increase in markers of persistently 
stalled replication forks upon exiting S phase.  Shown at left are representative images of 
all four genotypes co-stained for RPA (green) and γH2AX (red).  The average 
percentages of cells positive for 5 or more RPA foci (top right) or 5 or more RPA-
γH2AX co-localizations (bottom right) are also shown.  Error bars show the binomial 
error for the combined data set obtained from three independently performed 
experiments.  The scale bar is 10 µm.  Significance was determined by χ2-test.  (B)  
Mcm4
chaos3/chaos3
;Fancc
-/-
 cells experience a heightened accumulation in the G2/M phases.  
Shown are the average proportions of cells observed within the G1, S or G2/M phases for 
all four genotypes.  Error bars show the standard error of the mean (SEM) for at least 5 
independent replicates.  Asterisks denote: *p<0.05, **p<0.01 and ***p<0.001.  WT, C3, 
FAC and C3;FAC refer to wild-type, Mcm4
chaos3/chaos3
, Fancc
-/-
 and 
Mcm4
chaos3/chaos3
;Fancc
-/-
, respectively. 
 
Figure 3 
A higher number of prophase FANCD2 foci in Mcm4
chaos3/chaos3
 cells are the result of a 
sharp increase in EdU spots that co-localize with FANCD2.  (A) Shown are 
representative images of wild-type and Mcm4
chaos3/chaos3
 cells co-stained for EdU (green) 
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and FANCD2 (red) in the untreated (UNT) condition.  Prophase cells were identified by 
prominent chromatin condensation via DAPI staining (blue).  The scale bar is 10 µm.  (B) 
At top are the percentages of prophase cells positive for EdU spots (white bars) or EdU-
FANCD2 co-localization events (grey bars).  At bottom are the number of EdU spots 
(white bars) per prophase cell and the number of EdU-FANCD2 co-localization events 
(grey bars) per prophase cell.  Error bars show the binomial error for the combined data 
sets obtained from three independently performed experiments.  Significance was 
determined by χ2-test.  Asterisks denote: ***p<0.001.  (C)  Shown at top are the numbers 
of EdU spots with “EdU only” (white bars) as well as the number of EdU-FANCD2 co-
localization events (grey bars) observed in 150 prophase cells.  At bottom are the 
numbers of FANCD2 foci with “FANCD2 only” (black bars) as well as the number of 
EdU-FANCD2 co-localizations (shown again as grey bars) observed in 150 prophase 
cells.  WT and C3 refer to wild-type and Mcm4
chaos3/chaos3
, respectively. 
 
Figure 4 
A loss of dormant origins increases the number of EdU spots at prophase, which is 
further enhanced by disruption of Fancc.  (A) Shown are representative images of all four 
genotypes co-stained for EdU (green) and pH3 (red).  In this experiment, staining for 
pH3, a marker of condensed chromatin 
67
, was used to confirm the scoring of nuclei at 
prophase in addition to nuclear morphology by DAPI staining.  (B) Shown are the 
average percentages of prophase cells positive for EdU spots (top) and the number of 
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EdU spots per prophase cell (bottom).  (C) As in (A), with cells treated with 300nM APH 
for 24 hours.  (D) Shown are the average percentages of prophase cells positive for 10 or 
more EdU spots (top) and the number of EdU spots per prophase cell (bottom).  Nuclei 
(A,C) were stained with DAPI (blue).  Scale bars (A,C) are 10 µm.  Error bars (B,D) 
show the binomial error for the combined data sets obtained from three independently 
performed experiments.  Significance was determined by χ2-test.  Asterisks denote: 
**p<0.01 and ***p<0.001.  WT, C3, FAC and C3;FAC refer to wild-type, 
Mcm4
chaos3/chaos3
, Fancc
-/-
 and Mcm4
chaos3/chaos3
;Fancc
-/-
, respectively. 
 
Figure 5 
Mcm4
chaos3/chaos3
;Fancc
-/-
 cells show highly elevated  levels of MN and 53BP1-NBs.  (A) 
Shown are a representative image of binucleated cell positive for a micronucleus (left), 
the average percentages of binucleated cells positive for MN (middle) and a distribution 
of the number of MN per binucleated cell (right).  (B) Shown at left are representative 
images of a 53BP1-NB in a binucleated cell.  53BP1 staining is in red.  At middle are the 
average percentages of individual nuclei from binucleated cells positive for 53BP1-NBs, 
and at right are the distributions indicating the number of 53BP1-NBs per G1 phase 
nucleus.  All nuclei were stained with DAPI (blue).  All scale bars are 10 µm.  All error 
bars show the binomial error for the combined data sets obtained from three 
independently performed experiments.  Significance was determined by χ2-test.  Asterisks 
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denote: *p<0.05 and ***p<0.001.  WT, C3, FAC and C3;FAC refer to wild-type, 
Mcm4
chaos3/chaos3
, Fancc
-/-
 and Mcm4
chaos3/chaos3
;Fancc
-/-
, respectively. 
 
Figure 6 
(A) The average body weight of Mcm4
chaos3/chaos3
;Fancc
-/-
 mice derived in a C57BL/6J x 
C3HeB/FeJ mixed genetic background is slightly reduced.  Shown are the average body 
weights of the four genotypes in grams.  Error bars show the standard error of the means 
(SEMs) for at least 5 mice per genotype.  Significance was determined by t-test.  
Asterisks denote: *p<0.05.  (B) Mcm4
chaos3/chaos3
;Fancc
-/-
 mice succumb to tumors with a 
shorter latency than Mcm4
chaos3/chaos3
 mice in a C57BL/6J x C3HeB/FeJ mixed genetic 
background.  Shown are the tumor-free survival curves for all four genotypes.  (C) 
Shown are the tumor spectrums observed for Mcm4
chaos3/chaos3
 and Fancc
-/-
;Mcm4
chaos3/chaos3
 mice.  WT, C3, FAC and C3;FAC refer to wild-type, Mcm4
chaos3/chaos3
, 
Fancc
-/-
 and Mcm4
chaos3/chaos3
;Fancc
-/-
, respectively. 
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Table 1 
Genotype # of pups # of live pups % survival  
(all in Mcm4
chaos3/chaos3
) found at birth at birth at 3 wks at 3 wks p value 
Fancc
+/+
 20 18 17 85% - 
Fancc
+/-
 39 31 27 69% 0.00582 
Fancc
-/-
 15 2 2 13% 7.64E-15 
Total 74 51 46 62%  
 
  
Figure 1  Luebben et al., 2014 
128 
 
Figure 1 
 
Figure 2  Luebben et al., 2014 
129 
 
Figure 2 
 
Figure 3  Luebben et al., 2014 
130 
 
Figure 3 
 
Figure 4  Luebben et al., 2014 
131 
 
Figure 4 
 
Figure 5  Luebben et al., 2014 
132 
 
Figure 5 
 
Figure 6  Luebben et al., 2014 
133 
 
Figure 6 
 
  Luebben et al., 2014 
134 
 
Supplementary table and figure legends 
Supplementary Table S1 
Fancc
-/-
 mice are born at a frequency approximately equal to the expected Mendelian 
ratio in a C57BL/6J x C3HeB/FeJ mixed genetic background. 
 
Supplementary Table S2 
Mcm4
chaos3/chaos3
;Fancc
-/-
 mice are born at a frequency approximately equal to the 
expected Mendelian ratio in a C57BL/6J x C3HeB/FeJ mixed genetic background. 
 
Supplementary Table S3 
Summary of Mcm4
chaos3/chaos3
 tumor histopathology in a C57BL/6J x C3HeB/FeJ mixed 
genetic background. 
 
Supplementary Table S4 
Summary of Mcm4
chaos3/chaos3
;Fancc
-/-
 tumor histopathology in a C57BL/6J x C3HeB/FeJ 
mixed genetic background. 
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Supplementary Figure S1 
(A) Western blotting reveals a substantial reduction in the levels of MCM4 in both the 
total cell extracts (left) and chromatin fractions (right) of Mcm4
chaos3/chaos3
 and 
Mcm4
chaos3/chaos3
;Fancc
-/-
 cells.  Wild-type samples were also loaded in ratios of 0.4 and 
0.7 as a reference for the mutants.  (B) Mcm4
chaos3/chaos3
 cells display an increased number 
of FANCD2 foci in prophase.  Shown are the average percentages of prophase cells 
positive for 3 or more FANCD2 foci (top) as well as the average numbers of FANCD2 
foci per prophase cell (bottom).  Prophase cells were identified by prominent chromatin 
condensation via DAPI staining.  Error bars show the binomial error for the combined 
data set obtained from three independent experiments.  Significance was determined by 
χ2-test.  Asterisks denote: ***p<0.001.  (C) Western blotting shows that the amount of 
chromatin-loaded FANCD2 is below the threshold of detection in both Fancc
-/-
 and 
Mcm4
chaos3/chaos3
;Fancc
-/-
 cells.  This was consistent in both the untreated (UNT) and 
APH-treated (300nM, 4 hrs) conditions.  Stained membranes (A,C) were used as loading 
controls.  WT, C3, FAC and C3;FAC refer to wild-type, Mcm4
chaos3/chaos3
, Fancc
-/-
 and 
Mcm4
chaos3/chaos3
;Fancc
-/-
, respectively. 
 
Supplementary Figure S2 
Representative images of cell cycle analyses are shown for all genotypes.  Cell cycle 
analysis was performed by measuring EdU incorporation in combination with propidium 
iodide staining (DNA content) by flow cytometry.  The FL2-H channel was used to 
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quantitate DNA content while the FL4-H channel was used to measure EdU 
incorporation.  Cells were categorized according to the gates shown (R2: G1; R3: S; R4: 
G2/M).  WT, C3, FAC and C3;FAC refer to wild-type, Mcm4
chaos3/chaos3
, Fancc
-/-
 and 
Mcm4
chaos3/chaos3
;Fancc
-/-
, respectively. 
 
Supplementary Figure S3 
(A) Representative images of FANCI foci co-localizing with EdU spots are shown.  
Wild-type cells in the untreated (UNT) or APH-treated (150nM, 24 hrs) conditions were 
co-stained for EdU (green) and FANCI (red).  (B) Shown at left are representative images 
of FANCD2 foci co-localizing with EdU spots.  Wild-type and Mcm4
chaos3/chaos3
 cells 
were co-stained for EdU (green) and FANCD2 (red) following treatment with APH 
(150nM, 24 hrs).  At top, middle are the average percentages of prophase cells positive 
for EdU spots (white bars) or EdU-FANCD2 co-localization events (grey bars).  At 
bottom, middle are the number of EdU spots per prophase cell as well as the number of 
EdU-FANCD2 co-localization events per prophase cell.  While the number of EdU spots 
and EdU-FANCD2 co-localizations were drastically increased in both genotypes after 
APH treatment, Mcm4
chaos3/chaos3
 cells still showed a more severe phenotype.  Shown at 
top, right are the numbers of EdU spots with “EdU only” (white bars) as well as the 
number of EdU-FANCD2 co-localization events (grey bars) observed in 150 prophase 
cells.  At bottom, right are the numbers of FANCD2 foci with “FANCD2 only” (black 
bars) as well as the number of EdU-FANCD2 co-localizations (shown again as grey bars) 
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observed in 150 prophase cells.  These data were consistent with results obtained in the 
untreated conditions.  Error bars show the binomial error for the combined data sets 
obtained from three independent experiments.  Significance was determined by χ2-test.  
Asterisks denote: ***p<0.001.  All nuclei were stained with DAPI (blue).  Scale bars are 
10 µm.  WT and C3 refer to wild-type and Mcm4
chaos3/chaos3
, respectively. 
 
Supplementary Figure S4 
Shown are representative images of a T-cell lymphoma from a Mcm4
chaos3/chaos3
;Fancc
-/-
 
mouse in an inbred C57BL/6JR background, including hematoxylin and eosin (H&E) 
stains (left) and immunohistochemistry using the T-cell marker CD-3 (middle) and the B 
cell marker B220 (right).  The images were taken from slightly different areas of the 
same liver.  The scale bar is 200 µm.  WT and C3 refer to wild-type and Mcm4
chaos3/chaos3
, 
respectively. 
 
Supplementary Figure S5 
(A) Mcm4
chaos3/chaos3
;Fancc
-/-
 mice display a reduced average testes size in a C57BL/6J x 
C3HeB/FeJ mixed genetic background.  Shown are the average percentages of total testes 
weight relative to total body weight.  Samples were taken from mice euthanized at 6 
weeks of age.  Error bars show the SEMs for at least 5 mice per genotype.  Significance 
was determined by t-test.  Asterisks denote: *p<0.05, **p<0.01.  (B) Histological 
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analysis by hematoxylin and eosin (H&E) staining shows a mosaic pattern of normal and 
empty seminiferous tubules in Fancc
-/-
 and Mcm4
chaos3/chaos3
;Fancc
-/-
 mice, with 
Mcm4
chaos3/chaos3
;Fancc
-/-
 mice having the most severe phenotype.  Scale bars are 1500 
µm for the whole testis sections (top) and 75 µm for the enlarged images (bottom).  WT, 
C3, FAC and C3;FAC refer to wild-type, Mcm4
chaos3/chaos3
, Fancc
-/-
 and 
Mcm4
chaos3/chaos3
;Fancc
-/-
, respectively. 
 
Supplementary Figure S6 
The number of MN, 53BP1-NBs and UFBs are also increased in Mcm4
chaos3/chaos3
;Fancc
-/-
 
cells derived from a C57BL/6J x C3HeB/FeJ mixed genetic background.  (A) Shown are 
the average percentages of binucleated cells positive for MN (left) and distributions 
indicating the number of MN per binucleated cell (right).  (B) Shown are the average 
percentages of individual G1 nuclei from binucleated cells positive for 53BP1-NBs (left) 
and distributions indicating the number of 53BP1-NBs per binucleated cell nucleus 
(right).  (C) Only Mcm4
chaos3/chaos3
;Fancc
-/-
 cells display a significantly increased number 
of PICH-coated UFBs.  Shown at left are representative images of an anaphase cell 
positive for a PICH-coated UFB.  PICH staining is in red, and chromosomes are stained 
with DAPI (blue).  At middle are the average percentages of anaphases positive for 
UFBs.  At right are the distributions for the number of UFBs per anaphase cell.  All error 
bars show the binomial error for the combined data sets obtained from at least three 
independent experiments.  Significance was determined by χ2-test.  Asterisks denote: 
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*p<0.05 and ***p<0.001.  WT, C3, FAC and C3;FAC refer to wild-type, 
Mcm4
chaos3/chaos3
, Fancc
-/-
 and Mcm4
chaos3/chaos3
;Fancc
-/-
, respectively. 
 
Supplementary Figure S7 
Shown at top are representative images of lymphosarcomas from Mcm4
chaos3/chaos3
;Fancc
-
/-
 mice, including H&E stains (left) and immunohistochemistry using the T cell marker 
CD-3 (middle) and the B cell marker B220 (right).  The lymphosarcoma of mouse #58 is 
of T cell origin, while that of mouse #57 is of B cell origin.  At bottom are representative 
images of a presumed myeloid leukemia from a Mcm4
chaos3/chaos3
;Fancc
-/-
 mouse (#40), 
including an H&E stain (left) and immunohistochemistry using the pan-macrophage 
marker F4/80 (middle) and the myeloid precursor marker MPO (right).  Scale bars are 
100 µm.  C3;FAC refers to Mcm4
chaos3/chaos3
;Fancc
-/-
. 
Supplementary Table S1  Luebben et al., 2014 
140 
 
Supplementary Table S1 
Fancc
+/-
 x Fancc
+/-
 
Genotype Expected Observed 
Fancc
+/+
 or Fancc
+/-
 105 112 
Fancc
-/-
 35 28 
Total 140 140 
Χ
2
-test: p = 0.17186 
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Supplementary Table S2 
Mcm4
chaos3/chaos3
;Fancc
+/-
 x Mcm4
chaos3/chaos3
;Fancc
+/- 
Genotype Expected Observed 
Mcm4
chaos3/chaos3
;Fancc
+/+
 or 
Mcm4
chaos3/chaos3
;Fancc
+/-
 
73.5 81 
Mcm4
chaos3/chaos3
;Fancc
-/-
 24.5 17 
Total 98 98 
Χ
2
-test: p = 0.08018 
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Supplementary Table S3 
Mouse # Sex Age 
(Days) 
Location Diagnosis Immunohistochemistry 
33 F 269 LN, liver, lung, 
spleen 
Lymphosarcoma CD3+ 
25 M 314 Abdomen Myeloid or 
histiocytic 
sarcoma 
CD3-; B220-; MPO-; 
F4/80- 
32 F 318 Long bone of 
hind leg, 
ribcage 
Osteosarcoma N.D. 
62810 F 352 Spleen, 
pancreas, liver, 
lung, fat pad 
Lymphosarcoma CD3-; B220- 
31 F 354 LN, liver, lung, 
spleen 
Lymphosarcoma N.D. 
26 M 373 Behind front leg Schwannoma N.D. 
34 F 389 Abdominal fat 
pads, pancreas 
Histiocytic 
sarcoma 
Mac-2+; F4/80+ 
27 M 408 LN, thymus Hematopoietic 
neoplasia 
Mac-2+; F4/80- 
29 M 416 Abdomen Histiocytic 
sarcoma 
Mac-2+; F4/80+ 
328 M 425 LN, pancreas Histiocytic 
sarcoma 
N.D. 
28 M 425 N.T.F.   
56 M 425 N.T.F.   
36 F 425 N.T.F.   
37 F 425 N.T.F.   
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Supplementary Table S4 
Mouse # Sex Age 
(Days) 
Location Diagnosis Immunohistochemistry 
12910 F 109 LN, liver, lung, 
spleen, kidneys, 
thymus 
Lymphosarcoma CD3+; B220- 
58 F 110 LN, liver, lung, spleen Lymphosarcoma CD3+ 
41 F 117 LN, liver, lung, spleen Lymphosarcoma CD3+ 
57 F 142 LN, liver, lung, spleen Lymphosarcoma B220+ 
44 F 197 LN, liver, lung, 
spleen, kidneys, 
thymus 
Lymphosarcoma CD3+;B220- 
49 F 234 LN, liver, lung, 
spleen, kidneys 
Lymphosarcoma CD3-; B220- 
51 F 259 Within front leg Myeloid or 
histiocytic 
sarcoma 
CD3-; B220-; MPO-; 
F4/80- 
47 F 263 LN, liver, lung, spleen Myelomonocytic 
neoplasia 
MPO+; F4/80+ 
42 F 280 LN, liver, lung, 
spleen, pancreas, 
thymus 
Lymphosarcoma; 
myeloid leukemia 
B220+ 
235 M 288 Back Schwannoma N.D. 
48 F 351 LN, liver, lung, spleen Hematopoietic CD3+; B220+ 
40 F 421 LN, liver, uterus, 
pancreas, spleen 
Myeloid leukemia MPO+ 
30 M 425 Small mass adjacent to 
testis 
Histiocytic 
sarcoma 
Mac-2+; F4/80+ 
46 F 425 LN Lymphosarcoma N.D. 
50 F 425 Abdomen, liver, 
spleen 
Histiocytic 
sarcoma 
Mac-2+; F4/80+ 
55 M 425 LN, spleen Lymphosarcoma CD3+; B220+ 
43 M 425 N.T.F.   
52 M 425 N.T.F.   
45 F 425 N.T.F.   
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Summary 
HELQ is a superfamily 2 DNA helicase found in archaea and metazoans.  It has been 
implicated in processing stalled replication forks and in repairing DNA double-strand 
breaks and inter-strand crosslinks.  Though previous studies have suggested the 
possibility that HELQ is involved in the Fanconi anemia (FA) pathway, a dominant 
mechanism for inter-strand crosslink repair in vertebrates, this connection remains 
elusive.  Here, we investigated this question in mice using the Helq
gt
 and Fancc
- 
strains.  
Compared with Fancc
-/- 
mice lacking FANCC, a component of the FA core complex, 
Helq
gt/gt
 mice exhibited a mild of form of FA-like phenotypes including hypogonadism 
and cellular sensitivity to the crosslinker mitomycin C.  However, unlike Fancc
-/-
 primary 
fibroblasts, Helq
gt/gt
 cells had intact FANCD2 mono-ubiquitination and focus formation.  
Notably, for all traits examined, Helq was non-epistatic with Fancc, as Helq
gt/gt
;Fancc
-/-
 
double mutants displayed significantly worsened phenotypes than either single mutant.  
Importantly, this was most noticeable for the suppression of spontaneous chromosome 
instability such as micronuclei and 53BP1 nuclear bodies, known consequences of 
persistently stalled replication forks.  These findings suggest that mammalian HELQ 
contributes to genome stability in unchallenged conditions through a mechanism distinct 
from the function of FANCC. 
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Introduction 
Maintaining genome stability is critical for cells, given that the genome is under 
constant attack by numerous exogenous and endogenous agents
1
.  It is inevitable that 
cells will have to proceed with genome duplication using damaged template DNA, which 
can perturb the normal progression of replication forks.  To cope with this problem, 
organisms have developed multiple mechanisms to allow the rescue of stalled replication 
forks
2
.  Such mechanisms include firing of dormant origins, translesion synthesis with 
error-prone DNA polymerases and homology-directed fork recovery
3-5
.  Evidence 
suggests that the latter two mechanisms are in part coordinated by the concerted work of 
proteins that are mutated in Fanconi anemia (FA)
6
, a rare polygenic human genetic 
disorder
7
.  FA patients exhibit genome instability, congenital abnormalities, bone marrow 
failure, hypogonadism and a heightened predisposition to cancer
7,8
.  FA is uniquely 
characterized by its cellular hypersensitivity to agents that induce DNA inter-strand 
crosslinks (ICLs)
7,9
, although it is unclear how ICL repair is functionally linked with 
stalled fork recovery in unchallenged conditions. 
 The DNA helicase HELQ was first discovered in the human and mouse genomes 
through its homology to MUS308
10
, a DNA repair enzyme required for ICL resistance in 
Drosophila melanogaster
11,12
.  Although it is unlikely that its vertebrate ortholog POLQ 
plays a major role in ICL repair
13-15
, together they make up a unique family of DNA 
polymerases that possess a helicase domain in the N-terminus in addition to a C-terminal 
polymerase domain
16-18
.  Unlike its paralog POLQ, HELQ lacks a polymerase domain, 
Luebben et al., 2013 
 
159 
 
and several lines of evidence indicate that HELQ performs a distinct function from 
POLQ.  HELQ is an ortholog of the Drosophila mus301 gene
19
, which is allelic to the 
female-sterile mutation spindle-C (spn-C)
20
.  Mutations in spn-C result in the failed 
repair of meiotic double-strand breaks (DSB) and activation of the meiotic checkpoint
20
, 
which was not observed in mus308 mutants.  In line with this observation, it was also 
reported that the Caenorhabditis elegans ortholog helq-1 plays a role in meiotic DSB 
repair by promoting postsynaptic RAD-51 filament disassembly
21
.  These findings 
suggest that HELQ has a role in meiotic DSB repair through homologous recombination 
(HR) in these species.  In humans, HELQ is expressed in the testes, ovaries, heart and 
skeletal muscle
22
.  However, its function is largely unknown. 
Biochemically, human HELQ exhibits ATP-dependent 3'-5' DNA helicase 
activity in vitro
10,23
.  A recent study demonstrated that human HELQ preferentially 
unwinds the parental strands of forked structures with a nascent lagging strand, and that 
this activity is stimulated by replication protein A (RPA)
23
.  These findings suggest that 
HELQ is likely to participate in the recovery of stalled or collapsed replication forks.  
Several studies have suggested that this role of HELQ is closely linked with the FA 
pathway.  A genetic study in C. elegans demonstrated that helq-1 is required for ICL 
repair and is epistatic to fcd-2
24
, an ortholog of FANCD2 whose product is mono-
ubiquitinated by the FA core complex as a key step in this pathway
25
.  However, C. 
elegans contains only a few FA proteins and lacks multiple members comprising the FA 
core complex
26
.  HELQ may belong to a primitive FA pathway in C. elegans, but its 
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evolution seems to have taken a complex path.  Paradoxically, disruption of Helq in 
chicken DT40 cells, which contain all of the FA proteins, did not confer hypersensitivity 
to ICL inducing agents
14
.  In human cells, HELQ depletion confers hypersensitivity to the 
crosslinker mitomycin C (MMC) and HR deficiency, the latter reported to be epistatic to 
FANCD2
27
.  Consistent with this observation, exogenously expressed GFP-tagged HELQ 
co-localizes with RAD51 foci as well as FANCD2 foci after treatment with the 
topoisomerase I inhibitor camptothecin (CPT)
23
.  There is little information about the link 
between HELQ and the FA pathway in mammals, particularly in the absence of 
exogenous DNA damage. 
To decipher the enigmatic connection between HELQ and the FA pathway, we 
have generated Helq deficient mice using a gene-trap allele named Helq
gt
 for phenotypic 
comparisons to mice deficient for Fancc, encoding FANCC, a component of the FA core 
complex
28
 in the same genetic background.  For all traits examined including 
hypogonadism and MMC sensitivity, we found that loss of Helq results in phenotypes 
considerably milder than Fancc deficiency.  Moreover, our data show that combined loss 
of Helq and Fancc leads to further severe phenotypes than single mutants, presenting no 
evidence for epistasis.  Importantly, the strongest inter-dependence for Helq and Fancc 
was observed for the suppression of spontaneous genome instability derived from 
replication fork failures rather than MMC resistance.  These findings collectively suggest 
that HELQ contributes to genome stability in unperturbed conditions in a manner that is 
distinct from the function of FANCC. 
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Materials and methods 
Mouse strains and MEFs 
All experiments were performed using mice from a C57BL/6J background and were 
approved by the Institutional Animal Care and Use Committee (IACUC).  MEFs were 
generated from 12.5-14.5 dpc embryos and cultured using standard procedures as 
described previously
29
.  All mice were genotyped by PCR.  The primers used are 
available upon request. 
 
Quantitative RT-PCR 
RNA was isolated from either cultured MEFs or testes tissue using the PureLink RNA 
Mini Kit (Ambion, Life Technologies) and the RNeasy Kit (QIAGEN).  cDNA was then 
synthesized using the Superscript VILO cDNA Synthesis Kit (Invitrogen, Life 
Technologies).  q-PCR analysis was performed on the LightCycler 480 (Roche) using 
primer pairs specific for exons 1-2, exons 11-12 and the chimeric mutant transcript 
spanning between exon 11 and the inserted vector.  Expression was normalized to 
glyceraldehydes 3-phosphate dehydrogenase (GAPDH). 
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Western Blotting and Immunofluorescence Microscopy 
Western blotting and immunofluorescence staining were carried out using standard 
procedures as described previously
29
. 
 
Antibodies 
For immunofluorescence and western blotting procedures, we used anti-phospho-histone 
H3, anti-RPA32, anti-γH2AX, anti-CENP-A, anti-phospho-CHK1 (Cell Signaling; 
#9706, #2208, #2577, #2048, #2341, respectively), anti-FANCD2 for foci staining, anti-
FANCI, anti-53BP1, anti-MCM4 (Abcam; ab2187 or ab108928, ab74332, ab36823, 
ab4459, respectively), anti-FANCA (Bethyl Laboratories; #A301-980A), anti-CHK1 
(Santa Cruz; sc-8408), anti-FANCD2 for western blots (Epitomics; #2986-1) and anti-
HELQ (MyBioSource; #MBS120320).  For the DNA Fiber assay, anti-digoxigenin 
antibody conjugated with rhodamine from Roche (11207750910) and the streptavidin-
AlexaFluor488 from Invitrogen (S-32354) were used. 
 
siRNA transfection in MEFs, HEK 293T and PD331 cells 
One million cells were seeded per well in a six-well dish followed by transfection with 
either 50nM (MEFs) or 25 nM (HEK 293T, PD331) of non-targeted control small 
interfering RNA (siRNA) (#D-001206-13-20, siGENOME Smart pool), HELQ siRNA 
(#M-015379-01-0005, siGENOME Smart pool) or FANCA siRNA (#M-019283-02-
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0005, siGENOME Smart pool) from Dharmacon.  This was performed using OPTI-MEM 
and Lipofectamine RNAiMAX (Life technologies) transfection reagents.  Twenty-four 
hours later, a second round of transfection was performed using the same concentration 
of siRNA, followed by 24 h culture.  Cells were then re-plated according to the analysis 
performed.  The PD331 cell lines were obtained from the Oregon Health & Science 
University Fanconi Anemia Cell Repository (Portland, Oregon). 
 
Metaphase Analysis 
MEFs were treated with 600 nM MMC for 2 h and allowed 22 h to recover before 
harvest.   For experiments using the HEK 293T cell line, cells were treated with 300 nM 
MMC for 24 h before harvest.  In all experiments, cells were treated with colcemid for 1-
2 h prior to harvest.  Following hypotonic treatment, cells were fixed with fixative (3:1 
methanol: acetic acid in volume) and dropped on slides in a humidified environment to 
optimize spreading.  Slides were mounted in 1X 4’,6-diamidino-2-phenylindole, 
dihydrochloride (DAPI) anti-fade solution the following day and blinded for analysis.  
Only metaphases with 38-41 chromosomes (MEFs) or 64-72 chromosomes (HEK 293T 
cells) were included in the analysis.  Chromosome aberrations including radials, 
gaps/breaks, fragments and ring chromosomes were scored for all experiments.  HEK 
293T cells were cultured using the same procedures used for MEFs. 
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DNA Fiber Assay 
All techniques and methods of analysis used were performed as described previously
29,30
.  
Briefly, replication forks were sequentially labeled with deoxyuridine triphosphates 
(dUTPs) conjugated with digoxigenin (digoxigenin-dUTPs) for 20 min and with biotin-
dUTPs for 30 min.  Labeled cells were dropped onto slides, fixed, and dipped into lysis 
buffer for the release and extension of DNA fibers.  Incorporated dUTPs were visualized 
by anti-digoxigenin rhodamine conjugate (Roche, Branford, CT) and streptavidin, -Alexa 
Fluor 488 (Invitrogen, Carlsbad, CA). 
 
Colony Formation Assay 
Five hundred cells were plated in 6 cm dishes along with the corresponding doses of 
MMC.  For HEK 293T cells, the bottoms of the dishes were coated with poly-L-lysine 
beforehand to aid in cell adhesion.  Colonies were stained using crystal violet after a 
period of 1 week (HEK 293T) or 2 weeks (PD331 and PD331+FANCC) and counted. 
 
MTT Assay 
The Vybrant MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) Cell 
Proliferation Assay Kit (Life Technologies) was used.  Briefly, 5 x 10
4
 (experiments with 
MEFs) or 1 x 10
4
 (experiments with PD331 cell lines) cells of each genotype were plated 
per well in a 96-well plate.  The next day, cells were either treated with the corresponding 
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drug or left untreated for 5 days before the assay was performed according to the 
manufacturer’s instructions.  A570 was used to measure relative cell proliferation while 
A670 was used as a reference for background absorbance. 
 
Cytokinesis-Block Micronucleus Assay and G1 Phase Cell Analyses 
The cytokinesis-block micronucleus (MN) assay was performed as described 
previously
29,31
, except that cells were treated with cytochalasin B (0.72 µg/ml) for 4-5 h.  
The same procedure was used for all analyses of G1 cells. 
 
Measuring HR events using the fluorescent yellow direct repeat transgenic locus system 
Wildtype and Helq
gt/gt
 MEFs carrying the FYDR transgenic locus
32
 in the hemizygous 
state were generated as described above.  Cells at passage 2 were plated, grown for three 
days and then re-plated into three separate dishes.  The corresponding drug treatments 
(untreated, MMC, CPT) were then administered the following day and washed out after 
24 hours.  After a 48-hour recovery period, cells were analyzed by flow cytometry using 
the FL1-H and FL2-H channels of the FACSCalibur (BD Biosciences). 
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Results 
Helq deficient mice carry a gene-trap allele that generates HELQ--Geo 
To generate a mouse Helq mutant, we searched the BayGenomics database for mutant 
mouse embryonic stem (ES) cell clones
33,34
.  Gene-trap vectors are designed to have a 
splice acceptor site upstream of a reporter gene, typically -Geo, a fusion gene of the -
galactosidase and neomycin resistance genes.  We found that the ES cell clone RRF112 
has an insertion of the gene-trap vector pGT0Lxf in the intron between exons 11 and 12 
of the Helq locus (Supplementary Figure S1A).  This gene-trap allele was named Helq
gt
.  
The Helq
gt
 allele is expected to create a chimeric transcript containing exons 1-11 of Helq 
and -Geo (Figure 1A), producing a truncated HELQ protein that is fused with -Geo at 
its C-terminal end (Figure 1B).  This mutant protein still retains its helicase domain but 
lacks the three C-terminal domains with highly conserved motifs thorough archaea to 
metazoans
35,36
.  It has been demonstrated that these domains are required for normal 
helicase activity in other species
36-38
.  To generate mice that carry the Helq
gt
 allele, we 
microinjected RRF112 ES cells into blastocysts from an inbred strain of C57BL/6J (B6) 
females using a standard method.  High-percentage chimera males were mated with B6 
inbred females to produce carriers of the Helq
gt
 allele, which were identified by genomic 
PCR using primer pairs that amplify the boundary sequences of the insertion site 
(Supplementary Figure S1B).  Helq
gt
 heterozygous (Helq
gt/+
) carriers appear normal in 
every aspect and are undistinguishable from wildtype (WT) mice (data not shown).  A 
congenic line of Helq
gt
 has been established by backcrossing Helq
gt/+
 mice to inbred B6 
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mice at least 10 generations.  This B6 congenic Helq
gt
 line was used for the following 
studies unless otherwise indicated. 
 
WT Helq mRNA and protein are virtually undetectable in Helq
gt
 homozygous cells 
Helq
gt/+
 mice were timed-mated to generate mouse embryonic fibroblasts (MEFs).  We 
extracted total RNA from WT and Helq
gt
 homozygous (Helq
gt/gt
) MEFs for reverse-
transcription (RT)-PCR and verified the presence of the chimeric message in Helq
gt/gt
 
MEFs and the wildtype mRNA in WT MEFs (Figure 1A) by sequencing the RT-PCR 
products (Supplementary Figure S1C).  Furthermore, quantitative (q-)RT-PCR on RNA 
from WT and Helq
gt/gt
 cells revealed that the WT transcript containing exons 11-12 was 
nearly absent in Helq
gt/gt
 cells (less than 1 % of WT) that predominantly express the 
chimeric transcript containing exon 11 and -Geo sequences (Figure 1C).  As we found 
no difference between WT and Helq
gt/gt
 cells for the levels of transcript containing exons 
1-2 far upstream of the insertion site, the presence of the gene-trap vector likely has no 
effect on Helq expression.  Next, we performed western blots on whole cell extracts from 
WT and Helq
gt/gt
 MEFs (Figure 1D).  Consistent with the q-RT-PCR results, WT HELQ 
(~120kD) was undetectable in Helq
gt/gt
 cells.  Instead, they predominantly express the 
mutant HELQ protein (HELQ--Geo).  A semi-quantitative analysis indicated that 
Helq
gt/gt
 cells express WT HELQ protein less than 10% of the levels seen in WT cells, if 
any at all (Figure 1E).  These data suggest that the splice acceptor site at the Helq
gt
 allele 
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is very efficient, leading to very little expression of normal, full-length HELQ in Helq
gt/gt
 
cells. 
 
Helq deficiency causes a mild form of hypogonadism, which is not epistatic to Fancc 
As previous studies suggested an intriguing connection of HELQ to the FA 
pathway
23,24,27
, we generated Helq
gt/gt
 mice along with WT control mice to examine 
hypogonadism, one of the most consistent phenotypes seen in the FA mouse models
39
. 
We found that Helq
gt/gt
 males have significantly smaller testes (p<0.005, t-test), ~62% of 
WT males by weight at 6 weeks of age (0.165g0.01 and 0.102g0.01 for the average 
WT and Helq
gt/gt
 testes weights, respectively, Figure 2A).  Histological analysis revealed 
that approximately 10~20% seminiferous tubules in Helq
gt/gt
 males are atrophied and 
devoid of spermatocytes and spermatogonia (Figure 2B).  This mosaic pattern of normal 
and empty seminiferous tubules is very similar to what has been seen in a number of FA 
mouse models
40-48
.  For comparison, we also generated mice homozygous for a Fancc 
allele (Fancc
-
)
28
 in the same background.  As reported earlier
28,49,50
, Fancc
-/-
 males had 
extremely small testes weighing an average of only 0.027g0.001 (only 16% of WT by 
weight, p<0.0001, t-test) with >90% of seminiferous tubules exhibiting atrophy or 
hypotrophy (Figure 2A and B).  When compared to Helq
gt/gt
 males, Fancc
-/-
 testes were 
only 26% of Helq
gt/gt
 testes by weight (p<0.0001, t-test).  These data suggest that the 
hypogonadism observed in Helq
gt/gt
 testes is not as severe as in Fancc
-/-
 testes.  To test for 
an epistatic relationship between Helq and Fancc for this trait, we generated mice doubly 
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homozygous for Helq
gt
 and Fancc
-
.  Testes from Helq
gt/gt
;Fancc
-/-
 males were even 
smaller (the average 0.021g0.002) than those from Fancc-/- males (p<0.05, t-test), 
having all seminiferous tubules completely devoid of spermatogonia and spermatocytes.  
While Fancc
-/-
 and Helq
gt/gt
;Fancc
-/-
 mice are significantly smaller in size than WT and 
Helq
gt/gt
 mice, these observations still hold true after taking this into consideration 
(Supplementary Figures S2A and B).  Collectively, these findings indicate that mutations 
in Helq and Fancc are not epistatic to each other in causing hypogonadism. 
 
Female-specific sub-fertility in Helq
gt/gt
 mice is consistent with germ cell hypoplasia 
during embryogenesis 
It has been reported that hypogonadism in FA mouse models is attributed to severely 
compromised proliferation of primordial germ cells
40,41,45,51
.  This leads to sterility in a 
significant fraction of Fancc
-/-
 mice
28,49
.  However, as hypogonadism in Helq
gt/gt
 males is 
very modest, they are fertile, producing litters at size comparable to Helq
gt/+ 
males 
(Supplementary Table S1).  It should be noted that younger Helq
gt/gt
 males have a greatly 
increased fraction (>50%) of seminiferous tubules exhibiting atrophy or hypotrophy 
(Supplementary Figure S2C).  However, as they get older, the number of such tubules 
decreases.  This is most likely because surviving germ cells in Helq
gt/gt
 males can 
repopulate as spermatogonial stem cells and support fertility as previously seen in FA 
mouse models
42
.  Therefore, much like the FA genes, Helq is required for normal 
proliferation of germ cells during embryogenesis but has no effect on spermatogonial 
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stem cells at later stages.  Different from males, Helq
gt/gt
 females were more severely 
affected with hypogonadism (see Figure 2C and D).  The number of ova per ovary was 
reduced to 60.61 in Helqgt/gt females compared to 313.2 in WT females (p<0.0001, t-
test).  When initially tested in a 129/B6 mixed background, four of seven Helq
gt/gt
 females 
were sterile.  Fertile Helq
gt/gt
 females tended to have small litters, with an average litter 
size of only 3.5 (n=6).  This female-specific sub-fertility is consistent with germ cell 
hypoplasia during embryogenesis, as it is believed that the total oocyte pool is determined 
at this stage.  Taken together, while Helq
gt/gt
 mice exhibit hypogonadsim that is 
phenotypically similar to FA mouse models, its underlying mechanism is distinct given 
the non-epistatic relationship between Helq and Fancc. 
 
Helq
gt/gt
 mice are born in the expected Mendelian ratio, showing no growth retardation 
As Helq
gt/gt
 males are fertile, we performed crosses between Helq
gt/gt
;Fancc
+/-
 males and 
Helq
gt/+
;Fancc
+/-
 females to efficiently generate Helq
gt/gt
;Fancc
-/-
 mice in the B6 
background.  A total of 105 mice were genotyped at 3 weeks of age (Supplementary 
Table S2).  While Helq
gt/gt
 mice were found at the expected ratio, the number of Fancc
-/-
 
mice in this background was reduced to ~65% of the expected number (17 vs 26.25, 
p<0.05, 2-test) as described previously52.  Only 7 Helqgt/gt;Fancc-/- mice were observed 
at this age but this number was not statistically different from 13.125, the expected 
number (p>0.05, 2-test).  This relatively small number of Helqgt/gt;Fancc-/- mice is most 
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likely attributed to the sub-lethality of Fancc
-/-
 mice in this background.  As shown in 
Figure 2E, we also found that Fancc
-/-
 mice are significantly smaller in size (average 
weight of 7.4g0.61) compared to WT (8.7g0.15) and Helqgt/gt mice (8.8g0.39).  
Helq
gt/gt
;Fancc
-/-
 mice were even smaller than Fancc
-/-
 mice, weighing 6.0g0.71 on 
average, though this difference did not reach statistical significance likely due to the 
small number of mice examined.  Overall, Helq
gt/gt
 mice are quite healthy, exhibiting 
phenotypes milder than Fancc
-/-
 mice.  It was reported that Fancc
-/-
 mice in the B6 
background are essentially tumor-free
53
.  Similarly, a small-scale aging study with 11 
Helq
gt/gt
 mice (5 males and 6 females) in this background showed no significant increase 
in spontaneous tumor incidence up to 21 months of age.  This was not surprising, given 
the milder phenotypes of Helq
gt/gt
 mice compared to Fancc
-/-
 mice. 
 
Mono-ubiquitination and focus formation of FANCD2 are intact in Helq
gt/gt
 cells 
Our data so far did not support epistasis between Helq and Fancc.  Therefore, we next 
tested the role of Helq in FANCD2 focus formation, a signature of FA pathway 
activation
25
.  For this purpose, we used primary WT and Helq
gt/gt
 MEFs, as Fancc
-/- 
and 
Helq
gt/gt
;Fancc
-/-
 cells, both lacking a functional FA core complex, do not form FANCD2 
foci
25
.  As shown in Figure 3A and B, no significant difference was observed in the 
percentage of cells positive for FANCD2 foci between WT and Helq
gt/gt
 cells even after 
treatment with the crosslinker MMC.  The same was true after treatment with aphidicolin 
(APH), a replication inhibitor and robust inducer of FANCD2 and FANCI foci
54
 (Figure 
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3C and D).  Focus formation of FANCD2/FANCI at prophase, markers of unresolved 
replication intermediates
55
, were also unchanged between these two genotypes in 
response to MMC or APH (Supplementary Figure S3A and B).  Agreeing with these data, 
mono-ubiquitination of FANCD2 was also robustly induced in Helq
gt/gt
 cells following 
treatment with either MMC or APH (Figures 3E and F).  In comparison, no mono-
ubiquitinated FANCD2 could be detected in Fancc
-/- 
and Helq
gt/gt
;Fancc
-/-
 cells.  These 
data collectively suggest that Helq is not required for FANCD2 mono-ubiquitination or 
focus formation. 
 
HELQ plays a minor role in MMC resistance in a manner non-epistatic with FANCC 
Previous studies reported that HELQ is required for ICL resistance in worms and 
humans
24,27
 but not in chicken DT40 cells
14
.  Therefore, we tested Helq
gt/gt
 cells for MMC 
hypersensitivity, another hallmark of FA cells
6
.  For this line of experiments, we used 
primary MEFs with the following four genotypes, WT, Helq
gt/gt
, Fancc
-/-
, and 
Helq
gt/gt
;Fancc
-/-
.  First, we examined MMC-induced chromosome aberrations.  
Representative metaphase spreads for each genotype after MMC treatment are shown in 
Figure 4A.  Although we scored 120 metaphases per experimental group, the total 
number of MMC-induced chromosome aberrations was not statistically different between 
Helq
gt/gt
 and WT cells (Figure 4B and C).  However, Helq
gt/gt
 cells did exhibit a slight but 
significant increase in radials (9.2%2.6 as opposed to 5.0%2.0 in WT), a type of 
complex chromosome aberrations that occur frequently in MMC-treated FA cells (Figure 
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4A and D).  Consistent with their hypersensitivity to MMC, the majority of Fancc
-/-
 cells 
exhibited chromosome aberrations (72.5%4.09, Figure 4B) with a drastic increase in 
radials (36.7%4.42, Figure 4D).  Intriguingly, Helqgt/gt;Fancc-/- cells showed statistically 
higher levels of chromosome aberrations including radials (84.5%3.35 and 46.7%4.57 
in Figure 4B and D, respectively) compared to Fancc
-/-
 cells.  These data suggest that 
Helq
gt/gt
 cells are not as extremely sensitive to MMC as Fancc
-/-
 cells.  However, as 
Helq
gt/gt
;Fancc
-/-
 cells showed a significantly higher number of MMC-induced 
chromosome aberrations than Fancc
-/-
 cells, HELQ contributes to MMC resistance 
through a mechanism that is distinct from the function of FANCC.  Given the mild 
sensitivity of Helq
gt/gt
 cells to MMC, this mechanism is likely to be a secondary 
alternative to the FA pathway.  Finally, we tested the effect of MMC on the proliferation 
of these cells using a MTT assay.  In agreement with the metaphase analysis, a 5 days 
culture in multiple low doses of MMC significantly reduced the proliferation of Fancc
-/-
 
and Helq
gt/gt
;Fancc
-/-
, but not Helq
gt/gt
, cells (Figure 4E).  While Helq
gt/gt
;Fancc
-/-
 cells 
appeared to display an even greater reduction in proliferation than Fancc
-/-
 cells, this did 
not reach statistical significance.  Together, these data are consistent with the idea of 
HELQ performing a minor role in MMC resistance. 
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HELQ depletion leads to only mild MMC sensitivity compared with FANCA-
depleted/FANCC-deficient human cells 
Although Helq
gt/gt
 cells apparently lack normal full-length HELQ, they do express the 
mutant HELQ--Geo protein.  Therefore, we wondered whether the mild MMC 
sensitivity of Helq
gt/gt
 cells truly reflects a consequence of HELQ deficiency.  To test this 
possibility, we depleted HELQ and/or FANCA, another FA core complex member
56
, in 
human HEK 293T cells via small interfering RNAs (siRNA, see Supplementary Figure 
S4A).  At two different doses, FANCA depletion, but not HELQ depletion, led to MMC 
hypersensitivity as measured by colony formation assay (Supplementary Figure S4B).  
Similar results were obtained for MMC-induced chromosome aberrations 
(Supplementary Figures S4C and D).  To further confirm these results, we also performed 
siRNA-mediated depletion of HELQ in PD331 cells (Supplementary Figure S4E), a 
human cell line deficient for FANCC, or their complemented counterparts 
(PD331+FANCC).  In a colony formation assay, HELQ-depleted PD331+FANCC cells 
exhibited modestly decreased survival following MMC treatment (at 300nM) compared 
to control siRNA-treated counterparts, though this was still very mild compared with that 
of the PD331 cells (Supplementary Figure S4F).  Only when measured by MTT assay (5 
days culture, 15-45 nM doses) could we observe a clear non-epistatic relationship 
between HELQ and FANCC (Supplementary Figure S4G).  Together, these data 
collectively support the idea that HELQ plays a minor, backup role in MMC resistance in 
mammalian cells that is most likely non-epistatic to FANCC. 
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A loss of HELQ and/or FANCC alters the distribution of replication fork speed in 
unperturbed S phase, increasing persistent stalled forks 
Several studies have suggested that HELQ and its orthologs have a role in the recovery of 
stalled or collapsed replication forks
23,38,57
.  As we noticed a modest but significant 
increase in spontaneous chromosome aberrations in Fancc
-/-
 and Helq
gt/gt
;Fancc
-/-
 cells 
(Figure 4B), we examined replication fork speed in WT, Helq
gt/gt
, Fancc
-/-
, and 
Helq
gt/gt
;Fancc
-/-
 cells in unperturbed S phase using the DNA fiber technique 
(Supplementary Figure S5A)
29
.  Although the mean fork speeds were not different among 
the four genotypes (Figure 5A), the distributions of fork speed values were significantly 
different (p<0.001, Kolmogorov-Smirnov test, Supplementary Figure S5B).  
Categorizing fork speeds into three ranges (slow, mid and fast), we found that compared 
to WT cells, Helq
gt/gt
 cells exhibited a slight increase of forks in mid-range speed and a 
decrease in slow forks (Figure 5B).  Fancc
-/-
 cells had a higher frequency of faster forks 
with a decrease of mid-speed forks.  Increases in mid-speed and faster forks in these cells 
might have contributed to faster median fork speeds in these cells (Figure 5A).  
Helq
gt/gt
;Fancc
-/-
 cells displayed increases in both faster and slower fork speeds, 
indicating that their fork movement is greatly altered from WT cells even in unchallenged 
S phase.  Although counterintuitive, an increase in faster forks may suggest an increase in 
fork stalling events, as we previously reported
29
.  This is due to the number of fork 
termination events.  Faster forks that terminate within the duration of the assay likely 
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escape detection.  Thus, an increase in fork stalling leads to a decreased number of fork 
termination events, thereby leaving a greater number of faster forks visible for 
measurement.  To address if this was the case, we next looked at RPA32 foci, markers of 
stalled replication forks (Figure 5C)
58,59
.  Compared to WT cells (7.06%0.61), increased 
percentages of Helq
gt/gt
 and Fancc
-/-
 cells (9.20%0.61 and 12.5%0.88, respectively) 
were positive for RPA32 foci (Figure 5D), with an even further increase observed in 
Helq
gt/gt
;Fancc
-/-
 cells (15.6%0.98).  These differences were all significant to one 
another (p<0.001, 2-test).  The number of RPA32 foci co-localizing with H2AX foci, a 
marker of DSBs
60
, was also significantly increased in Helq
gt/gt
 and Fancc
-/-
 cells 
(5.46%0.48 and 7.44%0.70, respectively) compared to WT cells (4.08%0.47).  
However, unlike RPA32 foci, there was no significant increase in RPA/H2AX co-
localizing foci in Helq
gt/gt
;Fancc
-/-
  cells (8.02%0.73) compared to Fancc-/- cells.  These 
data present a new line of evidence that Helq and Fancc are not epistatic to each other in 
the recovery of stalled/collapsed replication forks even in unchallenged S phase. 
 
Helq and Fancc are independently required to prevent the formation of spontaneous MN 
Persistent stalled forks can lead to micronucleus (MN) formation if unresolved before M 
phase entry
29,61
.  Therefore, we measured spontaneous MN levels using the cytokinesis-
block MN assay (Figure 6A), a standard assay for this purpose
31
.  Compared to WT cells 
(4.33%0.48, see Figure 6B), significantly increased numbers of Helqgt/gt (9.56%0.98) 
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and Fancc
-/-
 (14.0%1.16) cells contained spontaneous MN (p<0.001, 2-test for both).  
Helq
gt/gt
;Fancc
-/-
 cells exhibited a >6-fold increase (26.1%1.47) compared to WT cells 
and this number was also statistically higher than that of Fancc
-/-
 cells (p<0.001, 2-test).  
These data indicate that Helq and Fancc function in a non-epistatic manner to prevent 
spontaneous MN likely through contributing to the recovery of stalled forks.  We 
exploited this modest but significant increase in spontaneous MN in Helq
gt/gt
 cells to 
validate that this allele accurately reflects the consequences of loss of HELQ function.  
We performed siRNA-mediated knockdown of Helq (or Helq
gt
) transcripts in WT and 
Helq
gt/gt
 MEFs, respectively (Supplementary Figures S6A and B).  This resulted in 
significantly increased spontaneous MN levels in WT cells (p<0.001, 2-test) but not 
Helq
gt/gt
 cells (Supplementary Figure S6C), suggesting that the HELQΔ-β-Geo mutant 
protein is likely devoid of any activity.  Unresolved replication intermediates can cause 
the formation of MN through two mechanisms; non-disjunction of sister chromatids and 
chromosome/chromatid breaks.  These two mechanisms can be distinguished by staining 
MN for the centromeric marker CENP-A
62
 (Supplementary Figure S6D).  We found that 
both types of MN were increased in these mutant cells with similar ratios (Supplementary 
Figure S6E).  We also measured MMC-induced MN in these cells.  Because of the 
relatively higher levels of spontaneous MN in mutant cells, we subtracted spontaneous 
MN frequency values from those in the MMC treatment to obtained differences (numbers 
in the white bars in Figure 6B).  These were then compared to evaluate the effect of 
MMC on MN formation.  Such values were very similar between WT and Helq
gt/gt
 cells 
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(7.44 and 7.22, respectively), while Fancc
-/-
 cells showed a 2-fold larger value (14.1) at 
the same dose used for the metaphase analysis (Figure 4).  These findings are consistent 
with the idea that the FA pathway is a major pathway for MMC resistance for which 
HELQ performs only a minor role.  Helq
gt/gt
;Fancc
-/-
 cells showed a value (15.0) that was 
not much higher than that of Fancc
-/-
 cells.  We think this may be due to the extreme 
sensitivity of Helq
gt/gt
;Fancc
-/-
 cells to MMC.  As the majority of them have multiple 
abnormal metaphase chromosomes (Figure 4C), a fraction of them may not complete M 
phase to form MN in the subsequent G1 phase, making this value smaller.  Unlike 
spontaneous conditions, MMC increased exclusively CENP-A- MN (Supplementary 
Figure S6E).  We also examined CPT-induced MN (Supplementary Figure S6F).  Both 
Helq
gt/gt
 and Fancc
-/-
 cells showed significantly increased levels of CPT-induced MN 
(14.2 and 14.2, respectively) compared to WT cells (9.93).  The largest increase was 
observed in Helq
gt/gt
;Fancc
-/-
 cells (16.2).  However, we were unable to determine 
epistasis for this, due to the limited sensitivity of the MN assay. 
 
Helq and Fancc are not epistatic to suppress the formation of 53BP1 nuclear bodies 
Recently, it was shown that unresolved replication intermediates can rupture during 
passage through M phase, leading to the formation of what are known as 53BP1 nuclear 
bodies (53BP1-NB) in G1 phase cells
63,64
.  Interestingly, such bodies are often exquisitely 
symmetrical in terms of their appearance within the daughter nuclei (Figure 6C).  To 
score 53BP1-NB, G1 phase cells are typically identified as cyclin A negative
63,64
.  
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However, owing to the lack of a cyclin A antibody that works well for mouse cells, we 
used the cytokinesis-blocking reagent, cytochalasin B, to identify G1 phase daughter 
nuclei as those contained within binucleated cells (Figure 6C).  Although there was no 
significant difference in the percentage of 53BP1-NB positive nuclei between WT and 
Helq
gt/gt
 cells (33.3%1.67 and 34.2%1.68, respectively), the number of nuclei 
containing 53BP1-NB was statistically higher in Fancc
-/-
 cells (37.8%1.71, p<0.01, 2 
test) (Figure 6D).  Much like spontaneous MN formation (Figure 6B), Helq
gt/gt
;Fancc
-/-
 
cells showed a drastic increase in 53BP1-NB containing nuclei (54.1%1.77) compared 
to Fancc
-/-
 cells (p<0.001, 2 test) with more nuclei containing multiple 53BP1-NB 
(Figure 6E).  These data are consistent with the non-epistatic relationship between Helq 
and Fancc in preventing genome instability derived from persistent stalled forks. 
 
Helq
gt/gt
 cells display recombinant frequencies at the FYDR locus that are comparable 
with wildtype 
Given its involvement in meiotic DSB repair in flies and worms
20,21
, we postulated that 
HELQ may function downstream of the FA pathway in HR, similar to other proteins such 
as BRCA2 and PALB2
65,66
.  Supporting this idea, it has been reported that depletion of 
HELQ in human cells lowers HR efficiency
27
.  To test this, we used the FYDR transgenic 
locus system
32
 to measure the levels of spontaneous, MMC-induced and CPT-induced 
HR events in Helq
gt/gt
 MEFs (Supplementary Figures S7A and B).  Under all conditions 
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tested, Helq
gt/gt
 cells showed levels of recombination that were comparable with WT 
(Figure 6F and Supplementary Figure S7C), suggesting the possibility that HELQ is not a 
major player in HR. 
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Discussion 
In this study, we have investigated a possible involvement of HELQ in the FA 
pathway using the Helq
gt
 strain as a model.  We showed that primary Helq
gt/gt
 MEFs are 
capable of FANCD2 mono-ubiquitination and focus formation (Figure 3).  By phenotypic 
comparison to Fancc
-/- 
mice/cells in the same genetic background, we found that Helq
gt/gt
 
mice/cells exhibit a mild form of FA-like phenotypes such as hypogonadism (Figure 2) 
and MMC sensitivity (Figure 4).  Importantly, double mutants for Helq
gt 
and Fancc
-
 had 
more severe phenotypes than single mutants (Table 1).  These findings are in stark 
contrast to the complete epistasis reported for Fanca/Fancc and Fanca/Fancg in 
mice
50,67
.  Collectively, our data show that Helq and Fancc are not epistatic to one 
another for any trait tested. 
Although our data strongly indicate that HELQ and FANCC function in parallel, 
it remains possible that HELQ could function in HR as a downstream step in the FA 
pathway.  If this is the case, then the non-epistatic relationship between Helq and Fancc 
implicates that the FA core complex and HR machinery have a complicated, non-linear 
relationship as seen previously for fancc and brca2 in chicken DT40 cells
68
.  However, 
using the FYDR transgenic locus system, we found that HELQ’s role in HR is likely to be 
non-essential or minor (Figure 6F).  This is further supported by the fact that (i) Helq
gt/gt
 
mice are fully viable as opposed to early embryonic lethality seen for disruption of major 
HR genes
69
, (ii) loss of HELQ results in only modest sensitivity to MMC (Figure 4), and 
(iii) Helq
gt/gt
 males are fertile, showing no apparent meiosis defects.  Alternatively, it may 
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be that the role of HELQ in HR is only visible when a major player in HR is 
compromised.  Thus, the precise role of HELQ in HR requires further investigation. 
Our data show that loss of Helq in mice results in phenotypes considerably milder 
compared with those seen in Fancc
-/-
 mice (Table 1).  This observation was not limited to 
Helq
gt 
homozygosity, as HELQ depletion in human HEK 293T cells did not cause a 
statistically higher level of MMC-induced chromosome aberrations or affect cellular 
survival as measured by colony formation assay (Supplementary Figure S4A-D).  
Furthermore, HELQ-depleted PD331+FANCC cells exhibited only modestly reduced 
cellular survival at 300 nM MMC (colony formation assay) (Supplementary Figure S4F).  
Although our data show a consistent trend towards HELQ and FANCA/FANCC being 
non-epistatic in human cells, the minor role of HELQ in MMC resistance may have 
prevented it from being manifested as statistically significant, except in the MTT assay 
(Supplementary Figure S4G). 
It is noteworthy that HELQ orthologs do not exist in bacteria or yeast but archaea 
have HELQ-like helicases (HELQa)
70
.  Atomic structures of HELQa from three species 
revealed the presence of five structural domains in HELQ, which are also conserved in 
HELQ in metazoans
36,38,71
.  Mutagenesis studies have demonstrated that normal helicase 
activity requires the three C-terminal domains
36,72
, which are missing from HELQ--
Geo in Helq
gt/gt 
mice (Figure 1B).  Therefore, it is likely that HELQ--Geo is also 
devoid of helicase activity.  Furthermore, the presence of -Geo is also likely to 
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jeopardize its enzymatic activity.  In line with this, siRNA-mediated knockdown of the 
Helq
gt
 transcript in Helq
gt/gt
 cells did not lead to increased levels of spontaneous MN 
(Supplementary Figure S6C).  Furthermore, given the normal phenotypes of Helq
gt/+ 
mice, we do not think that this allele confers any dominant-negative effect.  Future 
studies using a null allele may give definitive answers for these issues. 
Although there are definitely certain differences, HELQa and mammalian HELQ 
share similar biochemical properties with preference for structures resembling stalled 
replication forks, suggesting their role in stalled fork recovery
23,57,73
.  Consistent with this 
idea, loss of HELQ caused an increase in stalled forks even in unchallenged conditions, 
and this role of HELQ was not epistatic to Fancc (Figure 5D).  The non-epistatic 
relationship for Helq and Fancc is much clearer for the formation of spontaneous MN 
and 53BP1-NB (Figure 6), which are derived from persistent stalled forks, rather than 
MMC-induced chromosome aberrations (Figure 4).  Therefore, we propose that the major 
role of HELQ is the rescue of stalled forks in normal S phase.  Given that HELQ and the 
FA core complex function in parallel, elucidating such a role of HELQ may provide clues 
to decipher the function of the FA pathway in physiological conditions beyond ICL 
repair.  Furthermore, as HELQ remains functional in FA mutant cells, it could potentially 
be exploited to provide a therapeutic benefit against cancers with FA pathway disruption. 
Recent genome-wide associations studies have identified single nucleotide 
polymorphisms at loci within or near HELQ that are associated with increased risks for 
several different cancers including upper aerodigestive tract cancers and head and neck 
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cancers
74-77
.  Our study was unable to detect an increased incidence of spontaneous 
tumors in Helq
gt/gt 
mice.  This could be due to several different factors, such as genetic 
background and species difference.  The majority of FA mouse models do not show a 
strong cancer phenotype, despite the FA pathway’s tumor suppressive role in humans39.  
Therefore, it may be necessary to test the role of Helq in tumor suppression in a 
sensitized background. 
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Table and figure legends 
Table 1 
Summary of phenotypes following Helq and/or Fancc disruption.  “-“ indicates no 
significant change from wildtype, while “+”, “++” & “+++” refer to progressively more 
severe phenotypes.  “+/-“ refers to a small but significant effect.  N.D. means not 
determined. 
 
Figure 1 
Characterization of the Helq
gt
 allele.  Diagrams (drawn to scale) depicting the transcripts 
(A) and resulting peptides (B) for the wildtype (WT) Helq and Helq
gt
 alleles.  The HELQ 
protein is split into five domains, the first two of which contain the well conserved motifs 
of the DEAD/DEAH helicase box.  The Helq
gt
 allele has most of domain 3 and all of 
domains 4 and 5 replaced by -Geo.  (C) qRT-PCR analysis using total RNA extracted 
from WT or Helq
gt/gt
 (H
gt/gt
) MEFs is shown.  Data for the wildtype transcript containing 
exons 11 and 12 (top), the chimeric transcript containing exon 11 and the gene-trap 
vector (middle), and transcript containing exons 1 and 2 upstream of the insertion site 
(bottom) are shown.  Helq
gt/gt
 MEFs have less than 1/100
th
 of the levels of the wildtype 
Helq mRNA compared to WT cells (see top).  Experiments were duplicated using RNA 
samples from different MEF lines to confirm reproducibility.  A representative qRT-PCR 
data set is shown.  (D) Western blotting shows no detectable levels of wildtype HELQ 
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protein in Helq
gt/gt
 MEFs.  A band corresponding to the HELQ
Δ
-β-Geo fusion peptide 
appears at the predicted molecular weight of ~230kDa only in the lysate from Helq
gt/gt
 
cells.  (E) Loading differing ratios of protein reveals that the amount of wildtype HELQ 
protein (indicated by arrow) is extremely low in Helq
gt/gt
 MEFs.  Asterisk indicates non-
specific bands.  A stained membrane was used as a loading control for (D) and (E).   
 
Figure 2 
Helq
gt/gt
 mice exhibit a hypogonadism phenotype reminiscent of mouse models of 
Fanconi anemia.  (A) Helq
gt/gt
, Fancc
-/-
 and Helq
gt/gt
;Fancc
-/-
 males show significantly 
reduced testes weights at 6 weeks of age.  At least 5 males were observed per genotype.  
(B) Histological analysis by hematoxylin and eosin (H&E) staining shows a mosaic 
pattern of normal and empty seminiferous tubules in Helq
gt/gt
, Fancc
-/-
 and 
Helq
gt/gt
;Fancc
-/-
 mice, with the respective phenotypes becoming increasingly worse.  
Scale bars are 1500 µm for the whole testis sections (top) and 75 µm for the enlarged 
images (bottom).  (C) Helq
gt/gt
 females exhibit smaller ovaries with a reduced number of 
follicles at 3 weeks of age.  Six ovaries from 3 wildtype females and 10 ovaries from 5 
Helq
gt/gt
 females were observed.  (D) H&E staining of ovaries from wildtype and Helq
gt/gt
 
females.  Example ova-containing follicles are indicated by arrows.  Scale bars are 500 
µm.  (E) Helq
gt/gt
 mice display normal body weights at weaning age, unlike Fancc
-/-
 and 
Helq
gt/gt
;Fancc
-/-
 mice which are significantly smaller.  In (A), (C) and (E), error bars 
represent the standard error of the means (SEMs) and significance was determined by t-
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test.  Statistical significance at p<0.05, p<0.01, and p<0.001 are indicated as *, ** and 
***, respectively.  WT, H
gt/gt
, Fac
-/-
 and H
gt/gt
;Fac
-/-
 refer to wildtype, Helq
gt/gt
, Fancc
-/-
 
and Helq
gt/gt
;Fancc
-/-
, respectively. 
 
Figure 3 
FANCD2 mono-ubiquitination and focus formation remain intact in Helq
gt/gt
 cells.  
Shown are representative images of FANCD2 foci (green) in response to MMC (A) or 
APH (C) in WT and Helq
gt/gt
 cells.  Cells were harvested immediately following 
treatment except for the 2 hours treatment of 1200nM MMC, in which cells were given 
22 hours of recovery time before harvest.  Nuclei were stained with DAPI (blue).  Scale 
bar is 10 µm.  The average percentages of cells positive for FANCD2 foci in response to 
MMC or APH are shown in (B) and (D), respectively.  (E) Western blotting shows that 
Helq
gt/gt
 cells exhibit normal FANCD2 mono-ubiquitination in response to MMC.  The 
defect observed in Fancc
-/-
 and Helq
gt/gt
;Fancc
-/-
 cells is shown for a better comparison.  
(F) Helq
gt/gt
 cells do not display any defect in FANCD2 mono-ubiquitination in response 
to APH.  Cells were treated with 300 nM APH for either 4 hrs (4H) or 24 hrs (24H) prior 
to harvest.  Error bars (B, D) represent the binomial error for the combined data set.  A 
stained membrane and MCM4 were used as loading controls in (E) and (F), respectively.  
W, H, F and H;F in (E, F) refer to wildtype,  Helq
gt/gt
, Fancc
-/-
 and Helq
gt/gt
;Fancc
-/-
 cells, 
respectively.  UNT refers to untreated cells. 
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Figure 4 
Helq
gt/gt
 cells display modest sensitivity to MMC.  (A) Shown are representative images 
of DAPI-stained metaphase spreads from all genotypes following MMC treatment (600 
nM MMC for 2 hrs followed by 22-hr recovery before harvest).  White arrowheads 
indicate chromosome aberrations.  Enlarged images of radial structures from the Fancc
-/-
 
and Helq
gt/gt
;Fancc
-/-
 samples are shown at bottom.  Scale bar is 10 µm.  (B) Shown are 
the average percentages of metaphases positive for chromosomal aberrations in the 
untreated (left) or MMC-treated (right) conditions.  For each experimental group, 120 
metaphases were scored.  (C) A histogram displaying the number of aberrations per 
metaphase for each genotype after MMC treatment is shown.  (D) The average 
percentages of metaphases positive for radial structures after MMC treatment are shown.  
(E) The MTT assay reveals that Helq
gt/gt
 cells display little, if any MMC sensitivity 
compared to Fancc
-/-
 or Helq
gt/gt
;Fancc
-/-
 cells.  Cells were treated with the indicated 
doses of MMC for 5 days prior to analysis.  Error bars show either the binomial error of 
the combined data set (B, D) or the SEMs for at least three independent experiments (E).  
Significance was determined by either 2-test (B, D) or t-test (E).  Statistical significance 
at p<0.05, p<0.01, and p<0.001 is indicated as *, ** and ***, respectively.  WT, H
gt/gt
, 
Fac
-/-
 and H
gt/gt
;Fac
-/-
 refer to wildtype, Helq
gt/gt
, Fancc
-/-
, and Helq
gt/gt
;Fancc
-/-
 
respectively. 
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Figure 5 
A combined loss of Helq and Fancc greatly alters the distribution of replication fork 
speeds and leads to increased levels of RPA/H2AX foci.  (A) Box plots show the range 
of fork speed values for the four genotypes.  The line through the middle of the shaded 
box represents the median while the “+” sign shows the location of the mean (values 
shown at bottom along with the number of tracts, N, analyzed).  (B) Separating fork 
speed values into slow, mid and fast forks reveals statistically significant differences 
among the ratios of the four genotypes (p<0.001, 2-test).  Error bars show the binomial 
error.  (C) Shown are representative images of cells from all four genotypes co-stained 
for RPA (green) and γH2AX (red).  Nuclei were stained with DAPI (blue).  For RPA foci 
analysis, cells were pre-extracted prior to fixation using a 0.5% Triton X-100 solution.  
Scale bar is 10 µm.  (D) The average percentages of cells positive for RPA foci (top) or 
RPA/γH2AX co-localization events (bottom) are shown.  Error bars show the binomial 
error for the combined data set.  Statistical significance (determined by 2-test) at p<0.01 
and p<0.001 are indicated as ** and ***, respectively.  WT, H
gt/gt
, Fac
-/-
 and H
gt/gt
;Fac
-/-
 
refer to wildtype, Helq
gt/gt
, Fancc
-/-
, and Helq
gt/gt
;Fancc
-/-
 respectively. 
 
Figure 6 
Helq suppresses multiple forms of spontaneous genome instability in a manner that is not 
epistatic with Fancc, while Helq
gt/gt
 cells show levels of recombination comparable to 
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wildtype.  (A) Shown are representative images of binucleated cells with or without 
micronuclei (MN, indicated by white arrows).  Nuclei and MN were stained with DAPI 
(blue).  Scale bar is 10 µm.  (B) Shown are the average percentages of binucleated cells 
positive for spontaneous MN (left) or MMC-induced MN (right).  For the latter, the 
levels for the untreated condition are shown in gray with numbers in the white box 
showing the increase after MMC treatment.  At least three independent experiments were 
performed and a total of >900 cells were observed per experimental group.  (C) 
Simultaneous disruption of Helq and Fancc results in a significant increase in 53BP1-
NB.  Shown are representative images of binucleated cells with or without nuclei positive 
for 53BP1-NB (red).  Nuclei were stained with DAPI (blue).  Scale bar is 10 µm.  (D) 
Shown are the average percentages of nuclei positive for 53BP1-NB.  (E) A histogram 
detailing the number of 53BP1-NB per nucleus is shown.  Four independent experiments 
were performed and a total of >750 cells were observed per experimental group.  (F) No 
significant difference in the number of HR events was detected between wildtype and 
Helq
gt/gt
 MEFs as measured by the FYDR transgenic locus system.  Shown are the 
average numbers of EYFP
+
 recombinants per 10
6
 cells analyzed.  Scale bars in (B,D) 
show the binomial error of the combined data sets while those in (F) show the SEMs for 
data obtained from at least 7 different embryos per genotype.  Statistical significance was 
determined by either 2-test (B,D) or t-test (F).  p<0.05, p<0.01 and p<0.001 are 
indicated as*, ** and ***, respectively. WT, H
gt/gt
, Fac
-/-
 and H
gt/gt
;Fac
-/-
 refer to 
wildtype, Helq
gt/gt
, Fancc
-/-
, and Helq
gt/gt
;Fancc
-/-
 respectively. 
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Table 1 
Trait Wildtype Helq
gt/gt
 Fancc
-/-
 Helq
gt/gt
;Fancc
-/-
 
Sub-lethality - - + + 
Growth retardation - - + ++? 
Tumor - - -
53 
N.D. 
Hypogonadism - + ++ +++ 
MMC sensitivity - +/- ++ +++ 
MN formation - + ++ +++ 
53BP1-NB formation - - + ++ 
HR (measured by FYDR) - - N.D. N.D. 
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Supplementary table and figure legends 
Supplementary Table S1 
Helq
gt/gt
 males are fertile, producing about the same average litter size as Helq
gt/+
 males. 
 
Supplementary Table S2 
Helq
gt/gt
 mice are born in the expected Mendelian ratio but Fancc
-/- 
mice show sub-
lethality. 
 
Supplementary Figure S1 
Structure of the Helq
gt
 allele.  (A) A diagram (drawn to scale) depicting the insertion of 
the gene-trap vector (pGT0Lxf) into the mouse Helq locus is shown.  Exons are shown as 
rectangles and the coding region is filled with black.  The region corresponding to the 
DEAD/DEAH box is indicated by the thick double-sided arrow.  The gene-trap vector 
consists of the En2 (engrail 2) intron and the subsequent splice acceptor site (SA), as well 
as a -Geo reporter gene followed by a polyadenylation signal (pA).  (B) PCR using 
genomic DNA from Helq
gt/gt
 mice reveals the insertion of the gene-trap vector (8.6kb) 
within the intron between exons 11-12.  Sequencing chromatograms are shown with the 
shaded area highlighting sequence from the vector.  Primer pairs p1 & p3 and p5 & p6 
indicated in (A) were used to map the beginning and end of the insertion, respectively.  
Right after the end of the vector insertion, a 13-bp sequence in the intron was replaced 
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with an 8-bp sequence of unknown origin.  (C) RT-PCR on total RNA from testes shows 
the presence of the wildtype (with exons 11 and 12) and chimeric transcripts.  The 
sequencing chromatogram on the left is sequence from the wildtype transcript showing 
the junction between exons 11 and 12 (amplified with primers p1 and p2).  On the right is 
the sequence of the junction between exon 11 and the vector amplified using primers p1 
and p4.  Shaded areas indicate the end of the exon 11 sequence.  Information on all 
primers is available upon request. 
 
Supplementary Figure S2 
Helq
gt/gt
 mice are normal in size but display a significant reduction in testes size.  (A) 
Shown are the average body weights of mice from the four genotypes at the age of testes 
analysis (6 weeks of age).  (B) Shown is the average testes weight as a percentage of total 
body weight for the four genotypes.  Bars in (A) and (B) show the SEMs for  5 mice. 
Statistical significance (determined by t-test) at p<0.05, p<0.01 and p<0.001 are indicated 
as *, ** and **, respectively.  WT, H
gt/gt
, Fac
-/-
, H
gt/gt
;Fac
-/-
 refers to wildtype, Helq
gt/gt
, 
Fancc
-/-
, Helq
gt/gt
;Fancc
-/-
, respectively.  (C) The mosaic pattern of seminiferous tubules 
is more apparent in testes of Helq
gt/gt
 mice at 3 weeks of age.  Shown are H&E images of 
whole testis (top) and seminiferous tubules (bottom) from widltype (WT) and Helq
gt/gt
 
mice.  Scale bars are 1500 m for the whole testis sections and 75 m for the enlarged 
images. 
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Supplementary Figure S3 
Helq
gt/gt
 cells show normal levels of FANCD2 and FANCI focus formation in prophase.  
Shown are the average percentages of cells positive for 2 FANCD2 (A) or FANCI (B) 
foci at prophase.  Prophase cells were identified as those which displayed bright staining 
for phospho-Histone H3 (Ser10) and had not yet proceeded to prometaphase.  APH 
treatment was 150 nM for 24 hrs.  MMC treatment was 1.2 M for 2 hrs followed by 22-
hr recovery in fresh media.  Experiments were repeated twice with different MEF lines.  
At least 140 prophases were scored per experimental group.  Bars show the binomial 
error for the combined data set. 
 
Supplementary Figure S4 
HELQ depletion causes only mild MMC sensitivity compared to FA core complex-
depletion/deficiency in human cell lines.  (A) Western blotting shows that siRNA pools 
targeting HELQ (siHELQ) and/or FANCA (siFANCA) efficiently deplete HELQ and 
FANCA, respectively, to sub-detectable levels in HEK 293T cells, while a control siRNA 
pool (siCONT) has no effect.  (B) Depletion of HELQ does not confer MMC 
hypersensitivity in HEK 293T cells.  Shown are the results of two independently 
performed colony formation assays at the indicated doses of MMC.  Treatment with 
MMC was for 2 hours, followed by a one-week culture period.  (C) Shown are 
representative images of metaphase spreads from HEK 293T cells following 24 hours 
treatment with 300nM MMC.  Enlarged images show representative radial structures 
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observed in the siFANCA (bottom left) and siHELQ;siFANCA (bottom right) samples.  
Scale bar is 10 µm.  (D) FANCA depletion, but not HELQ depletion, leads to a 
statistically significant increase in metaphase chromosomal aberrations in response to 
MMC.  Shown are the average percentages of metaphases positive for chromosomal 
aberrations (top) or radial structures (middle).  The average number of aberrations per 
metaphase is shown at bottom.  At least 40 metaphases were scored per experimental 
group.  (E) siHELQ efficiently depletes HELQ to sub-detectable levels in the PD331 (or 
PD331+FANCC complemented) cell lines, while siCONT has no effect.  (F) Depletion of 
HELQ confers modest MMC hypersensitivity in the PD331+FANCC cell line.  Shown 
are the results of two independently performed colony formation assays at the indicated 
doses of MMC.  Treatment with MMC was for 2 hours, followed by a two-week culture 
period.  (G) An MTT assay reveals that HELQ depletion further decreases the 
proliferation of PD331 (FANCC-deficient) cells, suggesting non-epistasis between HELQ 
and FANCC.  MMC treatment was for 5 days at the indicated doses.  A stained 
membrane was used as a loading control in (A,E).  Error bars in (B, F, G) show the SEMs 
for at least three independent experiments while those in (D) indicate the binomial error.  
Statistical significance was determined by either t-test (B, F, G) or 2-test (D).  
Significance at p<0.01 and p<0.001 are indicated as ** and ***, respectively. 
 
  Luebben et al., 2013 
203 
 
Supplementary Figure S5 
(A) A diagram depicting the DNA fiber assay is shown.  In this assay, ongoing 
replication forks are observed via the sequential incorporation of digoxigenin- (red) or 
biotin (green)-conjugated dUTPs.  Fork speed measurements are then made by measuring 
the distance between the start of the red tract to the start of the green tract.  (B) The 
distributions of fork speed values for the four genotypes are shown.  Slightly different 
patterns between the four genotypes result in statistically significant differences as 
measured by Kolmogorov-Smirnov test.  (p<0.001 indicated as ***).  WT, H
gt/gt
, Fac
-/-
, 
H
gt/gt
;Fac
-/-
 refers to wildtype, Helq
gt/gt
, Fancc
-/-
, Helq
gt/gt
;Fancc
-/-
, respectively. 
 
Supplementary Figure S6 
(A) qRT-PCR analysis using total RNA reveals that siHELQ was able to efficiently 
deplete both the wildtype Helq transcript (E 11-12, top) in wildtype MEFs as well as the 
chimeric mutant transcript (Chimeric, bottom) in Helq
gt/gt
 MEFs by ~70% compared to 
siCONT-treated cells.  Experiments were duplicated using RNA samples from different 
MEF lines to confirm reproducibility.  A representative qRT-PCR data set is shown.  (B) 
Western blotting shows that siHELQ depletes HELQ or HELQ
Δ
-β-Geo to sub-detectable 
levels in wildtype or Helq
gt/gt
 MEFs, respectively.  A stained membrane was used as a 
loading control.  (C) Depletion of HELQ
Δ
-β-Geo does not have any effect on the levels of 
spontaneous MN in Helq
gt/gt
 MEFs.  The average percentages of binucleated cells 
positive for MN are shown.  Experiments were repeated using different MEF lines so that 
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600 cells were observed per experimental group.  (D) Shown are representative images of 
binucleated cells with MN (stained with DAPI, blue) that are either positive for CENP-A 
staining (CENP-A+, red) or negative for CENP-A staining (CENP-A-).  White arrows 
point to MN.  Scale bar is 10 µm.  (E) Compared to WT cells, Helq
gt/gt
, Fancc
-/-
 and 
Helq
gt/gt
;Fancc
-/-
 cells display an increase in both types of MN in untreated conditions 
(left), but an increase of CENP-A- MN in Helq
gt/gt
 cells is not statistically significant.  
MMC treatment (600 nM for 2 hrs followed by 22-hr recovery) leads primarily to a 
higher number of CENP-A- MN (right).  (F) The average percentages of binucleated cells 
positive for MN are shown after CPT treatment (250nM for 6 hrs followed by 18-hr 
recovery).  The levels for the untreated condition are duplicated on the right in gray for 
better comparison.  Numbers in the white box show the increase above untreated 
conditions.  Experiments were repeated at least three times using different MEF lines so 
that >600 cells were observed per experimental group.  Error bars in (C, E, F) show the 
binomial error for the combined data set.  Significance (determined by χ2-test) at p<0.05, 
p<0.01, and p<0.001 are indicated as *, ** and ***, respectively.  WT, H
gt/gt
, Fac
-/-
 and 
H
gt/gt
;Fac
-/-
 refer to wildtype, Helq
gt/gt
, Fancc
-/-
, and Helq
gt/gt
;Fancc
-/-
 respectively. 
 
Supplementary Figure S7 
Helq
gt/gt
 cells do not display any significant changes in recombinant frequencies at the 
FYDR locus compared to wildtype cells.  (A) The FYDR transgenic locus contains two 
tandem repeats of incomplete eYFP expression cassettes (jagged lines indicate deleted 
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sequence information).  An HR event at this locus can restore eYFP expression following 
either of two different methods of resolution: gene conversion as the result of a non-
crossover event (top) or unequal sister chromatid exchange as the result of a crossover 
(bottom).  Using wildtype and Helq
gt/gt
 MEFs that carry this locus in the hemizygous state 
allows for the detection of HR events only during and/or after this locus has replicated.  
(B) Shown are sample flow cytometry plots from wildtype FYDR non-carrier MEFs (left) 
and wildtype hemizygous FYDR carrier MEFs (right).  eYFP signals were detected using 
the FL1-H and FL2-H channels and counted using the “R2” gate.  (C) The distributions 
of the number of eYFP
+
 recombinants (per 10
6
 cells analyzed) from are shown.  Two 
samples were excluded from the data as outliers (number of recombinants in the 
untreated condition >25). 
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Supplementary Table S1 
Cross Number of pairs Number of litters Average litter size 
Helq
gt/+
 female x Helq
gt/+
 male  4 5 7.60.75* 
Helq
gt/+
 female x Helq
gt/gt
 male 6 15 6.30.62* 
*No significant difference was observed between the average litter sizes by t-test. 
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Supplementary Table S2 
Genotype Fancc
+/+
 or Fancc
+/-
 Fancc
-/-
 Total number Expected number 
Helq
gt/+
 40 10 50 52.5 
Helq
gt/gt
 48 7 55 52.5 
Total number 88 17* 105  
Expected number 78.75 26.25*   
* The observed number of 17 was significantly different from the expected number of 
26.25 (p<0.05 2-test). 
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CHAPTER V: Final Discussion and Future Directions 
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Final discussion 
Dormant origins, genome instability and cancer 
 In contrast to previous studies, which suggested that dormant origins are only 
required under conditions of replicative stress
1-3
, our findings using the Mcm4
chaos3
 mouse 
model have clearly shown their integral role in chromosome stability and tumor 
suppression even in unchallenged conditions.  These functions are apparently achieved 
through two distinct mechanisms.  First, dormant origins can be activated adjacent to 
stalled forks as the simplest form of fork recovery.  This role overlaps with several 
different mechanisms, such as the FA pathway, which work in parallel.  Second, dormant 
origins also preclude the presence of long, origin-poor loci that would otherwise be 
unable to finish replication prior to mitosis.  This function is unique and cannot be fully 
compensated by other mechanisms. 
 This latter finding was made possible by closely investigating the intrinsic FA 
pathway activation that occurs in Mcm4
chaos3/chaos3
 cells.  In our original study (Kawabata 
et al., 2011) we assumed that the elevated number of FANCD2 foci in prophase was an 
indication of persistently stalled forks, as proposed by others
4,5
.  However, our later 
analysis (Luebben et al., 2014) clearly showed that this increase in FANCD2 foci can be 
attributed solely to those that co-localize with EdU incorporation.  This indicates that 
such sites are very late-replicating rather than completely stalled, and may remain 
unreplicated before chromosome segregation at anaphase.  We interpret this finding such 
that the ~60% reduction in chromatin-bound MCMs caused by Mcm4
chaos3
 homozygosity 
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results in long stretches of the genome that are devoid of any origins and cannot be 
replicated except by distant incoming forks. 
 These observations fit well with a pair of studies showing that fragility at the 
FRA3B and FRA16C loci is dictated by a paucity of origin initiation events
6
 or an 
inability to activate additional origins following fork stalling
7
, respectively.  It is thus 
easy to imagine how Mcm4
chaos3
 homozygosity could generate additional “fragile sites” at 
genomic regions where origin levels are already limiting.  Indeed, initial studies 
characterizing the Mcm4
chaos3
 model found a significant increase in chromosome breaks 
following APH treatment
8
.  Based on our findings, it will be important to determine if 
there is a significant correlation between site-specific fragility and the levels of 
chromatin-bound MCMs. 
Although the Mcm4
chaos3
 model represents a unique case, what it has taught us 
about dormant origins may have major implications toward our understanding of human 
cancers.  It is now understood that oncogene-induced replication stress, which disrupts 
normal DNA replication kinetics, is a major source of cancer-driving chromosome 
instability
9
.  This includes genetic changes that deregulate the G1/S transition, as seen in 
the majority of human cancers
10,11
.  It may therefore be that an accelerated G1/S 
transition during the early stages of cancer could leave the chromatin under-licensed
12,13
, 
leading to under-replication as seen in the context of Mcm4
chaos3
 homozygosity. 
As cancer cells progress into later stages, the expression of MCM proteins is very 
often upregulated to help them maintain their high proliferative status
14-16
.  Meanwhile, in 
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normal cells, entry into S phase is inhibited by a “licensing checkpoint” only when the 
number of licensed origins is extremely low (5-10% of normal levels)
17-20
.  Putting these 
ideas together, it is tempting to speculate that an acute, modest reduction in licensing 
could be used to selectively kill cancer cells.  In fact, it has been shown that licensing 
inhibition can achieve the efficient killing of cancer cells while having negligible effects 
on normal cells
17,21,22
.  Therefore, it seems likely that a temporary, substantial knockdown 
of MCMs could exploit the replication stress in late-stage cancer cells as an effective 
therapeutic strategy.  We believe the Mcm4
chaos3
 model provides a useful model to test 
this hypothesis. 
Finally, it is worth noting that mutations in human MCM4 were recently found to 
be responsible for a rare, recessive genetic disorder causing growth retardation, adrenal 
failure and natural killer cell deficiency
23-25
.  Cells derived from these patients were 
shown to display a higher number of chromosome breaks after treatment with replication 
inhibitors
25
, similar to what was seen in Mcm4
chaos3/chaos3
 cells
8
.  However, they also 
exhibited normal levels of chromatin-bound MCMs, suggesting that the causative 
mutations may confer a very different defect on MCM4 function.  We therefore think it is 
important for these patients to be carefully monitored for cancer development throughout 
their lifetimes. 
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A loss of dormant origins reveals roles of the FA pathway in stalled fork recovery and 
replication completion 
To determine the functional significance of the intrinsic FA pathway activation in 
Mcm4
chaos3/chaos3
 cells, we disrupted the FA pathway in this background via a null allele of 
Fancc (Fancc
-
).  As expected, Mcm4
chaos3/chaos3
;Fancc
-/-
 double mutant cells revealed a 
distinct, overlapping function of FANCC in the recovery of spontaneously stalled forks.  
This function proved to be even more important in the absence of HELQ or upon a 
reduction in the number of dormant origins, highlighting how cells utilize a multi-layered 
system to maintain fork progression.  Several studies have confirmed the FA pathway’s 
role in protecting stalled forks from breakage and MRE11-mediated degradation
26-28
, 
though how exactly this is achieved remains a mystery.  One possibility is that the 
binding of monoubiquitinated FANCD2/FANCI to stalled forks starting at mid-S phase 
simply provides a protective function until mitosis.  Another possibility is that the FA 
pathway plays a direct role in fork rescue/restart.  For example, the loss of FANCC could 
compromise the FA core complex’s unique role in stimulating efficient TLS29-31.  Recent 
work has also revealed that FANCD2 is required for BLM-mediated fork restart
32
, though 
the role of the FA core complex in this process has yet to be determined. 
Our studies have brought to light a novel, yet perhaps related function of the FA 
pathway: replication completion.  While recent work by Bergoglio et al. found that 
FANCD2 foci localized to mitotic EdU spots
33
, our study is the first to show that an 
increased number of EdU spots occurs in prophase cell nuclei when FA pathway 
activation is compromised.  This function was only revealed under conditions of 
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replicative stress, including a loss of dormant origins or low levels of APH treatment.  
This could perhaps be a manifestation of the FA core complex’s role in recruiting TLS 
enzymes, as deficiency for Pol η led to a similar increase in mitotic EdU spots33.  The 
authors of this study found that this was because Pol η was more efficient at synthesizing 
past difficult-to-replicate CFS sequences than the replicative polymerases.  It could also 
be that FANCD2 itself plays a yet underappreciated role in the recruitment of TLS 
enzymes
34
.  Finally, it was shown that FANCD2 displays in vitro nucleosome-assembly 
activity in response to ICLs
35
.  This function of FANCD2 might allow for replication to 
resume at late replication intermediates during the G2/M phases.  For now, more 
biochemical studies are needed to determine the precise role(s) of the FA pathway in 
replication completion. 
Finally, two recent studies revealed exciting new information that mitotic 
FANCD2 foci co-localize with the structure-specific endonucleases MUS81-EME1 and 
XPF-ERCC1
36,37
.  These groups found that down-regulation of these nucleases led to a 
lack of CFS breaks, and that this paradoxically increased the levels of genomic instability 
manifesting as MN, anaphase brides, UFBs and 53BP1-NBs.  Therefore, it appears that 
CFS breakage is a programmed cellular event in which unresolved replication 
intermediates can be enzymatically processed to prevent potentially more severe forms of 
genomic instability.  Seeing as FANCD2 localizes at these sites during mitosis and has 
been observed to regulate other nucleases
38-42
, it might have been easy to imagine the FA 
pathway as being necessary for this processing.  However, it was clearly shown that cells 
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deficient for FANCC had no defect in the mitotic localization of MUS81 or ERCC1
36
, 
indicating that the FA pathway likely doesn’t directly regulate this step. 
One very important question still remains.  How does the role(s) of the FA 
pathway in replication relate to the clinical phenotypes of FA?  Could under-replication 
be the underlying factor causing bone marrow failure or cancer predisposition?  
Intriguingly, it is now well-understood that CFSs occur in a cell type-specific manner
6,43
, 
suggesting that cellular differentiation programs might lead to certain chromosomal 
regions having a lower number of initiation events in certain cell types.  Indeed, we 
observed that double homozygosity for Mcm4
chaos3
 and Fancc
-
 led to extremely high 
perinatal lethality in an inbred C57BL/6J background, which has an intrinsically lower 
density of active origins
44
.  It is therefore tempting to postulate that perhaps 
hematopoietic stem cells could have a unique hyper-dependence upon the FA pathway to 
finish replication, the loss of which triggers cell death and manifests as bone marrow 
failure.  Furthermore, based on the accelerated tumor latency observed in 
Mcm4
chaos3/chaos3
;Fancc
-/-
 mice, it may be even more likely that this has a role in FA-
associated cancers, whereby the cell types in which malignancy originates (e.g. myeloid 
cells in AML, squamous epithelial cells in head and neck cancers) could also suffer from 
under-replication in the absence of the FA pathway. 
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HELQ plays an important role in suppressing replication-associated genome instability 
 After utilizing the Helq
gt
 mouse model to investigate the function of mammalian 
HELQ, one role that stands out is its requirement for the recovery of spontaneously 
stalled replication forks.  This role proved essential for the suppression of MN and 
53BP1-NBs and works in parallel to the FA pathway component FANCC.  These 
findings were in agreement with the study of Adelman et al.
45
, who reported that cells 
derived from the same mouse model (called Helq
ΔC/ΔC
 in their study) displayed a 
significantly higher number of MN as well as asymmetric replication tract lengths, a 
measure of fork stalling events.  Because this function can be observed under normal, 
physiological conditions, it may best explain the hypogonadism phenotype clearly 
observed by both groups.  So while HELQ is unlikely to be one of the unassigned 
complementation groups of FA, it may still have very important roles in human health, 
such as that described recently for REV7
46
.  Future studies investigating why certain stem 
cell types are prone to replication-associated genome instability will be very important to 
understanding both the role of HELQ and the clinical manifestations of FA. 
 
The roles of HELQ in ICL repair, HR and tumor suppression remain unclear 
While Adelman et al. reported on the characterization of the exact same Helq 
mouse model, a third study by Takata et al. investigated the role of human HELQ using 
knockout cell lines
47
.  In general, both groups uncovered many findings very similar to 
ours, including HELQ’s role in ICL resistance and germ cell maintenance, with 
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Helq/HELQ being non-epistatic to Fancd2/FANCD2 for either phenotype.  In addition to 
our data, both studies also identified interacting partners of HELQ by mass spectrometry, 
including ATR, RPA, the FANCD2-FANCI heterodimer and the RAD51 paralogs, which 
are required for efficient HR
48-51
. 
Despite these similarities, there were also several discrepancies between these 
three studies that merit closer examination.  First, there were marked differences in the 
extent to which Helq/HELQ deficiency was reported to confer ICL hypersensitivity.  
While we showed that both Helq
gt/gt
 cells as well as HELQ siRNA-treated human cells 
were only modestly sensitive to MMC, Adelman et al. reported striking hypersensitivity 
in the very same mouse model as well as with siRNA-treated human cells.  Using their 
knockout human cell lines, Takata et al. reported modest hypersensitivities that seem to 
more closely resemble our findings.  Together, it appears that HELQ probably does not 
play a major role in ICL repair in mammals, acting only as a backup to the FA pathway. 
 A second major difference can be seen in regards to HELQ’s role in HR.  
Adelman et al. provided multiple lines of evidence to suggest that HELQ is an important 
HR factor, including the persistence of MMC-induced DSBs in Helq
ΔC/ΔC
 cells, reduced 
HR efficiency in HELQ siRNA-treated human cells as measured by a GFP reporter assay 
and the hypersensitivity of both cell types to poly-ADP ribose polymerase (PARP) 
inhibitors, a signature of HR-deficient cells
52,53
.  On the contrary, our in vivo analysis 
using the FYDR transgenic locus system clearly showed that the absence of Helq does not 
overtly affect spontaneous or damage-induced HR levels in mice.  In addition, the human 
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HELQ knockout cell lines used by Takata et al. did not show any reduction in the levels 
of spontaneous or MMC-induced sister chromatid exchange, a measure of crossover 
events resulting from HR.  Together with the fact that, unlike Helq, most major HR genes 
are embryonic lethal in mice
54
 and that Helq
gt/gt
 males do not exhibit any meiotic defect, 
it is very difficult to imagine Helq/HELQ being a major HR gene at this time.  A minor or 
backup role of HELQ should be tested in the future. 
Finally, in contrast to our finding that Helq
gt/gt
 mice exhibit no observable cancer 
phenotype, Adelman et al. reported that the same mouse model in their hands displayed a 
significant number of ovarian tumors and pituitary adenomas.  Upon closer examination, 
however, this phenotype was actually very mild as the vast majority of the mice exhibited 
tumor-free survival beyond 500 days of age.  Furthermore, a significant fraction of the 
wildtype mice in their study exhibited the same types of tumors at reduced frequencies.  
The fact that their mouse model was maintained in a mixed genetic background rather 
than a pure, inbred background like the C57BL/6J background we used could also 
explain some of the discrepancies between our studies.  Still, a possible tumor 
suppressive role of HELQ in humans should not be overlooked as many FA genes which 
have little effect on mouse tumorigenesis
55
 are found mutated in several sporadic human 
cancers
56
.  Indeed, multiple genome-wide association studies have already identified 
SNPs in HELQ that are associated with upper-aerodigestive tract cancers and head and 
neck cancers
57-61
. 
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The frequency of EdU spots, not MN, correlates more closely with cancer development 
 One thought-provoking observation from these studies is the lack of correlation 
between MN and cancer development.  For example, while Fancc
-/-
 (and especially 
Helq
gt/gt
;Fancc
-/-
) MEFs exhibited even higher MN frequencies than Mcm4
chaos3/chaos3
 
cells, these mice did not display any significant tumor phenotypes.  This is interesting as 
the Mcm4
chaos3
 allele was originally identified in a genetic screen for increased levels of 
MN in erythrocytes with the idea that such chromosome instability might be an accurate 
marker of cancer susceptibility
62
.  Since then, other studies have suggested that the 
defective replication and reintegration of micronucleus DNA could be a significant driver 
of the aneuploidy and/or chromosome pulverization observed in cancer
63
.  However, our 
results in mice do not support this. 
Rather, what distinguished Mcm4
chaos3/chaos3
 cells from others was the number of 
late-replicating loci, manifesting as EdU spots in prophase.  It is thus tempting to 
speculate that an inability to finish replication at these sites could lead to deletions in the 
resulting daughter cells, which may not otherwise be detected by the MN or 53BP1-NBs 
assays.  Over time, such deletions could lead to the loss of tumor suppressor genes or 
cause other genetic alterations that drive Mcm4
chaos3
 tumorigenesis. 
 
   
231 
 
Future directions 
What are the consequences of late-replicating loci? 
 Our findings indicate that the cancer phenotype of Mcm4
chaos3/chaos3
 correlates 
better with an increased number of EdU spots rather than an increase in MN per se.  This 
suggests that late-replicating/un-replicated regions may lead to a different form of 
genomic instability that has serious consequences for cancer progression.  We have 
begun to test this by developing a series of pulse-chase experiments to determine the fate 
of late-replicating regions after prophase.  By treating cells with a 10 minute pulse of 
EdU labeling and then waiting 90 minutes prior to fixation, we found that EdU detection 
could be achieved on metaphase spreads.  Strikingly, we found that EdU spots can often 
be observed to co-localize at chromosome breaks and radial structures.  Importantly, the 
frequency of such events was significantly elevated in Mcm4
chaos3/chaos3
 and 
Mcm4
chaos3/chaos3
;Fancc
-/-
 mutant cells, and the majority of breaks in APH-treated cells 
contained EdU staining.  Furthermore, dual labeling with fluorescent probes targeting 
mouse-specific fragile sites shows that a number of EdU-associated breaks occur at these 
sites.  These preliminary findings strongly indicate that late-replicating regions, rather 
than stalled forks per se, are the major precursor to chromosome breakage at CFSs, in 
agreement with recent findings
36
. 
 We have also utilized EdU pulse-labeling to determine the relationship between 
EdU spots and G1 phase markers of chromosome instability, namely MN and 53BP1-
NBs.  After a 10 minute pulse-labeling with EdU, cells were given 4 hours to progress 
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into G1 phase.  G1 phase nuclei were then easily identified as those contained within 
binucleated cells using a protocol similar to the cytokinesis-block MN assay.  Punctate 
EdU spots were observed in wildtype, Mcm4
chaos3/chaos3
, Fancc
-/-
 and 
Mcm4
chaos3/chaos3
;Fancc
-/-
 cells in similar ratios to those observed at prophase.  However, 
the vast majority of these spots did not reside in the MN or 53BP1-NBs of these cells, 
suggesting that the majority of either of these markers do not arise directly from late-
replicating/un-replicating regions.  In addition, it is possible that EdU spots could 
manifest as a different form of genomic instability all together, like large deletions.  
While not as easily detectable as MN and 53BP1-NBs, such significant losses of genetic 
information could have a much greater effect on driving Mcm4
chaos3
 tumorigenesis.  
Future studies using array-based comparative genomic hybridization technology may be 
able to adequately address this intriguing possibility. 
 
What are the distinct functions of the FA core complex and FANCD2? 
 Although the FA pathway is usually described as being one linear pathway, there 
is an abundance of evidence to suggest otherwise.  As additional interactions and 
functions are identified for each component, this pathway grows more and more complex, 
blurring our understanding of what FA pathway functions correspond to FA disease 
phenotypes.  For example, one study reported that the levels of genomic instability are 
higher in Fancd2
-/-
 mice when compared to Fancg
-/-
 mice, and that double homozygosity 
for these alleles results in embryonic lethality
64
.  Therefore, distinguishing the separate 
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roles of individual FA pathway components is essential for us to more fully understand 
the FA pathway’s role in genome stability. 
 One important study that could be done would be to test the effects of Fancd2 
nullizygosity in a Mcm4
chaos3/chaos3
 mutant background, as we have done for Fancc.  This 
would allow us to determine if the fork recovery mechanism performed by FANCC is 
mediated by FANCD2 or if it involves a distinct pathway (like FA core complex-
stimulated TLS).  We have already used such a strategy to test the genetic interaction 
between Mcm4
chaos3
 and Brca2
Δ27
, a hypomorphic truncation allele of Brca2
65
, revealing 
a synthetic lethal interaction between the two.  It would be interesting to see if 
Mcm4
chaos3/chaos3
;Fancd2
-/-
 mice are viable in a C57BL/6J inbred genetic background and 
if their tumor latency is significantly different than that of Mcm4
chaos3/chaos3
;Fancc
-/-
 mice. 
 
Is HELQ part of the downstream FA pathway? 
 Our data clearly indicate that HELQ is dispensable for FANCD2 
monoubiquitination and is unlikely to be part of the FA core complex.  However, this 
does not rule out the possibility of HELQ being a part of the downstream FA pathway.  
This would not be difficult to imagine seeing as the majority of the downstream FA 
members play a critical role in HR and that multiple studies (excluding our own) have 
implicated HELQ as either playing a role in HR
45,66-68
 or associating with HR factors
45,47
.  
As a preliminary investigation, we have recently generated mice doubly mutant for the 
Helq
gt
 and Brca2
Δ27
 alleles to test for epistasis.  Thus far, the data indicate that the two 
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are non-epistatic for germ cell maintenance as well as suppressing replication-associated 
genome instability (MN and 53BP1-NBs).  Although this does not completely rule out a 
potential role of HELQ in HR, this coincides with all our previous findings that HELQ is 
unlikely to be an essential HR factor or to function within the FA pathway. 
 
Does Helq have any significant tumor-suppressive role in mice? 
 Because Helq
gt/gt
 mice did not exhibit any tumor phenotype in our hands, we 
hypothesized that a more sensitized background, such as Mcm4
chaos3
 homozygosity, might 
reveal a significant tumor suppressive role of Helq, much like it did for Fancc.  However, 
our preliminary results clearly show that Mcm4
chaos3/chaos3
;Helq
gt/gt
 double mutants do not 
display any significant difference in tumor latency compared to Mcm4
chaos3/chaos3
 single 
mutants.  These data make it more difficult to implicate Helq as having a significant role 
in suppressing murine tumorigenesis at this time. 
 
Can manipulation of HELQ activity provide a therapeutic benefit for FA patients? 
 Though it appears unlikely that HELQ is another FA gene, our findings do 
provide an intriguing possibility that it could be a therapeutic target for treating FA, as 
HELQ should be present in the cells of FA patients and work in parallel to the FA 
pathway to maintain genome stability.  Our data suggest that down-regulation or 
disruption of HELQ as a method of killing cancer cells in FA would probably not be an 
   
235 
 
effective strategy, as Helq
gt/gt
;Fancc
-/-
 cells were fully viable and exhibited even greater 
genomic instability.  However, strategies to up-regulate HELQ expression have potential 
to mitigate genomic instability in FA patient cells, as HELQ is normally so lowly 
expressed in humans
69
.  Importantly, it seems unlikely that this would have any negative 
effect on cells.  Transfecting FA patient cells with a robust HELQ expression vector and 
measuring its effects on genomic instability would be an effective first step in testing this 
possibility.  Finally, it should be investigated whether the proteins found to interact with 
HELQ (such as the RAD51 paralogs) are also needed for stalled fork recovery in a 
manner that is non-epistatic to FA pathway members, as these also could be targeted for 
therapeutic benefit. 
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